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ABSTRACT
STUDY OF THE MECHANISM OF ACTIVATION OF THE CARDIAC THIN
FILAMENT
CHRISTOPHER SOLIS OCAMPO
2016
Heart disease is the leading cause of death in the United States. Understanding
heart function at the molecular level is critical for developing of more effective
treatments. In the cardiac muscle, the thin filament is composed by troponin (Tn),
tropomyosin (Tm), and F-actin. It provides Ca2+-dependent regulation of contraction by
modulating myosin attachment and force generation in a cooperative scheme. However,
this mechanism remains unclear. To understand thin filament activation, we studied the
binding and functional properties of Tn and Tm to F-actin at single particle resolution by
employing fluorescence image colocalization, in vitro motility assays, and Förster
resonance energy transfer based on fluorescence lifetime imaging (FLIM-FRET). Our
results suggest that under physiologically relevant conditions, Tn and Tm binding to Factin is not cooperative and it is not affected by Ca2+. This suggests that one single type
of interaction is involved in fully regulated thin filaments. Thin filament activation has
been confirmed by in vitro motility assays, where phosphorylation of serine 23 and 24 in
TnI, truncation of TnT C-terminal region, and incorporation of a Ca2+ desensitizer altered
the Ca2+ response to filament sliding. FLIM-FRET measurements revealed an allosteric
dependence on thin filament activation as a function of myosin and Ca2+. Our results
provide evidence of multiple allosteric elements within thin filaments responsible for the
molecular modulation of cardiac muscle activation.
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CHAPTER I
HISTORICAL PERSPECTIVE ON THE MOLECULAR
MODELS OF THE CARDIAC MUSCLE CONTRACTION

1.1 Abstract
This chapter describes the development of the working mechanism of the cardiac
muscle from a historic perspective. This review underscores that a unifying theory of
contraction of striated muscle has yet to be defined. Cardiovascular diseases represent the
leading cause of death in the United States. Heart disease can be caused by single point
mutations within cardiac muscle proteins that alter normal cardiac function at the
molecular level. Therefore, understanding the molecular foundations of cardiac muscle
function may facilitate the development of novel treatments for cardiovascular disease.
This review will cover the milestones achieved from the early physiological studies to the
contemporary molecular-scale observations and analytical models of muscle activation. I
will describe the molecular implications of the steric blocking model, the two-state
allosteric model of regulation of thin filaments, the three-state blocking model, and the
regulatory role of troponin (Tn) and tropomyosin (Tm) in these models. I will describe
recent advances in the development of mathematical models of activation and relaxation
of the thin filaments. Finally, I will explain the research problem that motivated my
research work, which is centered in the resolution of an experimental model of activation
of thin filaments based on single particle analysis of thin filaments.
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1.2 The Early Days of Cardiac Muscle Research
The Frank-Starling Law of the Heart
By the first half of the 20th century, the state of knowledge on the working
mechanism of the cardiac muscle lacked of a structural basis. Most of the progress came
out of physiological studies developed by German scientists and later by English
scientists (Katz, 2002). Early observations of increments in the venous pressure were
found to produce larger blood outflow from ventricles (Howell & Donaldson, 1884;
Takeda, Yamashita, Maeda, & Maeda, 2003). At the muscle fiber level, increments in
muscle tissue stretching produced larger contractile forces and consequently larger
ventricular volume ejections (Evans & Hill, 1914). In other words, this mechanism
described an underlying feedback control system in the heart that depended solely on the
hydrodynamic load (Figure 1) (Starling, 1918). This became to be known as the FrankStarling Law of the Heart and represented the first well-accepted theory of the
physiological activation of the cardiac muscle (Moss & Fitzsimons, 2002).

Early anatomic descriptions and discovery of proteins within the sarcomere
Although this principle remains consistent through many different studies, a
fundamental description of the underlying process was and continues to be absent. Most
of the key structural information came from early studies in polarization microscopy
(Galler, 2015). Imaging of muscle fibers trough polarization microscopy revealed
periodic anisotropic (A) and isotropic (I) bands oriented perpendicularly to the muscle
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fiber grain (Figure 2). Krause’s (1869) work (as cited in Galler, 2015) was the first to
mention that muscle stretching caused the I band to contract with no change in the A
band. Even though, this evidence could explain muscle contraction, its relevance was not
immediately recognized (Galler, 2015).
A major leap came from the elucidation of the constituent proteins of striated
muscle. Myosin was purified by Kühne (1864) (as cited in Szent-György, 2004) and it
was further characterized by the Nobel Laureate Albert Szent-Györgyi (Szent-Györgyi,
2004). Actin was discovered by Straub (1942) (as cited in Kabsch, 1990) and actin was
found to produce viscous solutions in presence of myosin, but the process was reversed
by incorporation of ATP (Kabsch, Mannherz, Suck, Pai, & Holmes, 1990). The
regulatory proteins, tropomyosin (Tm) and troponin (Tn), were discovered by Bailey
(1946) (as cited in Bailey 1948) and Ebashi (1965), respectively (Bailey, 1948; Ebashi &
Kodama, 1965). This marked the beginning of the biochemical period of muscle research.
These studies depended largely on the ATP catalytic activity of myosin or ATPase
activity. This ATPase activity is catalyzed by the presence of F-actin and inhibited by Tn
and Tm. At this point very little was known about the internal organization of these
proteins in the muscle. It was thought that the mechanism behind muscle contraction
would involve the coiling and extension of myosin during each muscle stretch (SzentGyorgyi, 1974).
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Figure 1.1. The Frank-Starling Law of the heart. The Frank-Starling Law dictates a
direct relation between the left ventricle end diastolic pressure (LVEDP) and the
stroke volume (SV). Assuming that each figure depicts the end diastolic volume of the
heart, after the sinoatrial contraction is triggered the heart will further contract during
systole. The SV produced during systole will vary depending on the initial stretching
state of the ventricle walls; in other words, the diastolic blood flow pressure to the left
and right ventricles (right and left asterisks respectively). Thus, highly stretched
ventricle walls (case 3) will develop a much larger SV than in low stretched ventricles
(case 2) or a intermediate stretching level (case 1) (C. Solis Ocampo).
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1.3 The Elucidation of the Striated Muscle Ultrastructure and the Sliding Filament
Model
Even though the main components of muscle were identified, there was a lack of
consensus on the interplay of all the proteins in a cellular context. Hugh E. Huxley (1953)
studied the X-ray diffraction properties of frog muscles where hexagonal mosaic patterns
were found in perpendicular to the muscle fiber orientation (Hanson & Huxley, 1953). In
combination with electron microscope measurements, it was possible to assign the
location of actin and myosin to the thin and thick filaments, respectively. The
interdigitated architecture of the muscle structure suggested that actin belonged to the
thin filament and myosin to the thick filament; thus, muscle contraction was caused by
actin and myosin sliding in opposite directions causing shortening of the I band due to
increased overlapping (Figure 1.2). This is known as the sliding filament model (Hanson
& Huxley, 1953). Reedy et al. (1965) observed the orientation of myosin heads in relaxed
(no Ca2+ and ATP) and rigor (no Ca2+ nor ATP) states presenting tilting angles of 90 and
45 º respectively (Reedy, Holmes, & Tregear, 1965). The rigor state resembles the muscle
condition after death where ATP is depleted and the muscle is highly stiff due to a
maximal number cross-bridges between actin and myosin. This observation led to
propose a swinging cross-bridge model of muscle activation (Huxley, 1969). However,
this model failed to explain how myosin tilting (~5 nm displacement) is enough to induce
full shortening of muscles in vivo.
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Figure 1.2. Hierarchical organization of the cardiac muscle. Muscle fibers are composed of
single cells interjoined longitudinally by intercalated disks. Each muscle fiber contains multiple
myofibrils compossed by alternated actin and myosin filaments. I bands are composed by thin
and thick filaments; conversely, A bands are composed by thin filaments. The sarcomere is
stabilized by the Z-disc, which anchors thin filaments; and the M line that holds thick filaments.
Titin spans half sarcomere and it is responsible for maintaining thin and tick filaments in
register (C. Solis Ocampo).
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1.4 The Regulatory Proteins Troponin and Tropomyosin and the Steric Blocking
Model
Troponin, Ca2+ binding and the steric hindrance model
Although the swinging cross-bridge model explained structural data, there was a
gap in how Ca2+ intervened in muscle regulation. It is important to notice that Ca2+dependent muscle regulation can be studied from two perspectives: (i) cytosolic
regulation of free Ca2+ and (ii) thin filament-mediated regulation of Ca2+ binding (Ebashi,
1963; Ebashi & Ebashi, 1964; Ebashi & Kodama, 1965; Ebashi & Lipmann, 1962;
Weber, Herz, & Reiss, 1963). From the Cold Spring Harbor Symposia, a better picture of
the process of muscle regulation emerged and the steric blocking model was proposed.
This model suggests that Tm occupies axial binding sites in actin filaments. When Tn
binds Ca2+, Tm position shifts azimuthally enabling myosin and actin activation, and
subsequent force production (Robert D. Bremel, Murray, & Weber, 1973; R. D. Bremel
& Weber, 1972; Cohen et al., 1973; Haselgrove, 1973; Spudich, Huxley, & Finch, 1972).
At this time Tn was recently discovered from the delaying effect of Tn extracts on
the aggregation of actin and myosin in the absence of Ca2+ (Ebashi & Kodama, 1965).
Subsequent studies determined that Tn consisted on a heterotrimer composed by troponin
C (TnC), troponin I (TnI), and troponin T (TnT) (Greaser & Gergely, 1971). The capital
letters I, C, and T correspond to the Ca2+ binding, inhibitory, and tropomyosin binding
properties respectively (Gordon, Homsher, & Regnier, 2000). Tn intra-heterotrimeric
interactions with Tm and F-actin were subsequently characterized and this allowed to
establish the basic structure of the thin filament (Potter & Gergely, 1974).
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In the 1990s, the steric blocking model experienced an upgrade in light of
controversial physiological and biochemical results. First, when fibers of thin filaments
were exposed to myosin subfragment 1 (S1) at low ATP concentrations (~1 µM) (R. D.
Bremel & Weber, 1972). Second, isometric force development measurements in cardiac
muscle fivers developed force at sub-saturating Ca2+ levels by incorporating myosin S1NEM, which is a strong binding analog of myosin S1 without ATPase activity
(Fitzsimons, Patel, & Moss, 2001; Swartz & Moss, 1992). Third, substantial amount
myosin S1 in presence of ATP associated to thin filaments regardless of the free Ca2+
concentrations; only the ATPase activity depended on the free Ca2+ concentrations (J M
Chalovich & Eisenberg, 1982; Tobacman & Adelstein, 1986). Fourth, myosin
subfragment-1 (S1) binding experiments demonstrated three different binding affinities
for rAc as a function of Ca2+ and ATP concentrations (McKillop & Geeves, 1993). Fifth,
electron microscopy measurements resolved the existence of three different azimuthal
positions by tropomyosin while binding to F-actin and Tn (Vibert, Craig, & Lehman,
1997; Xu, Craig, Tobacman, Horowitz, & Lehman, 1999). This accumulated evidence
justified the existence of a three-state model over a two-state steric blocking model
(figure 1.3) (Geeves & Conibear, 1995; McKillop & Geeves, 1993). Recent evidence
suggests that myosin strongly-bound states (i.e. rigor myosin, myosin.ADP.Pi, and
myosin.ADP) play a significant role in favoring closed to blocked transitioning in Tm
bound to F-actin (Behrmann et al., 2012).
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Figure 1.3. Models of the thin filament activation mechanism. The ilustration shows
the interactions between myosin and the thin filament depicted in a cross-sectional
representation. (A) In the two-state model, Ca2+ regulates the on/off state of the thin
filament by Ca2+ binding to Tn. In the blocked state all myosin affinity sites are
inhibited by Tm superimposition. Ca2+ binding favors Tm occupany of a differnet
azimuthal position in the F-actin surface that exposes myosin affinity sites in F-actin.
This step favors myosin binding to thin filaments wich promotes myosin strong
binding and ATPase cycle turnover. (B) In a three-state model Ca2+ binding promotes
Tm conformational shifting between the blocked and closed state. In the closed state a
limited number of affinity sites are exposed and myosin binds weakly to thin filaments
without ATPase activity. A conformational transition in myosin favors shifting of Tm
to the open state conformation. This Tm conformation exposess all the myosin affinity
sites in F-actin and favors ATPase activity. Adapted from McKillop and Geeves
(1993) and Behrmann et al. (2012).
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Regulation of muscle contraction and the role of allostery
In recent years, the focus has been devoted to resolve the allosteric mechanism of
activation of the muscle. The tight structural coupling between the sarcomeric proteins
that causes concerted response to ligand binding represents allostery in muscle.
Particularly, Ca2+ and strongly bound myosin states are most widely recognized allostery
effectors of muscle regulation. This evidence resides on the differential effects of
saturating and substaruating Ca2+ concentrations on the binding dynamics of strongly
bound myosin (Greene & Eisenberg, 1980; T. L. Hill, Eisenberg, & Greene, 1980).
Conversely, myosin ATPase activity is allosterically altered by the presence of the
regulatory units bound to actin filaments (S S Lehrer & Morris, 1982).
Resolution of the crystal structures of cardiac and skeletal Tn has expanded the
knowledge of the Ca2+-mediated regulation (Takeda et al., 2003; Vinogradova et al.,
2005). The resolution of myosin structure and thin filament components has increased the
structural detail of the muscle activation models (Behrmann et al., 2012; I Rayment et al.,
1993; I. Rayment et al., 1993). Knowledge of the absolute structure of thin filaments
during all the actomyosin cycle steps represents the long term goal of the muscle
regulation field. By solving these structural changes, the molecular implications of
inherited mutations present in thin and thick filament proteins can be established. A direct
benefit will be to rationally design drugs that act exclusively on these proteins in response
to inherited mutations. Current models of myosin activation highlight the active
contribution of elementary steps on the myosin ATPase cycle to the muscle affinity and
force development (Behrmann et al., 2012; Muretta, Rohde, Johnsrud, Cornea, &
Thomas, 2015; Wulf et al., 2016). However, questions such as the origin of the
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cooperative activation of the myofilament continue to remain un-addressed (Farman,
Allen, Schoenfelt, Backx, & de Tombe, 2010; Moss, Razumova, & Fitzsimons, 2004).
Allostery regulation by Tn is reflected in the strong functional communication
during Ca2+ binding. Cardiac TnC is responsible for binding Ca2+ and Mg2+ into three
different affinity sites: site II found in the N-terminal domain (N-lobe), and site III IV
found in the C-terminal domain (C-lobe) (Figure 1.4) (Gordon et al., 2000). Only site II
exchanges Ca2+ during each neurohumoral-activated cytosolic Ca2+ release (K~105 M-1).
The C-lobe is responsible for anchoring TnC to the Tn complex (Takeda et al., 2003). In
the C-lobe, site III and VI bind Ca2+ with higher affinity (K~107 M-1) and Mg2+
competitively (K~103 M-1) (Holroyde, Robertson, Johnson, Solaro, & Potter, 1980). Ca2+
binding to site II facilitates opening of a hydrophobic patch which is constituted by the
N-lobe helixes and the N-to-C lobe interlinking helix (Herzberg, Moult, & James, 1986).
However, opening of the hydrophobic patch depends on the binding of TnI switch region
located in TnI N-terminal domain (cardiac TnI residues 148-163) (Dong et al., 1999; M.
X. Li, Spyracopoulos, & Sykes, 1999). Conversely, in the presence of F-actin TnI Nterminal domain binds to F-actin through three affinity sites corresponding to the
inhibitory peptides I/II/III (cardiac TnI residues 128-148/172-180/193-210) (Figure 1.4)
(Galinska et al., 2010; Gordon et al., 2000; Tripet, Van Eyk, & Hodges, 1997). Thus
cardiac TnI N-terminal region is found in equilibrium bound to TnC, to F-actin, or any
state in between that represents free difussion of the peptide within the thin filament
microenvironment. This case ilustrates an example of allosteric communication within
the thin filament that cause conformational fluctuations in TnI N-terminal region due to
interactions with multiple protein interfaces and Ca2+ binding to TnC.
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Figure 1.4. The Tn complex. (A) TnC, TnI, and TnT are higlitted as ribbons (black) in
the Ca2+-free cardiac Tn model (transparent van der Waals envelope). TnC depicts the
N- and C-terminal lobes. TnI highlights the inhibitory peptides I/II/III (red) and the
switch peptide (SP, green) respectively. TnT depits the IT (upper) arm and the H1-T2
helix (lower). (B) The linear sequences indicate the amino acid (AA) position of each
α-helixe (black boxes), and the functional regions highlited in (A) in colored bars
(color preserved), the Ca2+ binding sites, and the TnI phosphorylation sites (serines
23/24). The location of each region is based on the Ca2+ bound state structure of the
cardiac Tn complex. The models in (A) and (B) are based on Manning et al. (2012)
and Takeda et al. (2003) in silico model and X-ray structure respectively (Manning et
al., 2011).
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Simlarly, allostery has been observed in Tm and it is considered to be responsible for thin
filament cooperativity. Tm head-to-tail connectivity is maintained by TnT T1 domain
wich spans two contiguos Tm (A. S. Mak & L. B. Smillie, 1981; White, Cohen, &
Phillips Jr, 1987). Since Tm was found to bind F-actin in parallel strands, models
considering neighborg Tm-Tm units were popossed early after the discovery of Tm
localization on F-actin (Tawada & Tawada, 1975). Tm can not only influence activation
of nearest –neighbor cooperative units, but also the effective number of open state F-actin
protomers (S. S. Lehrer & Geeves, 1998). Therefore, Tm cooperativity is defined by
neighbor Tm-Tm contacts and intra Tm activation of actin monomers (S. S. Lehrer &
Geeves, 1998). Originally the neighbor-Tm connectivity was considered to be stiff (T. L.
Hill et al., 1980). More recent models have accounted for the compliance in the Tm-Tm
contacts and the Tm rod itself (Mijailovich, Kayser-Herold, Li, Griffiths, & Geeves,
2012). Together with Ca2+-dependent activation in Tn, Tm and Tn define the activation
state of thin filaments and coordiante the attachmet strength of myosin during the crossbridge cycle.
Due to the close proximity of myosin heads in the sarcomeric environment myosin
activity is affected by allosteric processes occurring in the thin filament. It has been
recognized that the regulatory proteins Tn and Tm influence myosin catalytic activity
depending on the nucleotide binding state (R. D. Bremel & Weber, 1972). Generally,
rigor-like myosin (Myosin and ADP.Myosin) activates thin filaments in absence of Ca2+
(Metzger, 1995; Swartz & Moss, 1992). However this duality presents intermediate
affinities depending on the nucleotide bindign state (Geeves, 1991; Thompson, Naber,
Wilson, Cooke, & Thomas, 2008). Since the myosin ATPase cycle turnover depends on
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the access to open thin filament states (Figure 1.3), which strongly-bound myosins
accomplish, myosin activation is considered to be an activation-dependent process where
myosin cross-bridges retulate themselves (Moss et al., 2004). Since 20% of the myosin
heads can be found in a rigor statate during isometric contraction, this accesbility to the
thin filament open conformation is preserved by myosin itself (Ostap, Barnett, &
Thomas, 1995).

1.5 Analytical models of muscle activation
Analytical models have proven to be an insightful compliment to experimental
results. One of the first models captured the cooperative interactions occurring between
neighbor regulatory units (RU) established by Tn-Tm linkages (Tawada & Tawada,
1975). Hill et al (1980) introduced a comprehensive model that explained a vast number
of biochemical and physiological events. This model included Ca2+ bidding effects on
TnC (skeletal TnC binds two Ca2+ ions whereas cardiac Tn binds one Ca2+ ion), neighbor
Tn-Tm unit interactions, and a two-state (on/off) activation model for each RU (Gordon
et al., 2000; T. L. Hill et al., 1980). However, as stated earlier, accumulated experimental
results leaded to reformulation of thin filament activation into a three-state model (Figure
1.3) (McKillop & Geeves, 1993).
Although these mentioned models proved to be correct in the intermediate thin
filament environment, their predictions were not suitable translated into a whole cell
level. A number of models address these considerations by introducing neighbor crossbridge effects, neighbor RU effects, and neighbor RU to cross-bridge communication that
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facilitated a kinetic explanation of steady-state conditions (Razumova, Bukatina, &
Campbell, 2000; Rice & de Tombe, 2004; Rice, Winslow, & Hunter, 1999). These
models exploited the advantage of fully representing the number of regulatory units
present in a whole thin filament (Rice, Stolovitzky, Tu, & de Tombe, 2003).
More recent models have been extended to account for “imperfections” existing
in the contractile apparatus. One of these models studied the incorporation of discrete and
sparse localization of Ca2+ insensitive RUs within the thin filament lattice. This
consideration accounts for multiple phenotypic manifestations such as defective proteins
and sarcomeric protein mutations (Aboelkassem, Bonilla, McCabe, & Campbell, 2015).
A second line of models introduced elasticity (compliance) on thin and tick filaments to
recreate heterogeneities in cross-bridge detachment kinetics (Campbell, 2016; Tanner,
Daniel, & Regnier, 2012). These augmented considerations are clearly necessary to
explain essential tissue manifestations such as length-dependent effects (de Tombe et al.,
2010) and ultimately explain whole organ activation mechanics (Moss et al., 2004).

1.6 The Modulation of Cardiac Muscle Contractility
At the time even more refined models of muscle activation became available, it
was noticed that cardiac muscle activation could be tuned in response to specific factors.
One of these is epinephrine, which is responsible for increased sympathetic activity such
as increased heart rate during a fight-or-flight response. A major role of catecholamines
such as epinephrine is as an agonist of β-receptors (specifically β1 in the heart). Their
activation leads to increased secondary messengers such as cAMP that lead to faster Ca2+
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release/uptake kinetics and decreased sensitivity of Tn for Ca2+ (Ladage, Schwinger, &
Brixius, 2013). The decrease in Ca2+ sensitivity of the troponin complex is caused by
protein kinase A (PKA) phosphorylation of two serines (Ser23/24) in TnI in its Nterminal extension, causing faster Ca2+ release kinetics from TnC (S. P. Robertson et al.,
1982; R. J. Solaro, Moir, & Perry, 1976). In mice, genetic removal of the cardiac TnI Nterminal extension has shown to reduce Ca2+ sensitivity in a similar way to TnI
phosphorylation leading to deficiencies of β- adrenergic responses in heart failure
(Biesiadecki et al., 2010). Although these post-translational modifications such as
phosphorylation are part of the normal homeostatic state of the heart, other maladaptive
processes as well as missense mutations have shown to cause maladaptive changes in the
heart (Bayliss et al., 2013; Bristow et al., 1986). Therefore, it is important to understand
the specific molecular events involved in order to develop therapies and treatments for
heart failure (Papadaki, Vikhorev, Marston, & Messer, 2015).

1.7 Statement of the Research Problem
The motivation behind this project is to understand the molecular mechanisms of
biological functions through single particle analysis. Of particular interest to this work, it
is the underlying mechanism of assembly and function of the cardiac thin filament.
Conventional biochemical approaches rely on indirect measurements that may not reveal
the true nature behind biological processes. By combining microscopy and spectroscopic
techniques, an additional layer of elucidation is established. Due to the spontaneous
assembly of thin filament proteins into supramolecular assemblies larger than the
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diffraction limit of light, single particle analysis results suitable to interrogate these
biological structures. My general hypothesis is that thin filaments exhibit contrasting
functional properties compared to classic ensemble-based measurements. This work was
divided into four specific objectives corresponding to (i) study of Tn-Tm assembly on Factin, (ii) development of a noise-suppression algorithm to obtain accurate speed
estimates of regulated actin sliding on in vitro motility assays, (iii) study of the effect of
TnI and TnT intrinsically disordered regions on activation of thin filaments on in vitro
motility assays, and (iv) structural dynamics of TnI mobile domain as a function of Ca2+
and myosin activation state; these objectives correspond to Chapters II, II, IV, and V
respectively.
In Chapter II, I present the results of three-color colocalization microscopy of TnTm assembly into F-actin. I found that under physiologically relevant conditions Tn-Tm
binding to F-actin is non-random and insensitive to free Ca2+ concentration. In Chapter
III, I developed a Kalman filter to improve data acquisition from in vitro motility assays
(IVMA). I determined that the Kalman filter was able to suppress intrinsic noise present
during the image acquisition. In Chapter IV, I describe the application of optimized
IVMA analysis scheme to the study of intrinsically disordered regions (IDRs) in Tn.
Truncation of the C-terminal region of TnT, phosphorylation of TnI Ser23/24 in TnI, and
incorporation of EGCG affected filament activation state trough allosteric changes in Tn.
In Chapter V, I measured the FRET response of a donor-acceptor labeled Tn complex,
bound to thin filaments, to Ca2+ and myosin in a surface-deposited myosin surface.
Together, my data supports the hypothesis that that Ca2+ and myosin respond as allosteric
effectors of Tn activation within the thin filament microenvironment.
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CHAPTER II
ANALYSIS OF CARDIAC TRPONIN-TROPOMYOSIN
BINDING TO F-ACTIN BY FLUORESCENCE
COLOCALIZATION
1.1 Abstract
In cardiac muscle, troponin (Tn) and tropomyosin (Tm) associate to F-actin and provide
Ca2+-dependent regulation of contraction. Isometric contraction of cardiac muscle fibers
demonstrates that Ca2+ activation is a highly cooperative process, presumably caused by
Tn, Tm, and F-actin specific arrangement within the thin filament. Current structural
models lack a complete molecular description of the Tn-Tm-F-actin binding interphase.
This gap limits our ability to associate functional steps to structural changes during
muscle contraction. Here, we characterized the binding of Tn-Tm to F-actin under near
physiological conditions by direct visualization of reconstituted three-color-fluorescently
labeled regulated actin (rAc) filaments. Tn, Tm, and F-actin were labeled with Alexa
Fluor 546, ATTO655, and phalloidin-Alexa Fluor 488 respectively. rAc was
reconstituted at 1Tn: 1 Tm: 7 F-actin stoichiometry. Colocalization of fluorescent probe
suggests that Tn-Tm binds non-cooperatively (Hill coefficient, nH, approaches to 1) to Factin with a dissociation constant (Kd) of 0.5 µM. Second, Ca2+ does not alter Tn-Tm
binding to F-actin. Based on my experimental results, I modeled the binding of Tn-Tm as
a two-step process consisting on the formation of a single Tn-Tm unit (nucleation) a
subsequently stabilized by formation of adjacent regulatory units (elongation). This
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model suggests that under physiologically relevant conditions Tn-Tm binding to F-actin
presents positive cooperativity; however this is not reflected in the empirical calculation
of cooperativity (nH) as a result of the lineal arrangement of Tn-Tm units bound to Factin. These results are discussed in terms of its implications to muscle activation.
1.2 Introduction
Myocardial contraction is regulated within thin filaments by action of troponin
(Tn) and tropomyosin (Tm) bound to actin filaments. Transient increases in cytosolic
Ca2+ concentrations induce rapid exchange of Mg2+ to Ca2+ in the TnC N-terminal lobe,
leading to conformational changes in Tn-Tm that encourage myosin binding and
subsequent force development (Gordon et al., 2000). At the physiological level, the
myocardial isometric force response to cytosolic Ca2+ concentration increments reveals a
highly cooperative process (Gordon et al., 2000; Moss et al., 2004). This high
cooperativity is necessary to develop concerted muscle contraction and relaxation at the
millisecond time scale (Bers, 2002).
One prominent question is how molecular interactions define the concerted
activation of the cardiac muscle. Within the sarcomere, protein-protein interactions,
protein-ligand interactions, and allostery constitute communication nodes responsible for
muscle activation. These interactions produce cooperative communication responsible for
adjusting response to stimulus. Cooperativity can arise from myosin binding to thin
filaments (R. D. Bremel & Weber, 1972), Ca2+ binding to TnC (Rosenfeld & Taylor,
1985), neighbor regulatory units (T. L. Hill et al., 1980; Tawada & Tawada, 1975), Tm
positioning on F-actin (Haselgrove, 1973; Vibert et al., 1997), or a combination of any of
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all these factors (Moss et al., 2004). Recent evidence points to the thin filament as a
pivotal determinant of cooperativity (J. P. Davis et al., 2007; J. M. Robinson, Dong,
Xing, & Cheung, 2004; Sun, Lou, & Irving, 2009). For this reason, dissecting the
contribution of thin filaments to muscle activation is a necessary step to understand the
molecular cues responsible for physiological response.
The first biochemical and physiological evidence of cooperative interactions
within the thin filament indicated a strong dependence between the free Ca2+
concentration and the myosin nucleotide binding state on the activation of thin filaments
(R. D. Bremel & Weber, 1972). Equilibrium binding studies on skeletal Tm and F-actin
determined that Tm is not capable to fully regulate F-actin by itself (Ebashi & Lipmann,
1962; Wegner, 1979). Light scattering studies on the incorporation of Tn-Tm in F-actin
revealed a positive binding cooperativity with relatively smaller effects due to Ca2+
binding to Tn (Wegner & Walsh, 1981). These two observations were later confirmed by
sedimentation studies (Mehegan & Tobacman, 1991).
To better understand the source of tight activation coupling in the thin filament is
necessary to consider the main interaction nodes within thin filaments. Tm binds to Tn on
the TnT C-terminal domain. TnT interaction spans two neighbor Tm units connected in a
head-to-tail basis (Figure 2.1) (White et al., 1987). This arrangement is responsible for (i)
the high binding affinity of Tn-Tm (Kd ~ 2 µM) to F-actin and (ii) a two orders of
magnitude change in the binding of Tn-Tm next to a Tn-Tm bound to F-actin than to an
isolated site (Dahiya, Butters, & Tobacman, 1994; L. E. Hill, Mehegan, Butters, &
Tobacman, 1992). Tn posses an additional low-affinity binding site on F-actin (Kd ~50
µM) located on the N-terminal domain (Van Eyk, Strauss, Hodges, & Rüegg, 1993). This
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binding is inhibited upon Ca2+ binding to TnC, leading to myosin binding (Gordon et al.,
2000). TnI N-terminal domain and F-actin interactions have been considered to be non
significant to Tn-Tm stability (Dahiya et al., 1994); however, other results highlight
existing interactions (Potter & Gergely, 1974).
Despite of this evidence in equilibrium binding, direct visualization of the thin
filament assembly process has not been addressed. Most of these studies employing
regulated actin (rAc, composed of Tn, Tm, and F-actin) have been done at ionic strengths
(300 mM) far from physiological levels (~120 mM) and by indirect measurements
(Dahiya et al., 1994; L. E. Hill et al., 1992). Therefore, a detailed view of thin filament
dynamics in a near-physiological environment needs to be addressed to better understand
the role of molecular interactions in physiological processes.
In this study, we determined the binding properties of Tn, Tm, and F-actin by
reconstitution of rAc by three-color fluorescence colocalization imaging under
physiologically relevant conditions. Our results suggest that Tn and Tm bind to F-actin
non-cooperatively and Ca2+ does not play a significant role on Tn-Tm binding. Our
results describe an isotropic and predominant type of interaction between nearestneighbor RUs independent of Ca2+ saturation state across F-actin.
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Figure 2.1. Interactions between Tn-Tm and F-actin. F-actin (gray rectangle),
Tm (black lines), and Tn (green) are represented within the thin filament
context. The larger box represents the triplet interaction between Tn, Tm and
F-acting occurring every 7 actin monomers where two Tm bind head-to-tail.
The smaller box represents Tn interaction with actin. This interaction is
inhibited in presence of Ca2+.
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1.3 Materials and Methods
Protein preparation and purification - Actin and tropomyosin were purified as
described (J. D. Pardee & Spudich, 1982; Smillie, 1982) from acetone powder derived
from bovine left ventricles. Recombinant TnC (C35S, C84S, S89C) from chicken (whose
gene product is identical to mouse TnC), wild type (wt) TnI from mouse, and wt TnT
from rat were expressed and purified as described (J. M. Robinson et al., 2004).
Dye labeling of proteins - C89 in TnC was selectively labeled with AF 546 (Alexa
Fluor 546, Life Technologies, Grand Island, NY). Tm was labeled in the single
endogenous cysteine (190C) with ATTO 655 (ATTO-TEC, Siegen, Germany). Cysteines
were reduced by dialysis against labeling buffer [LB: 3 M urea, 100 mM KCl, 1 mM
EDTA, 50 mM MOPS (3-(N-morpholino)-3-propanesulfonic acid), pH 7.2] containing 5
mM DTT (dithiothretiol). Free DTT is removed by 3 steps of dialysis against LB.
Reduced proteins (100 µM) were reacted with a 5-fold excess of dye molecule for 12 hr
at 4 °C under nitrogen with stirring. Labeling was terminated by the addition of 10 mM
DTT. Unreacted dye molecules were removed by size-exclusion chromatography
(Sephacryl S-100 HR, GE Life Sciences) in LB using a fast protein liquid
chromatography (FPLC, Akta GE Life Sciences, Pittsburg, PA). Fluorescent dye labeling
was repeated until the labeling efficiency exceeded 95%. Protein concentration and
labeling efficiencies were determined by absorption spectroscopy using the following
extinction coefficients (M-1 cm-1): Alexa546, 104,000 at 555 nm; ATTO655, 125,000 at
663 nm; Tn, 36040 at 280 nm; Tm, 23,230 at 280 nm; F-actin, 48,300 at 280 nm. Typical
labeling ratios for Tm and Tm are >0.95 and >0.9 respectively. F-actin was alternatively
labeled with N,N'-Dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)
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ethylenediamine (IANBD) on C374 by incubation of F-actin with 5-fold excess of dye
molecule as described previously. Typical labeling efficiencies were 0.3 based on an
extinction coefficient of 25000 M-1cm-1 for IANBD.
Preparation of the troponin assembly - Fluorescently labeled cardiac Tn was
reconstituted from TnC, TnI, and TnT using stepwise dialysis as described previously (J.
M. Robinson et al., 2004). Briefly, TnC, TnI, and TnT were separately dialyzed in
reconstitution buffer (50 mM Tris, 6 M urea, 500 mM NaCl, 5mM CaCl2, 5mM DTT, pH
8.0), then mixed at a molar ratio of 1:1.2:1.4 TnC:TnI:TnT (15,10, and 12 µM
respectively). The mixture was gently shaken for two hours at room temperature and then
dialyzed against high salt buffer (1 M KCl, 20 mM MOPS, 1.25 mM MgCl2, 1.25 mM
CaCl2, 1.5 mM DTT, pH 7.0). The urea was removed in four stepwise changes (6, 4, 2,0
M), then KCl removal by dialyzing against working buffer (WB: 75 mM KCl, 5 mM
MgCl2, 2 mM EGTA, 5 mM 2-mercaptoethanol, 50 mM MOPS) supplemented with KCl
(1, 0.7, 0.5, 0.3, 0.15 M KCl). Uncomplexed TnI and TnT, which precipitate in SB, were
removed by centrifugation at 10,000 × g for 1 min. The Tn assembly was further purified
by size-exclusion chromatography (Sephacryl S-100 HR) in WB containing 150 mM KCl
and stored at -80 °C.
Preparation of the regulated actin filaments - Regulated actin filaments (rAc)
were reconstituted as described (J. M. Robinson et al., 2004). Tm, Tm, and F-actin were
mixed at 1:1:7 stoichiometry in WB for an hour at 4°C. Successful reconstitution was
confirmed by imaging filaments in an epifluorescence microscope at low concentration (2
nM) on aminosilanized coverslips. Free Tn concentration was determined by
centrifugation of rAc in spin column filters. Free fluorescently labeled Tn concentration
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was determined by filtering of filaments in WB supplemented with 0.01% (v/v) Tween
20 (23336-2500 Acros Organics, NJ). This procedure prevented non-specific adsorption
of proteins to the filter membrane and the tubing walls. Filaments were centrifuged at 500
× g for 20 min in a 100 kDa molecular weight cutoff regenerated cellulose column
(Milipore, Darmstadt, Germany). Serial dilutions of fluorescently labeled Tn stock
solutions of known concentration were centrifuged under the same conditions as the
sample. Fluorescence emission in the flow-through was determined on each sample and
standard solution. Free Tn concentrations were obtained by interpolation of fluorescence
emission values in a standard curve made from the standard Tn solutions. The procedure
described above to quantify free Tn was adopted because conventional centrifugation
resulted in irreproducible results due to protein aggregation at low ionic strengths (125
mM).
Preparation of aminosilanized coverslips - Coverslips were aminosilanized as
described previously (Selvin & Ha, 2008). Briefly, circular coverslips (No. 1 25 mm,
Fisher Scientific) were cleaned by successive sonication in (i) 1% NaPO4, 1% SDS, 1%
NaHCO3; (ii) ddH2O (double distilled water); (iii) acetone; and (iv) 1 M NaOH for 10
min each. Cleaned coverslips were rinsed with ddH2O then dehydrated by immersion in
methanol, then aminosilanized through incubation (2 periods of 10 min, interrupted by 1
min of sonication) with 1% (v/v) Vectabond (Vector Labs, Burlingame, CA) and 5%
(v/v) glacial acetic acid in methanol. The coverslips were extensively rinsed with
methanol, then with ddH20 before drying in a dust-free chamber. The aminosilanized
coverslips were stored at room temperature in a closed container for up to 2 weeks.
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Microscopy and image analysis - Wide field epifluorescence images were
acquired on an inverted IX71 Olympus microscope with TE cooled interline CCD camera
(Clara, Andor) using a 100x (N.A. 1.4) oil immersion objective (UPlanSApo, Olympus).
Videos were acquired at 2 frames per second with a 5 ms shutter. Excitation was from a
Xe lamp (X-Cite 120PC, Lumen Dynamics). Filters (excitation: dichroic: emission)
were FF01-475/35: FF495: FF01-550/88 (Semrock) for AF 488, ET545/25: T565lpxr:
ET605/70m (Chroma) for AF 546; ET620/60: T660lpxr: ET700/75m (Chroma) for
ATTO 655. Length was calibrated by imaging a dual axis linear scale (Edmund Industrial
Optics). Measurements were performed at room temperature (18 ± 2 ºC).
Data analysis and simulation - Wide field epifluorescence images were acquired
using an inverted IX71 Olympus microscope with TE cooled interline CCD camera
(Clara, Andor) using a 100x (N.A. 1.4) oil immersion objective (UPlanSApo, Olympus).
Videos were acquired at 2 frames per second with a 5 ms shutter. Excitation was from a
Xe lamp (X-Cite 120PC, Lumen Dynamics). Filters (excitation: dichroic: emission)
were FF01-475/35: FF495: FF01-550/88 (Semrock) for AF 488, ET545/25: T565lpxr:
ET605/70m (Chroma) for AF 546; ET620/60: T660lpxr: ET700/75m (Chroma) for
ATTO 655. Imaging length was calibrated using a dual axis linear scale (Edmund
Industrial Optics). Measurements were performed at room temperature (18 ± 2 ºC).
Image processing and computer vision were performed using MATLAB (MathWorks,
Natick, MA R2011b) and Image J 1.47t (National Institutes of Health, Bethesda, MD).
The customized filament analysis software is available in an online repository (see
Supplemental Information). Data derived from free Tn concentration and Tn-Tm
saturation was fitted to the Hill equation (A. V. Hill, 1910):
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where the saturation degree of Tn-Tm on F-actin !!"!# depends on the free Tn
concentration [!"] and defines the Hill coefficient !! and the dissociation constant !!
parameters. Cross-correlation analysis of fluorescence intensity values as a function of a
filament coordinate were determined according to:
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where !! and !! correspond to the average values of the series A and B respectively; !!
and !! correspond to the standar deviation values of A and B respectively; n, l, and N
correspond to a determined time series point, the lag interval, and the maximum
extension of the inspection respectively.
Modeling and simulation - The stochastic simulation was modeled by the Monte
Carlo approach using MATLAB (MathWorks, Natick, MA R2011b). Tn-Tm was
considered to be the ligand and F-actin (Ac) a one-dimensional lattice, where each
binding space represents one RU (see Appendix 2 for an extended explanation). The
reaction follows the scheme:
!!
TnTpm + Ac! ⇌ TnTpmAc!
!!!

(2.3),

where !! and !!! define the forward and backward stochastic reaction constants
respectively (Gillespie, 1977). Since our goal is to adopt a simple model, we considered
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two assumptions: (i) !! constitutes the diffusion controlled and activation controlled rate
constants; (ii) this assumption is equivalent for a ligand binding to an empty site adjacent
to one or two ligand occupied spaces. Positive cooperativity is considered in this model
by introducing a coefficient that depends on the number of nearest neighbor ligands
bound to the lattice. This coefficient affects the backward reaction constant !!! . For a
given time interval dt, the deterministic solution to the rate of saturation of a linear lattice
is given by

!"
!"

= !! !" − !"
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!! − 1

!" !
!
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!!

!!

!" !
!

(2.4),

where !" − !" ! is the free Tn-Tpm concentration found at time t, !! is the fractional
saturation density, !"

!

is the total Ac concentration, ! is a cooperativity parameter,

and ! is the average number of nearest-neighbor interactions in a bound Tn-Tm unit at
the previous iteration step k-1 (! = {0,1,2}).
2.4 Results
The objective of this work was to study the structural dynamics of Tn-Tm and
Ca2+ binding to F-actin through direct imaging of Tn, Tm, and F-actin. We proceeded to
study Tn-Tm binding to rAc filaments as a function of total filament concentration while
maintaining a constant stoichiometry. The filament concentration is represented by the
total regulatory unit concentration (1 RU equals 1Tn: 1Tm: 7 actin). Tn, Tm, and F-actin
concentrations were varied simultaneously because under near-physiological conditions
(ionic strength is 125 mM) and excess of Tn-Tm filaments present severe aggregation
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(Figure 2.2). Moreover, excess of free fluorescently labeled Tn-Tm deteriorates the image
analysis due to oversaturation of the field of view. For this reason, we proceeded to
explore the binding properties of Tn-Tm on F-actin by varying the total RU
concentrations.
To understand Tn-Tm binding properties on F-actin, we surface-deposited
reconstituted filaments on aminosilanized coverslips. The surface deposition prevents
filament drifting off the surface during the image acquisition (Figure 2.3 A).
Reconstituted rAc filaments contain fluorescently labeled Tn-AF 546 (TnC89C), TmATTO 655 (Tm190C), and phalloidin AF 546. Imaging of fluorescently labeled proteins
confirms reconstitution and presence of heterogeneous populations of Tn-Tm-regulated
actin filaments and non-regulated actin filaments (Figure 2.3 B). To study Tn-Tm
binding, we developed an image analysis protocol (Figure 2.3 C). This algorithm enabled
to identify Tn-Tm co-localization in F-actin. We classified Tn-Tm binding to F-actin into
two categories: regulated regions containing Tn, Tm, and F-actin; and non-regulated
regions devoid of Tn-Tm (Figure 2.3 D). To discard possible effects of phalloidin on
filaments, we reconstituted rAc in the absence of phalloidin-AF488 and by covalent
labeling of IANBD to Cys 374 in F-actin (Figure 2.4). We determined that phalloidin
does not cause apparent effects on Tn-Tm binding to F-actin. We conclude that the
surface deposition of rAc filaments facilitates the simultaneous imaging of Tn, Tm, and
F-actin.
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Figure 2.2. Saturation of F-actin filaments with Tn-Tm. Filaments were labeled with
AF 546 on Tn Cys 89, ATTO 655 on Tpm Cys 190, and phalloidin AF 488 on F-actin
and reconstituted as described in Materials and Methods. (A) Regulated actin
filaments were incubated at different ratios of Tn-Tpm relative to F-actin (0.5 µM). As
the Tn-Tpm concentration increases, the filament aggregates becomes more frequent
and the number of filaments per field of view decreases. (B) Representative filament
bundle at 5 µM Tn-Tpm. Scale bar 5 µm.
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Figure 2.3. Imaging and interpretation of reconstituted regulated actin filaments. (A)
Scheme depicting the surface deposition of rAc filaments on an aminosilanized
surface. Tn AF 546 (orange, red, and green) and Tm ATTO 655 (purple and red) bind
to F-actin filaments (gray and brown) are labeled with phalloidin AF 488 (light blue)
(B) Representative epifluorescence images of surface-deposited rAc on
aminosilanized coverslips. Reconstitution was done at 750 nM RU and filaments were
diluted in WB and imaged at 2 nM. Images of Tm (red), Tn (green), F-actin (blue),
and the merged images are shown. Scale bar, 5 µm. (C) Schematic of the imageprocessing protocol used to resolve regulated regions in actin filaments. (D) Merged
image of rAc (left) and its interpretation (right) are shown. In the interpreted image,
the margins of actin filaments are outlined in white, and the filament coordinates of a
Tn-Tm regulated region is shown in red. Scale bar, 5 µm.
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Figure 2.4. Phalloidin labeling does not affect regulated actin reconstitution. Filaments
were fluorescently labeled and reconstituted as described in Materials and Methods with
the described exceptions: (upper panel) F-actin was labeled with IANBD before
reconstitution of regulated actin and incorporation of phalloidin AF 488 was omitted;
(lower panel) reconstitution omitted incorporation of phalloidin AF 488. Scale bar 5 µm.
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Given the validation of the filament reconstitution and analysis protocol, we
proceeded to reconstitute rAc filaments under constant stoichiometry and variable total
RU concentration. Tn-Tm occupancy on F-actin, driven by the total RU concentration,
was studied at saturated Mg2+ (pCa 9) and Ca2+ (pCa 3) conditions (Figure 2.5 A). At low
RU concentrations (12.5 nM), Tn-Tm forms nucleation points on actin filaments.
Reconstitution at ≥500 nM RU produces rAc clusters that finally coalesce. A visual
inspection suggests that the Ca2+ saturation state does not affect the filament
reconstitution process. From our images, is it possible to identify traces of free Tn-Tm
molecules, represented by discrete fluorescent dots. Inspection of these unbound
fluorescent molecules suggests that free Tn and Tm are not colocalized. This is seen
across all the filament concentrations used. Thus, under our experimental conditions, TnTm binding is very weak. This is caused by low Tn-Tm affinities (Dahiya et al., 1994).
Direct imaging of reconstituted filaments demonstrates that F-actin is required to stabilize
strong Tn and Tm interactions at physiological conditions.
To clarify the mechanism by which Tn-Tm elongates, we studied the length
distributions of rAc and F-actin. Average filament length histograms plotted at each RU
concentration reveal an exponential model (Figure 2.5 B, C). Both, regulated regions and
F-actin fit to a single exponential distribution. In the case of F-actin, the exponential
length distribution coincide with previous reports (Burlacu, Janmey, & Borejdo, 1992).
Regulated regions show incremental length changes in proportion to RU concentration
while F-actin length remains invariant. The average length as a function of the free Tn
concentrations reveals a sudden change in the average length of the rAc regions (Figure
2.5 D). One possibility is that when the filament concentrations are >100 nM, the
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elongated nucleation points coalesce causing a sudden change the average length. Ca2+
saturation state does not appear to affect Tn-Tm elongation on F-actin.
The amount of Tn-Tm bound to the actin filaments provides a direct measure of
the degree of Tn-Tm saturation (θ) on the F-actin linear dimension. We quantified the
saturation state of Tn-Tm in rAc filaments by direct imaging of the fluoresce signal from
Tn-AF546, Tm-ATTO655 and phalloidin-AF488 (bounds to F-actin). The image
processing protocol employs binarization and region selection of regulated filaments. A
regulated region is identified by the combined fluorescence signal from Tn and Tm (an
AND Boolean operator, See Appendix A2). Figure 6 shows a saturation curve of Tn-Tm
as a function of the free Tn concentration. Data fitting to the Hill equation (Equation 2.1)
reveals an nH and Kd of 1.4 ± 0.1 and 0.68 ± 0.30 µM at pCa 9 and 1.3 ± 0.2 and 0.52 ±
0.32 µM at pCa 3 respectively. Our results suggest that Tn-Tm binding is not cooperative
under the selected concentrations. The Kd value found is smaller than in previous reports
(~ 2 µM). This difference can be caused by the larger ionic strength (300 mM) used in
previous studies (Dahiya et al., 1994). In addition, Ca2+ is not affecting Kd in agreement
with previous reports (Dahiya et al., 1994; Mehegan & Tobacman, 1991).
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Figure 2.5. Length analysis of regulated actin filaments. Assemblies were prepared at
a constant stoichiometry (1Tn: 1Tm: 7F-actin) but varying the total RU concentration.
(A) Merged epifluorescence images of regulated actin filaments deposited on glass
coverslips. Pseudo-coloring preserved as in Figure 1. Scale bar, 5 µm. (B, C) Analysis
of length distributions of reconstituted filaments. The effect of increments in total RU
concentration is analyzed on the length histograms of actin (B) and regulated actin
regions (C) at pCa 9 respectively. Total RU concentrations of 12.5, 25, 50, 125, 250,
and 750 nM are represented as colored transitions from red, to orange, to yellow. The
black lines represent the exponential curve fit in a y-axis log scale. Length
distributions at pCa 3 are comparable to pCa 9 results. (D) Summary of the average
lengths of Tn-Tpm regions recovered from the length distribution histograms. Average
lengths of Tn-Tpm decorated regions are plotted against the free Tn concentration in
solution at pCa 9 (empty circles) and pCa 3 (filled circles).
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Figure 2.6. Morphologic binding analysis of Tn-Tm to F-actin at constant
stoichiometry. The fraction of filament regions regulated by Tn and Tm is plotted as a
function of the concentration of the free Tn concentration at pCa 9 (open circles) and
pCa 3 (filled circles). Fits to the Hill equation for pCa 9 (dashed line) and pCa 3
(continuous line) provided recovered values for the dissociation constant, Kd, and the
Hill coefficient, nH. Curve fitting results are summarized in Table 2.1
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To increase the confidence in our results, we determined the saturation of Tn-Tm
by comparing the correlation between Tn-F-actin and Tm-F-actin fluoresce signals. We
interrogated the florescence intensity signal present in the raw microscope images of Tn,
Tm, and F-actin using the recovered F-actin coordinates as a template. Figure 2.7 A
shows Tn, Tm, and F-actin fluorescence intensity traces at 12.5, 250, and 750 nM. The
filament coordinate axis corresponds to the aligned F-actin filament coordinates an the
intensity traces correspond to the fluorescence intensity values found in localized pixels
derived from Tn, Tm and F-actin images (green, red, and blue respectively). The rotated
histograms derived from he cumulative fluorescence intensity traces reveal a bimodal
distribution of intensities in Tn and Tm corresponding to bound and unbound regions.
Notice the similarity in the fluorescence signal distribution between Tn and Tm. In the
case of F-actin, the fluorescence signal is unimodal suggesting that phalloidin binding is
uniform. As the concentration of filaments increases, Tn and Tm increasingly incorporate
into the filaments and the vacant regions become less frequent. Computing the crosscorrelation (Equation 2.2) for each free Tn concentration reveals a sigmoidal dependence
(Figure 2.7 B and C). Hill equation curve fits (Table 2.1) reveal a Hill coefficient
proximal to one in agreement with the saturation measurements. Similarly, our results
reveal no effect of Ca2+ on the binding of Tn-Tm. We observe that Tn-Tm binding is not
cooperative under our experimental conditions and Ca2+ does not significantly affect this
process.
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Figure 2.7. Intensity-based binding analysis of Tn-Tm to F-actin at constant
stoichiometry. F-actin filament coordinates were used to interrogate the florescence
intensity in Tn, Tm, and F-actin images. (A) Linear fluorescence densities in Tn, Tm,
and F-actin images based on the concatenated F-actin filament coordinates (n = 27
concatenated filaments) at 12.5, 250, and 750 nM total RU concentration. Intensity
histograms on the right reveal Tn-Tm bound and unbound populations. Crosscorrelations of (B) Tn-F-actin and (C) Tm-F-actin intensity signals are plotted as a
function of the unbound Tn concentration. The cross-correlations between Tn and Factin and Tm and F-actin are calculated from the linear fluorescence densities in (A)
under pCa 9 (open circles) and pCa 3 (filled circles). Correlation values at zero
distance lags are plotted against the concentration of unbound troponin. Fits to the
Hill equation at pCa 9 (dahsed line) and pCa 3 (continuous line) are summarized in
Table 2.1.
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Based on our experimental results, we modeled Tn-Tm binding to F-actin using a
Monte Carlo simulation (Gillespie, 1977). In the simulation, we considered a Tn-Tm unit
as a single ligand and every seven contiguous actin monomers as a single lattice element
in a one-dimensional array (L. E. Hill et al., 1992). Thus, Tn-Tm bind to an isolated
binding site with a forward and backward stochastic reaction constant c1 and c-1 (Figure
8.6 A). These constants should not be confused with the experimental kinetic constants k1
and k-1 (Gillespie, 1977). When a ligand binds next to a binding site containing a bound
ligand, c-1 is affected by new protein-protein interactions, which promotes increased
binding affinities. For simplification, we assumed that c1 is not affected by cooperative
interactions. Figure 2.8 B illustrates transient reactions reaching equilibrium at different
total RU concentrations. We measured the lattice saturation for several free-ligand
concentrations and their respective stochastic reaction constants were adjusted to match
our experimental results for Kd. Our results reveal a sigmoidal dependence with a Hill
coefficient close to one in agreement with our experimental results (Figure 2.8 C).
Representing the average length as a function of the free-ligand concentration reveals a
sudden increase in the length (Figure 2.8 D) in agreement with Figure 2.5 D. Finally, we
quantified the type of interactions existing on each RU bound to the lattice as a function
of the free Tn concentration. Our results reveal that under low free ligand concentrations
(<10-7 M) each RU is predominantly found isolated from other RUs or bound to a single
RU (Figure 2.8 E). As the concentration of free Tn increases, contiguous RU interactions
become more frequent and outpace the number of isolated RUs at high free Tn
concentrations. From Figure 2.8 E, the relative abundance of each binding state across the
titration curve in corresponds to 2.7%, 1.5%, and 95.8% for isolated RUs, one-sided, and
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two sided interactions respectively. A weighed average number of binding interactions
corresponds to 1.9 and it corresponds to a stochastic cooperativity factor of ω = 12 (see
Appendix 2). Based on previous reports this cooperativity factor is smaller by a factor of
three (L. E. Hill et al., 1992). From our simulations, we conclude that Tn-Tm binding to
F-actin can be modeled as a two-step process composed by a nucleation event proceeded
by successive elongation of regulated regions.

Table 2.1. Summary of binding curve parameters.
Binding curve
pCa 9
Kd (µM)

pCa 3
nH

Kd (µM)

nH

Saturation (Figure 2.4)

0.68 ± 0.30 1.4 ± 0.1

0.52 ± 0.32 1.3 ± 0.2

Tn-actin Corr. (Figure 2.5 B)

0.06 ± 0.03 0.9 ± 0.3

0.02 ± 0.02 0.7 ± 0.3

Tm-actin Corr. (Figure 2.5 C)

0.12 ± 0.35 1.2 ± 0.6

0.07 ± 0.06 1.0 ± 0.1

* n = 5 analyzed images per data point. Data reported as mean ± asymptotic standard
error.
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Figure 2.8. Stochastic simulation of Tn-Tm binding to F-actin. (A) Scheme of a
transient stochastic simulation of Tn-Tm units binding to an actin filament linear
lattice. Binding of a single Tn-Tm unit (nucleation) with forward and backward
stochastic rate constants c1 and c-1, respectively, precedes the contiguous binding of
Tn-Tm units (elongation). Cooperativity effects caused by neighbor-to-neighbor
interactions between Tn-Tm units are considered in the simulation by introducing a
weighing factor that alters the stochastic dissociation rate constant c-1. (B) Simulation
traces at 10, 250, and 500 nM total RU concentration (Compare to Figure 2 A). Tn-Tm
units are represented as black pixels in a white linear lattice (1x40 pixels). Each pixel
represents a regulatory unit or seven F-actin protomers. (C) Binding curve of Tn-Tm
to the F-actin lattice under steady-state conditions (Compare to Figure 3, 4 B, and 4
C). The simulation results (dots) were fitted to a Hill equation (continuous line) with
Kd corresponding to 0.04 ± 0.02 µM and nH to 1.2 ± 0.1 (mean ± asymptotic standard
error). (D) Average length of regulated actin regions under steady-state conditions
(Compare to Fig. 2d). (E) Number of interactions within the lattice during the titration.
The number of isolated RUs formed (gray dots) is compared to the number of
contiguous, one-sided (open dots) or two-sided (black dots), interactions (black dots)
between RUs under steady-state conditions. Insert represents each interaction type in
the context of the simulation lattice (white) and the bound ligands (gray).
Measurements under steady-state conditions were achieved by sampling the last three
iteration steps from each stochastic reaction. The lattice population (n = 100 filaments)
is generated from exponentially distributed histograms, which describe an average
number of 40 RUs per filament (1.6 µm long filaments).
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2.5 Discussion
Our observations of Tn-Tm assembly on F-actin through direct imaging provide a
unique view of the thin filament assembly process. To the best of our knowledge, this is
the first study aimed to derive quantitative binding information of Tn-Tm to F-actin using
three-color fluorescence imaging. The main advantage of this approach resides on the
direct confirmation of proper assembly of thin filaments. Previous works have found
aggregation and uncorrelated results in co-precipitation studies (L. E. Hill et al.,
1992).This effect is demonstrated by observing severe aggregation of filaments when the
concentration of Tn-Tm far exceeds the stoichiometric concentration of F-actin (Figure
2.2). This observation enabled us to redesign our approach to study thin filament
assembly under near-physiological ionic strengths (125 mM).
We further studied filament decoration by exhaustively interrogating the length
distributions of Tn-Tm regulated regions. Our analysis revealed single exponential length
distributions for both, F-actin and rAc regions. We did not proceed to fit the length
distribution data to a Hill curve because the coalescence process of regulated regions
introduces an artifact. Conversely, saturation measurements, which represent the degree
of occupancy of F-actin by Tn-Tm, are more appropriate. The source of an exponential
distribution on Tn-Tm regulated regions (Figure 2.5 C) is a direct consequence of the
reaction mechanism of Tn-Tm binding. This problem was addressed by employing a
simple stochastic simulation discussed later in this section.
Although our procedure is designed to prevent Tn-Tm dissociation, Tn-Tm
detachment might occur. However, we consider that any Tn-Tm detachment during the
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dilution and immobilization process (<20 s) does not significantly affect our
observations. Tm dissociation from F-actin is approximately 0.33 molecules/s (Schmidt,
Lehman, & Moore, 2015). Based on the evidence that Tn-Tm interactions with F-actin
are stronger compared to Tm with F-actin (L. E. Hill et al., 1992), we discard any
significant Tn-Tm dissociation during the dilution and surface-deposition process.
We have introduced a novel method to determine binding isotherms by direct
imaging of binding events. As mentioned earlier, this approach has the advantage of
avoiding artifacts present in the sample. Determination of the saturation state by
colocalization and cross-correlation of fluoresce signals across the filaments facilitates
the validation of our results. It is important to mention that the latter method has a
potential advantage over the former in the fact that colocalization is limited by the
diffraction limit of light. The cross-correlation method is based on the intensity across the
filament, which is directly proportional to the amount of Tn-Tm bound to F-actin
regardless of the optical light diffraction limitation. However, both methods report
different results, particularly for Kd values. This difference between the two methods
could be due to a higher precision in the determination of bound Tn-Tm units at low free
Tn concentrations by the correlation approach. A second possibility is that the correlation
approach has a lower resolution at high ligand occupancies where the fluorescence
intensity path adopts a noisier pattern. There is an evident difference in the Kd values
recovered by both methods; although, this does not alter the conclusions of this work, this
discrepancy needs to be addressed in future studies. Nevertheless, both methods revealed
comparable results in relation to the effect of Ca2+ on Tn-Tm binding to F-actin and the
cooperativity of this process. Therefore, it is possible to exploit this technique to
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interrogate other lattice-ligand binding problems like DNA-binding proteins
(Kowalczykowski et al., 1986).
Although TnI interacts with F-actin through its C-terminal domain, we did not
observe increased affinity of the Tn-Tm complex for F-actin in the absence of Ca2+.
Assuming that TnI C-terminal interactions have a significant effect on Tn-Tm binding to
F-actin, these interactions would have generated a leftward shift in the saturation curves
in absence of saturating Ca2+ concentrations. There is evidence that TnI C-terminal
domain exerts little effects in the overall stability of Tn-Tm on F-actin with no regardless
of the free Ca2+ concentrations (Kozaili, Leek, & Tobacman, 2010). Previous binding
studies have reported that incorporation of Tm is responsible for a 1000-fold increase in
Tn affinity for F-actin (Dahiya et al., 1994; L. E. Hill et al., 1992). It is possible that the
weak binding affinity of troponin (Kd = 1.7 mM (Dahiya et al., 1994)) to F-actin derives
not only from the TnI C-terminal domain, but also from the existing actin binding regions
in TnT (residues 95 119) (Hinkle, Goranson, Butters, & Tobacman, 1999). These
additional Tn interactions further dilute the direct contribution of TnI C-terminal to the
reported binding affinity of Tn to F-actin. Additionally, we did not observe independent
binding of fluorescently labeled Tn to F-actin. Therefore, we suggest that TnI C-terminal
domain and actin interactions are not a significant factor to thin filament assembly. This
idea supports the notion that Ca2+ concentration transients within the myofibrils do not
compromise the stability of thin filaments. However, physiological results challenge this
assumption (Swartz, Yang, Sen, Tikunova, & Davis, 2006). This observation highlights
the subtle differences found within the sarcomeric environment and the need to
harmonize biochemical and physiological studies.
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F-actin sliding on vitro motility experiments has been reported to follow discrete
on/off states, where motility appeared at low (pC9) Ca2+ concentrations (Fraser &
Marston, 1995). However, in those experiments insufficient Tn-Tm was present (10 nM
Tm and 5 nM Tn) to fully regulate F-actin and filaments would be expected to be semioccupied. Even at higher concentrations we see short filaments devoid of regulatory
proteins (Figure 2.5 A). This should not be an inconvenience in more recent in vitro
motility assay protocols as Tn-Tm is incorporated in large excess (Homsher, Kim,
Bobkova, & Tobacman, 1996).
Considering our estimates on non-cooperative binding of Tn-Tm (n ≈ 1), there is
no sufficient evidence to directly relate Tn-Tm binding cooperativity to cooperativity
seen in Ca2+-dependent isometric muscle force development. In the latter case,
remarkably high cooperativity values (n ≥ 3) are commonly observed in skinned muscle
fibers (Brandt, Cox, & Kawai, 1980; Moss et al., 2004; Shiner & Solaro, 1984). In
cardiac Tn, a single Ca2+ binding site exists; therefore, cooperativity does not necessarily
arise from Tn itself (Gordon et al., 2000). Other results point to structural transitions
within actin responsible for giving rise to cooperativity (Galkin, Orlova, Schroder, &
Egelman, 2010; Tobacman & Butters, 2000); however, mixed results have been found for
the degree of flexibility of F-actin (Fujii, Iwane, Yanagida, & Namba, 2010; Funatsu,
Harada, Tokunaga, Saito, & Yanagida, 1995). Our results suggest that the interactions
between adjacent Tn-Tm units are rather simple and cooperativity in isometric force
measurements may arise from other structural features.
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There is a critical advantage in a non-cooperativity Tn-Tm binding process. One
hypothesis is that for fully rAc filaments, a single type of interaction occurs throughout
the entire thin filament. When Ca2+ binds to thin filaments, the activation process is
concerted. This notion is supported by results where TnC is partially extracted from
myofibrils or exchanged with a mutant TnC that does not bind Ca2+, which causes decay
in the Ca2+-isometric force development cooperativity (Farman et al., 2010; Moss, Allen,
& Greaser, 1986).
Our measurements were developed under near physiological ionic strength levels
(125 mM). This is considerably difficult to achieve due to Tn-Tm tendency to aggregate
in presence of sub-stoichiometric F-actin concentrations (Figure 2.2). Nevertheless, we
accommodated our measurements by estimating Tn-Tm binding relative to the total
protein concentration. Although the scope of this work did not include the effects of ionic
strength on Tn-Tm binding, it is possible to compare our results with previous works.
From solution studies, increments in the ionic strength from 60 to 300 mM KCl appear to
decrease Kd from 0.1 µM to 1.8 µM in absence of Ca2+ (Dahiya et al., 1994). In contrast,
our results for Kd values are found in between these two cases (Table 2.1).
One of the goals of this work was to develop binding studies under near
physiological ionic strength levels (125 mM). This is considerably difficult to achieve
due to Tn-Tm tendency to aggregate in presence of sub-stoichiometric F-actin
concentrations (Figure 2.2). Our results at near physiological conditions were achieved
by estimating Tn-Tm binding relative to the total protein concentration and direct
imaging of reconstituted filaments. Although the scope of this work did not include the
effects of ionic strength on Tn-Tm binding, it is possible to compare our results with
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previous works. From solution studies, increments in the ionic strength from 60 to 300
mM KCl appear to decrease Kd from 0.1 µM to 1.8 µM in absence of Ca2+(Dahiya et al.,
1994). In contrast, our results report Kd values close to the 60 mM KCl results (Table
2.1). We consider that our results reflect a better model of Tn-Tm binding dynamics
within the sarcomere.
We complemented our results by applying an stochastic simulation based on a
excluded lattice occupancy problem (McGhee & von Hippel, 1974) (Figure 2.6 B). Since
the stochastic reaction constants are not known a priori, we proceeded to match the
binding curve results (Figure 2.6 and Figure 2.7 B, C) to our simulation output (Fig 2.8
C). This iterative process revealed that it is possible to obtain a non-cooperative binding
curve (nH = 1.2) with nearest-neighbor cooperative interactions in a linear lattice. We did
not proceed to draw conclusions from our stochastic reaction constants regarding their
relation to Kd because this is a more elaborate process (Gillespie, 1977). To understand
what drives an apparent masking of this cooperativity, we quantified the types of
interactions present under steady-state conditions. Here, the most predominant
interactions correspond to contiguous, two-sided, RUs while single RUs are only relevant
at low free-ligand concentrations. Therefore, paired interactions, specifically RUs in
contact with two RUs, represent the most predominant binding interphase under
physiologically relevant conditions. The difference between our stochastic cooperativity
factor and previous reports can be attributed to our binding model design. One possibility
is that it is necessary to include cooperativity effects in the stochastic association constant
c1. However, our goal is to produce simplified binding model and this change will
increase the degrees of freedom. We suggest that our results represent a case where
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geometric constraints define the number of interactions, which leads to biased
conclusions on the empirical determination of the cooperativity parameter nH (Koshland,
Némethy, & Filmer, 1966). In other words, most of the RUs are in direct contact with two
regulatory units, but the nH parameter does not reflect this situation due to the structural
arrangement of the Tn-Tm binding interactions.
2.6 Conclusions
Cooperative activation is a fundamental property of the thin filament responsible
for concerted activation of the sarcomere. The structural basis of this process remains an
active topic of investigation. We have contributed to resolving this problem by
introducing a novel method of determination of binding isotherms using direct imaging.
This enables to avoid artifacts due to sample preparation. We demonstrated the Tn-Tm
binding is Ca2+-insensitive and non-cooperative. The binding mechanism suggests that a
single type of interaction is predominant under physiologically relevant conditions.
Certainly, more studies will need to identify the molecular elements that relate
myofibrillar isometric force-Ca2+ cooperativity to binding cooperativity of regulatory
proteins.
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CHAPTER III
APPLICATION OF A KALMAN FILTER TO in vitro
MOTILITY ASSAYS TO ASSES MYOFILAMENT
FUNCTION

3.1 Abstract
Striated muscle contracts by cyclic sliding between interdigitated thin and thick
filaments. Troponin regulates this sliding by Ca2+-dependent cross-bridge development
between myosin thick filaments and actin thin filaments. The in vitro motility assay
(IVMA) replicates filament sliding in an in vitro setting, enabling the study of unloaded
shortening properties of muscle contraction. Sliding velocity estimates are influenced by
noise associated with experimental conditions and spatial resolution of the system,
limiting data interpretation of the Ca2+-dependent activation of thin filaments. Here, we
used the Kalman filter to obtain accurate velocity estimates of regulated actin (rAc) by
implementing a protocol for obtaining optimized filter parameters. We derived an
experimental strategy to optimize the Kalman filter based on the statistical parameters of
noise. A Ca2+-dependent titration on rAc revealed a reduction in the output noise in
particular at low speeds where noise intensifies. Based on our results, we propose the
application of the Kalman filter as a post-processing approach to suppress intrinsic noise
from the video acquisition process.
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3.2 Introduction
Inside cells, stochastic and directional processes govern motion of biomolecules
like proteins. These events are responsible for controlling normal cellular activity like
cell motility, signaling pathways, and gene expression. A heavy dependence exists on the
integration of multiple responses from single molecules to consolidate a cellular process.
Accurate description of these processes is necessary to describe the mechanical principles
that control biological responses (Funatsu et al., 1995; Toyoshima et al., 1987; Yildiz et
al., 2003).
In cardiac muscle, mechanical output from contraction is generated through
sliding of alternated arrays of thin and thick filament (Huxley, 1969). Thin filaments,
composed mainly by F-actin, troponin, (Tn), and tropomyosin (Tm), are responsible for
supporting the axial motion of the motor protein myosin, member of the thick filament,
during the cross-bridge cycle. ATP hydrolysis is converted into mechanical energy by
myosin’s lever arm domain transduction (Behrmann et al., 2012; I. Rayment et al., 1993;
Thomas, Kast, & Korman, 2009).
Muscle activation has been studied at different hierarchical levels, from tissue to a
molecular level (Gordon et al., 2000). From the bottom-up approach, the in vitro motility
assay (IVMA) (Figure 3.1) takes advantage of the directed motion of thin filaments and
F-actin in presence myosin heads fixed to a surface, enabling to study the actomyosin
interactions by measuring the sliding speed in a two-dimensional plane (Harada,
Sakurada, Aoki, Thomas, & Yanagida, 1990; Homsher et al., 1996; Kron & Spudich,
1986). Increments in the ATP concentration increase the filament sliding speed, which
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proofs that this technique reproduces ATPase measurements (Homsher, Wang, & Sellers,
1992; Kron & Spudich, 1986). Conversely, myosin is fixed to discrete positions in the
surface, which mimics the thin filament microenvironment within the sarcomere. This
approach has enabled to better assess the effect of mutations, post-translational
modifications, and microenvironment on thin filament activation through changes on the
maximal velocity, Ca2+ sensitivity, cooperativity, and percent of motile filaments
(Debold, Longyear, & Turner, 2012; Debold, Turner, Stout, & Walcott, 2011; Deng et al.,
2001; Evangelista et al., 2010; Homsher et al., 1996; Homsher, Nili, Chen, & Tobacman,
2003; Köhler et al., 2003; Snook, Li, Helmke, & Guilford, 2008). Additionally, the in
vitro motility assay has proven to be pivotal on testing drugs responsible for controlling
the contractibility properties of the sarcomeric proteins (Limouze, Straight, Mitchison, &
Sellers, 2004; Messer & Marston, 2014; Sakamoto, Limouze, Combs, Straight, & Sellers,
2004).
The most prominent parameter obtained from Ca2+ titrations is represented by the
apparent Ca2+ sensitivity, pCa50 (Homsher et al., 1996). Another parameter of importance
is the maximum sliding speed (Vmax). The latter has been effectively used in early stages
of the in vitro motility assay and more recently to evaluate de effect of cardiac mutations
(Kron & Spudich, 1986; Sommese et al., 2013; Umemoto & Sellers, 1990). Early work
suggested that Ca2+-dependent activation could be studied interchangeably in terms of
sliding speed of percent of motile filaments (Fraser & Marston, 1995; Homsher et al.,
1996). Although, estimation of the percentage of motile filaments achieves the desired
asymptotic increase as a function of the Ca2+ concentration, this approach is susceptible
to lack of reproducibility due to variable conditions in surface preparation and protein
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muscle sources (Höök, Sriramoju, & Larsson, 2001). On the other hand, speed estimates
are susceptible to noise amplification caused by the evaluating filament centroids at short
intervals of time (Homsher et al., 1992). This can lead to unsatisfactory correlation of the
speed and Ca2+-dependent activation of filaments(Bayliss et al., 2013). Recently, patch
reconstruction algorithms have addressed complex filament shapes by parameterization
of filament shape and interpolation of their position (Ruhnow, Zwicker, & Diez, 2011).
Conventional estimates on the filament sliding speed rely on adjusting the frame
acquisition speed on video recordings depending on the filament speed (Homsher et al.,
1996; Warshaw, Desrosiers, Work, & Trybus, 1990). Studies on the effect of variable
vide capture rates were first characterized by Sellers group (Homsher et al., 1992). They
identified that a fast frame grabbing of immotile filaments produces overestimates
filament speeds; whereas, slow frame acquisition speeds produce coarse estimates in the
displacement. Ideally, a higher sampling rate is desirable to improve the measurement of
filament sliding speed.
In the field of time series analysis, noise suppression in spatiotemporal data
recordings has ben addressed in a number of approaches. In 1960, Rudolf Kalman
proposed a recursive approach to solve the hidden state of a time trajectory corrupted by
noise (Kalman, 1960). This algorithm has been effectively applied to multiple problems
from improving the navigation system of the Apollo missions to the developing of more
efficient GPS navigations systems (Grewal & Andrews, 2010). Only recently, the
Kalman filter has found applicability in biological and biomedical problems (Lillacci &
Khammash, 2010; Wu, Agarwal, Hess, Khargonekar, & Tseng, 2010).
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Figure 3.1 The in vitro motility assay. The in vitro motility assay setup consists on a
confluent layer of myosin deposited on a microscope coverslip. Fluorescently labeled
rAc slides on a surface driven by the presence of free Ca2+ and the ATP-dependent
catalytic activity of myosin.
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Here we present a post-processing approach employing a Kalman filter to reduce
noise present on reconstructed tracks derived from fluorescently labeled F-actin and
regulated actin filaments sliding on surface-deposited myosin. Optimal parameters were
determined directly from experimental conditions and we demonstrate the noise
suppression capacity from Ca2+-dependent sliding speed estimates.

3.3 Materials and Methods
Protein preparation - Actin and tropomyosin were purified from acetone powder
derived from bovine left ventricles as described (Joel D. Pardee & Aspudich, 1982;
Smillie, 1982). Recombinant wild-type (wt) cardiac troponin C (TnC) from rat (C35S,
C84S, S89C), wt cardiac troponin I (TnI) from mouse, and wt Troponin T (TnT) from rat
were expressed and purified as described (J. M. Robinson et al., 2004). F-actin, Tn, and
Tm were dialyzed and stored in working buffer (WB: 75 mM KCl, 50 mM MOPS, 5 mM
MgCl2, 2 mM EGTA, 5 mM 2-mercaptoethanol). Myosin was purified from chicken
pectoralis muscle as described (Margossian & Lowey, 1982). Purified myosin was
suspended in 600 mM NaCl, 10 mM Na3PO4 (pH 7.0), 1 mM EDTA, 1 mM DTT,
diluted to 50% glycerol and stored at -20ºC for up to one year. F-actin was dialyzed in
working buffer (WB: 75 mM KCl, 50 mM MOPS, 5 mM MgCl2, 2 mM EGTA, 5 mM 2mercaptoethanol), labeled at a 1:2 ratio phalloidin-labeled Alexa Fluor 488-(A12379,
Life Technologies)-to-actin monomers, and stored at 4ºC for two months.

56
In vitro motility assay - The in vitro motility assay surface is prepared as
described (Homsher et al., 1996; Saber, Begin, Warshaw, & VanBuren, 2008) by addition
of the components described below in assay buffer (AB, 25 mM KCl, 50 mM MOPS pH
7.0, 5 mM MgCl2, 2 mM EGTA, 0.2 mM DTT) and the motility assay is performed in
motility buffer (MB, 25 mM KCl, 50 mM MOPS pH 7.0, 1 mM Na2ATP, 5 mM MgCl2,
2 mM EGTA, 10 mM DTT, 0.5 % (w/v) methylcellulose in ddH20, 2.5 mg/mL glucose,
50 µg/mL glucose oxidase, 10 µg/mL catalase, and 1% (v/v) dimethyl sulfoxide). MB
solutions containing approximate concentrations of free Ca2+ are prepared using available
software (Bers, Patton, & Nuccitelli, 2010). Free Ca2+ concentrations in MB are
experimentally determined on the prepared solutions by measuring the reported
fluorescence of each MB supplemented with 50 nM Fluro-4FF (Life Technologies), using
a steady state fluorimeter (Horiba Fluorolog 3) (Ex: 490 nm, Em: 520 nm). The free
calcium concentrations are determined using the relation [Ca2+]i = Kd (Fi-Fmin)/(Fmax -Fi),
where the free calcium concentration in solution i is determined by the fluorescence
signal, Fi, relative to a MB with no Ca2+ added (Fmin), a MB supplemented with 10 mM
Ca2+ (Fmax), and a Kd of 9.7 µM (D. Thomas et al., 2000). See Supporting Information for
a Ca2+ calibration curve sample using Fluro-4FF.
A customized flow chamber was assembled (from bottom upward) from a
nitrocellulose-coated coverslip, a 0.5 mm thick silicon gasket (Electron Microscopy
Sciences, Hatfield, PA), and a 25 mm circular microscope slide with two 0.75 mm
internal diameter tubes (IDEX Health & Science, Oak Harbor, PA) inserted into drilled
holes on the slide (see Appendix section). Nitrocellulose-coated coverslips were made by
applying a 1% (w/v) nitrocellulose solution in amyl acetate (Ladd Research, Williston,
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VT) to the surface of a coverslip. An additional glass coverslip is placed on top to spread
the solution evenly. The coverslip-coverslip sandwich is separated and the solvent is
allowed to evaporate.
On the day of the experiment, myosin (200 µg/mL) that contained catalytically
inactive motors (dead heads) is removed by co-sedimentation with F-actin (50 µg/mL) in
AB supplemented with 300 mM KCl, 1 mM ATP, and 10 µM dithiothreitol, proceeded
by centrifugation for 15 min at 180,000x g and 4 ºC. Myosin remaining in the supernatant
was aspirated and stored on ice for up to 12 hours. Reserved myosin was injected into the
flow chamber and incubated for 2 min, then perfused with 5 volumes of binding buffer
supplemented with 1 mg/mL BSA. Remaining dead heads were blocked by incubation (2
min) with F-actin (5 µM) in AB that had been sheared by aspirating several times through
a 26-gauge syringe. To remove unbound F-actin, the chamber was perfused with 5
volumes of AB. F-actin was released from the catalytically active heads by incorporating
5 volumes of AB supplemented with 1 mM ATP then chased with 5 volumes of AB. Factin that remained bound to the catalytically inactive heads was decorated with Tn and
Tm through incubation with wt Tn (500 µM) and native Tm (500 µM) in AB for 7 min
then washed to remove unbound Tn and Tm. 10 nM of fluorescently labeled F-actin in
was injected into the flow chamber and incubated for 2 min to allow capture by the
myosin heads. Bound F-actin filaments were decorated by incubation of 0.5 µM Tn and
0.5 µM Tm for 7 min. Filament sliding was initiated by perfusion of MB under certain
free Ca2+ concentration. All measurements were performed at 30 ºC. The motility
experiments for the phosphorylated Tn and the presence of EGCG were done as
described for the WT. In the phosphorylated Tn, the WT Tn was substituted for the
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phosphorylated form. In the case of the EGCG, the optimal concentration of EGCG
found was loaded in the MB using the 1% DMSO added to all the buffers.
Microscopy and imaging - Wide field epifluorescence images were acquired on
an inverted IX71 Olympus microscope with TE cooled interline CCD camera (Clara,
Andor) using a 100x (N.A. 1.4) oil immersion objective (UPlanSApo, Olympus). Videos
were acquired at one frame per second (fps) in a 512x512 pixels field of view. Excitation
was from a mercury vapor lamp (X-Cite 120PC, Lumen Dynamics). Filters (excitation:
dichroic: emission) were FF01-475/35: FF495: FF01-550/88 (Semrock) for Alexa Fluor
488. The CCD camera field of view was calibrated by imaging a dual axis linear scale
(Edmund Industrial Optics).
Image processing and computer vision - Identification of filament tracks were
done using the FIESTA software (Ruhnow et al., 2011). The Kalman filter script was
built in MATLAB (MathWorks, Natick, MA; version R2011b). A script sample is
attached in the Appendix section.
Kalman filter setup - In the Kalman filter (Figure 3.2), two requisites must be
accomplished: (i) provide a mathematical model for the filament's motion in presence of
a noise source and (ii) approximate a solution for the noise parameters. First, we describe
the filament motion in a linear discrete system:
x! = Ax!!! + Gw!!! ,
z! = Hx! + v! .
In Equation 3.1, the particle state x! at a time series point k is related to the

(3.1)
(3.2)
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previous state x!!! by the transition model A and the process noise w!!! , where the
matrix G gives dimensional consistency to w!!! . Equation 3.2 accounts for the finite
properties of the acquisition system. It describes the relation of x! to the observed state
z! by H (has similar purpose to G) and a measurement noise v! .
The noise can be divided into an error in the position v! , and an error in the
process w! . The former is related to the precision, σ! , assigned on finding a particle
position in a given time step k; the latter accounts for the finite properties of the position
acquisition process of a particle in motion (Savin & Doyle, 2005). Both noise sources can
be considered to be Gaussian:
w! ~N(0, Q ! ) ,

(3.3)

v! ~N(0, R ! ) ,

(3.4)

where Q ! and R ! represent the process noise and error in the position matrices
respectively.
The Kalman filter is divided into a prediction and a correction phase. The goal is
to minimize the error, between the hidden, real state, x! , and the optimal estimate, x! ,
based on the covariance estimate P! :
P! = E[ x! − x! x! − x! ! ] .

(3.5)

The optimization process is executed using the steady state Kalman equations,
using estimates x!!!|!!! and P!!!|!!! from the previous iteration in combination with the
input variable, z! , to recursively find optimal solutions for x!|! and P! .
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x!|!!! = Ax!!!|!!! ,

(3.6)

P!|!!! = AP!!!|!!! A! + Q ! ,
K ! = P!|!!! H ! HP!|!!! H ! + R !

(3.7)
!!

,

(3.8)

z! = z! − Hx!|!!! ,

(3.9)

x!|! = x!|!!! + K ! z! ,

3.10)

P! = P!|!!! I − K ! C ,

(3.11)

Eqns. 3.6 and 3.7 represent the estimation phase; Eqns. 3.8-3.11 comprehend the
correction phase. The Kalman gain, K ! (Equation 3.8), determines the significance of the
predicted state compared to the experimental data.
Filament sliding on a myosin-coated surface can be described as a steady-state
process, where ATP concentration, temperature, ionic strength, and pH remain constant
during the video acquisition time (~15 min). This leads to filaments being propelled at a
constant velocity by myosin heads. Acceleration in the filament trajectories can arise
from random forces imparted by surface obstacles, random orientation of myosin heads,
and inactive myosin motors (dead heads) that inhibit motility. The random forces impart
random velocities. The random force at time t is represented by ξ(!), 2D Gaussian white
noise with zero mean and correlation given by
!(!)!(!′) = !! ! ! !! − t !!! ,

(3.12)
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where ! represents and identity matrix and ! !! − t !!! is the Kronecker delta function
defined over the time interval t !!! to !! . The time evolution of the filament is governed
by the stochastic differential equation (SDE)
x = ξ! ,

(3.13)

where ! = !, ! is the 2D position of the center of the filament. Equation 3.13 is a
special case of the Langevin equation
Mx = −∇U ! − γM! + Mξ! ,

(3.14)

with constant velocity ! = −∇U ! /γM that is determined by the experimental
conditions. Integrating Equation 3.13 by a backward differencing scheme, the time
evolution of the filament velocity !! at time t is
x! = x!!! + ξ! !" ,

(3.15)

Integrating a second time, the time evolution of the position is
!

x! = x!!! + x!!! !" + ! ξ! !! ! .
Defining the state variable x! = ! !

!

!

(3.16)

consisting of the position and velocity, Equation

3.16 can be written in matrix notation as
x
x

!

=

1 ∆t x
0 1 x

!!!

+

!
!

∆t !
σ! ,
∆t

(3.17)

where ξ! = σ! . The process noise matrix Q can be defined according to Equation 3.1 and
3.2:

Q=

GG! σ!!

=

!
!
!
!

∆t !
∆t !

∆t ! !
σ .
∆t ! !

!
!

(3.18)
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Figure 3.2. The Kalman filter workflow. Schematic of the Kalman filter operation.
The real position (!! ) is convolved with the noise source, resulting in the measured
data (!! ). An approximate solution to the hidden, real, state is performed by an
iterative state estimation. During a step k, the previous iteration (!!!|!!! ) is compared
with !! to approximate the real state (!!!|! ). The schematic below illustrates the
compensatory effect of the model (blue vector) with an process error, wk (blue shades),
on the noisy measured positions, zk (black dots), with an estimated measurement error,
vk (gray shades), results in the corrected state estimate, !!!|! (red dots).
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The error in the position matrix R can be defined based on Equation 3.1:
R = HH ! σ!! = ! σ!! ,

(3.19)

where !! is the measurement noise strength, which is assumed to be isotropic. !
corresponds to an nxn identity matrix where n is the number of spatial dimensions.
Equations 3.17 to 3.19 are applied to the y-axis data. Input data consists of !! =
!! !!

!
!

, where z are the position measurements. The initial assigned state in the x-

dimension corresponds to x!!! = !! !

!!!

!

and P!!! . The mean sliding speed of a

filament is the time-average of its instantaneous sliding speeds during a measurement.
!

!=!
where !! is the sliding speed !! =

!
!!! !!

,

!!! + !!! at time ! =

(3.20)

!
!!! ∆t.

3.4 Results
To determine the effectiveness of the Kalman filter (Figure 3.2) on reconstructed
tracks, we developed a conventional in vitro motility assay where regulated actin
filaments slide on a myosin-coated coverslip (Figure 3.3 A). Addition of motility buffer
containing 1 mM ATP under pCa 4 or pCa 7 resulted in motility at pCa 4 only (Figure
3.3 B). At pCa 4, filaments were considered motile when displacing > 2 µm within 30
frames (3 sec, green-colored traces). After resolving the filament tracks, a Kalman filter
was applied to the time-dependent x-y coordinates at the maximum frame acquisition of
10 frames/s.
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The effectiveness of the Kalman filter in our reconstructed filament tracks at pCa
9 and 3 was demonstrated by assigning arbitrary values to the noise covariance matrices.
First, Q and R can be related to the scalars !! and !! respectively (Eq. 3.18 and 3.19).
Figure 3.3A exemplifies the effect of the Kalman filter on the estimated positions when
!! = 1 µm/s2 and !! = 0.25 µm. The effect of σa on the speed estimation is visualized in
Figure 3.3B, where incremental values of !! (!! is constant) reduce the confidence on the
output data from the model and the filter relies more on the measured data. A histogram
of the speeds for each condition (black, raw data; red, !! = 0.1; green, !! = 1; and blue,
!! = 10 µm/s2) illustrates the effect on the process noise (Figure 3.3 C). Notice that the
most dramatic affect on the estimated speeds occurs in the pCa9 sample, where the speed
decays proportionally to !! .
To provide an experimental estimate of the measurement noise, we tracked the
position of fluorescently labeled rAc filaments in absence of ATP. Figure 3.5 A
encompasses a collection of x-y filament positions found in a single video file. The
scatter plot displays each ordered pair represented with a plus (+) and a different color
assigned to each filament. The elliptical dashed lines represent the parameterized regions
containing 68% of the data points for each filament. We found that the orientation of the
ellipses is random (Figure 3.5 B); therefore, !! was defined as the standard deviation
derived from the grouped filament positions found in a given filed of view. Usually !!
ranges from 120-50 nm.
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Figure 3.3. Reconstructed filament sliding paths. Representation of reconstructed rAc
sliding paths under pCa 7 and pCa 4. Motile filaments (green tracks) were separated
from immotile (red tracks) when displacing ≥ 2 µm within 3 seconds (30 slides). Scale
bar, 5 µm. Conditions, 25 mM KCl, 50 mM MOPS pH 7.0, 1 mM Na2ATP, 5 mM
MgCl2, 2 mM EGTA, 10 mM DTT, 0.5 % (w/v) methylcellulose in ddH20, 2.5 mg/mL
glucose, 50 µg/mL glucose oxidase, and 10 µg/mL catalase and CaCl2 at the specified
pCa.
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Figure 3.4. Application of a Kalman filter to rAc reconstructed tracks. (A)
Representative filament tracks (black lines) are compared to the Kalman filter output
(green lines) under pCa 9 and pCa 3 buffer conditions (track length is 30 and 10 s
respectively). (B) The effect of incremental levels in the noise acceleration (σa) on the
Kalman filter. The calculated speeds from the filament tracks in (A) (black lines) are
compared to with estimated speeds with σa values of 0.1, 1, and 10 µm/s2 (blue, green,
and red respectively). (C) Speed histograms from the stepwise speed calculations in
(B) for the measured data and the displayed σa values under pCa 9 and pCa 3
conditions. The color-coding in the histograms is in agreement with (B). Conditions,
as in Figure 3.2.
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Figure 3.5. Measurement noise is isotropic. The noise associated to the measured
position in filaments was determined by resolving the centroids of surface-deposited
actin filaments in rigor state. Small frames show the centroid of an individual filament
(“+”) during a single video recording (30 sec, 10 fps). The ellipses (black dashed
lines) represent fit to bivariate Gaussian distribution. All distributions are shown at the
68% density contour. Arrow indicates the long axis of the distribution. The large
frame shows the pooled data from the small boxes. The dashed ellipses represent a fit
to a bivariate Gaussian. Solid circle represents a fit to bivariate Gaussian with null x-y
correlation and equal standard deviations for the x-y axis resulting in σz = 0.038 µm
(equation A.3.3). Grid lines indicated the pixel size (67 nm) of the CCD camera. (B)
The Pearson correlation coefficient (equation A.3.2) was computed on individual
reconstructed filament tracks derived from filaments in rigor state. The normalized
histogram indicates no preferred orientation for the ensemble of filaments. Videos
were recorded for 30 seconds and 10 video frames per second. A total of n = 85
filaments were extracted from n = 5 preparations. Conditions, as in Figure 3.2.
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To provide an optimal solution for the process noise, we developed a numerical
approximation for σa based on the dynamic properties of regulated actin filaments under
pCa 9, where filaments are considered to be static. Figure 3.6 A illustrates the monotonic
increase in speed as a function of !! ; the gray line represents the standard deviation for
several filaments (n = 10). From our results, no inflection or critical point was found. We
proceeded to implement a second criterion based on the fact that, according to the
Kalman filter theory, the input data contains white noise (i.e., noise is Gaussian and
uncorrelated in time). Therefore, a noise-free data output should depict a close-to-zero
skewness in the innovation residuals (i.e., the output noise). Figure 3.6 B indicates that
increments of σa cause an asymptotic tendency to zero on the innovation residuals
skewness. Therefore, we considered the optimal value for σa, and consequently to Q, as
the minimum value that satisfies an approximation to zero in the skewness. Under our
experimental conditions, the optimal value of !! ranged from 0.5 to 3 um/s2.
To demonstrate satisfactory optimization of the measurement and process noise
parameters, we evaluated the filter output data from motile regulated actin filaments
under pCa 3. The autocorrelation in the innovation residuals (Figure 3.6A) for individual
filament tracks indicates no trends, suggesting a white noise pattern. The root-meansquared-displacement (RMSD, Eq. A.3.5) indicates a reduction in the variability and offrate displacements at low time intervals (Figure 3.5 B). The Kalman-filtered data (blue
lines) shows less bias relative to the unfiltered data (red lines) in agreement with previous
studies (Wu et al., 2010; Wu, Arce, Burney, & Tseng, 2009). From Figure 3.5 B, it is
possible to estimate the slope ΔRMSD/Δτ, resulting in a quotient dimensionally
equivalent to the speed (µm/s).
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Figure 3.6. Estimation of acceleration noise. Analysis of n = 6 filaments examined at
low (pCa 7) and high (pCa 4) free Ca2+ concentrations using different values for
acceleration noise (σa) parameter in the Kalman filter. (A) Effect of σa on estimated
sliding speed. Mean (black line) and SD (gray area) are shown. Red line represents the
average sliding speed of unfiltered data. (B) Effect of σa on the skewness in
distribution of innovation residuals !̃! (Eq. 3.9), the time-dependent difference
between model position and measured position. A skewness of zero (red dot, σa =
2.51 µm/s2) identifies the optimum parameter value. Conditions, as in Figure 3.2.
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To visualize the effect of the optimized filter under several motile regimes, we
proceeded to measure sliding speed on regulated actin at different pCa levels. Figure 3.6
C summarizes the resulting speeds for the unfiltered data (red), the Kalman filter data
(blue), and the ΔRMSD/Δτ derived from the Kalman filtered data (green). The Kalman
filter causes an overall speed decay in the curve compared to the unfiltered data. The
ΔRMSD/Δτ data has an onset closer to zero compared to the two previously mentioned
cases. Hill equation curve fits reveal that the pCa50 remains unbiased after any of the
speed estimation approaches illustrated (Table A.3.1). Through the evidence shown, we
conclude that the Kalman filter effectively suppresses white noise associated to
reconstructed filament tracks.
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Figure 3.7. The Kalman filter improves estimates of filament position and sliding
speed. (A) Log-log plot of root-mean-square displacement (RMSD) vs. time step.
Unfiltered data (red) and Kalman filtered data (blue) are shown for n = 6 filaments.
Inset shows traces of unfiltered data diverging from the filtered data at short time
steps. (B) Ca2+-dependent sliding speed from unfiltered data (red) and Kalman filtered
data (blue). Data are mean ± SD (error bars) from 22-67 filaments in n = 5
preparations. Conditions, Kalman filter parameters were σz = 0.134 µm, σa = 2.16
µm/s2. Data was fit to a Hill equation. The recovered parameters are listed: pCa50
(maximum likelihood estimate ± asymptotic SE), 4.99 ± 0.10 and 5.02 ± 0.07; nH, 1.3
± 0.3 and 1.2 ± 0.2; Vmax, 1.7 ± 0.1 and 1.8 ± 0.1 µm/s; Vmin, 0.32 ± 0.05 and 0.09 ±
0.05 µm/s for unfiltered and filtered data respectively. Conditions, as in Figure 3.2.
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3.5 Discussion
The main advantage of implementing a Kalman filter is to rescue instantaneous
velocities from reconstructed paths corrupted by noise. Previous methodologies
circumvent this problem by undersampling video frames on slowly moving filaments
(Homsher et al., 1996; Homsher et al., 1992). Disadvantages of this approach are (i) the
sample size becomes reduced, and (ii) in a single video recording it is possible to have
slow and fast moving filaments. In the former case, the speed of fast moving filaments is
underestimated by skipping video frames, because the filament trajectories are not
necessarily linear (Homsher et al., 1992). We found the Kalman filter enables use of all
video frames to resolve instantaneous speeds regardless of the average filament sliding
speed. Conversely, this increases the number of data points used to estimate average
speeds.
To the best of our knowledge, our Kalman optimization approach applied to
biological problems is the first to rely exclusively on experimental data. A limitation of
our optimization approach is that σz is determined on static objects (Savin & Doyle,
2005). Consequently, this approach can be difficult to apply to diffusion phenomena
inside the cells. Studies on the microrheological properties of particles inside and outside
cells could clarify whether noise modeling in an ex vivo context is applicable to particle
motion in cytosolic environment.
We measure R in a complex shape. Previous studies have addressed measurement
error in symmetric particles, where R is essentially independent of the coordinate system.
In these circumstances simulations can be a reliable source to estimate R. In this work,
however, the estimation of R required to establish an experimental estimation strategy
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due to variability in the filament length and orientation. We demonstrated that a purely
experimental approach to estimate R could be achieved by analysis of the ensemble of
centroids identified in video recordings of static filaments. Other problems like threedimensional diffusion represent potential routes to explore the dynamic of particles with
more complex shapes in a cellular context.
In the case of Q, its significance is related to the Brownian dynamics of the
system (Savin & Doyle, 2005; Wu et al., 2010). However, our experimental optimization
of Q revealed an intrinsic source of noise in static filaments (Figure 3.5 A), suggesting
other factors in the image acquisition process are more relevant than potential stochastic
fluctuations. To test this hypothesis, we can compare the filament centroid dynamics with
the Brownian diffusion of a freely diffusing filament. Considering that molecular weight
of a thin filament is on average 8 MDa (see Appendix 1), the diffusion coefficient of a
filament (modeled as a cylinder) is determined by the Einstein–Smoluchowski relation,
where D! = 1.70 µm s !! (Ortega & Garcı́a de la Torre, 2003). The time elapsed between
each frame is 0.1, thus the root-mean-squared distance traveled by a freely diffusing
filament is r = 0.84 µm (see Appendix section). Based on our experimental results of
filaments under sub-saturating Ca2+ concentrations (Figure 3.3 and Figure 3.5), it results
unlikely that a filament will travel 0.84 µm within two video frames or 2.61 µm in one
second. We conclude that filaments are sufficiently anchored to the surface to prevent
Brownian effects. Therefore, the nature of the noise in the process is not related to the
statistical mechanics of the filaments, but to the data acquisition step.
One limitation of IVMAs is that maximum sliding speeds occur at pH levels
higher that physiological conditions. Left ventricle intracellular pH is close to 7.0 (Roos
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& Boron, 1981). IVMAs are conventionally developed at pH 7.4, which maximizes
filament-sliding speeds (Kron & Spudich, 1986). As it is seen in Figure 6, slow filament
sliding speeds cause overestimation of sliding speeds. Therefore, operating at low pH
values can complicate analysis of filament sliding speeds (Edward P. Debold et al., 2011;
Walcott, Warshaw, & Debold, 2012). I have demonstrated that the Kalman filter
suppresses data corruption at low filament sliding speeds. Therefore I consider that
implementing the Kalman filter can alleviate the analysis of filament speeds near
physiological pH levels.

3.6 Conclusions
I have developed a post-processing approach to improve the analysis of filament
sliding speeds in the IVMA. The application of exclusively experimental data to resolve
the optimization process of the Kalman filter proved to be feasible. The most significant
progress resides on the exploited statistical properties of the experimental noise
embedded within the data to resolve the most suitable operating conditions. I expect that
this approach will facilitate the application of this algorithm to other biological problems.
Of special interest is to study the regulatory role of Tn as a nodal point of regulation of
muscle contraction. This is because novel therapeutic strategies can rely on drugmediated regulation Ca2+ sensitivity in Tn to ameliorate heart muscle disease.

75

CHAPTER IV
EFFECT OF INTRINSICALLY DISORDERED REGIONS
OF TROPONIN ON THE SLIDING DYNAMICS OF THE
CARDIAC THIN FILAMENT
4.1 Abstract
Muscle contraction is regulated by the Ca2+-sensing troponin (Tn) complex, which is
responsible for inhibiting F-actin and myosin interactions in absence of saturating Ca2+
concentration transients. Although there is a general knowledge of the molecular steps
involved in the core structure of Tn, the role of intrinsically disordered regions (IDRs) is
unclear because their crystal structures have not being resolved yet. Here, I investigated
the function of two IDRs in Tn: the amino N-terminus of TnI and the carboxy C-terminus
of TnT. I perturbed the structure/function of the regions by (i) PKA-dependent
phosphorylation of serine 23 and 24 (Ser23/24) within N-TnI, and (ii) 14-amino acid
deletion at the C-terminal region of TnT (Δ14TnT). Case (i) was compared to effects
from the Ca2+ desensitizer epigallocatechin-3-gallate (EGCG). Ser23/24-phosphorylated
TnI and EGCG desensitized filaments to Ca2+, and decreased sliding velocity. Δ14TnT
increased the maximum sliding velocity (Vmax) and residual sliding speeds were visible at
subsaturating free Ca2+ concentrations. My results suggest the TnI and TnT IDRs exert
profound influence on the Ca2+-dependent activation of rAc, suggesting these regions
play a major role in the activation state of the thin filament.
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4.2 Introduction
Muscle contracts through the sliding of thin filaments past stationary thick
filaments. Sliding is from cycling cross-bridges formed between myosin motors
projecting from the thick filament and filamentous actin (F-actin) within the thin
filament. F-actin is decorated along its length by assemblies of tropomyosin (Tm) and
troponin (Tn), comprised of troponin C (TnC), Troponin I (TnI), and troponin T (TnT),
which regulate sliding in a Ca2+-dependent manner (Gordon et al., 2000; Potter &
Gergely, 1974).
Although TnC binding Ca2+ is the main signaling node of muscle activation,
structural and extrinsic factors can influence the Ca2+ binding equilibrium of Tn.
Intrinsically disordered regions (IDR) in Tn are peptide regions corresponding to the
terminal domains in TnI and TnT not resolved in crystal structures (Takeda et al., 2003;
Vinogradova et al., 2005). The role of these unstructured regions on Tn activation is
demonstrated by the effect of protein kinase A (PKA)-dependent phosphorylation of
serines 23/24 (Ser23/24) in TnI (S. P. Robertson et al., 1982), and the defective splice of
TnT leading to truncation of 14 amino acids in the C-terminal domain (Thierfelder et al.,
1994) (Figure 1). The former confers Ca2+ desensitization, while the latter increases the
Ca2+ sensitization of isometric force development of cardiac muscle fibers (Franklin,
Baxley, Kobayashi, & Chalovich, 2012; Nakaura et al., 1999; R. J. Solaro, Henze, &
Kobayashi, 2013).
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Figure 4.1. Molecular model of the core domain of troponin and the IDRs. The Tn
model corresponds to the computational reconstruction of the Tn complex by
Schwartz group (Manning, Tardiff, & Schwartz, 2011). TnC, TnI, and TnT are colored
tan, light blue, and pink respectively. The N-terminus of TnI (residues 1 to 33) and the
C-terminus of TnT (residues 275 to 288) are represented as surfaces. TnI serines 23/24
are colored yellow.
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Although the physiological implications (i.e. muscle contraction, force
generation) have been well studied, there is little information of the molecular processes
that operate in IDRs. Recent evidence suggests the N-terminal domain of TnI is in close
proximity to the TnC N-terminal domain (Warren, Kobayashi, & Solaro, 2009).
Phosphorylation appears to reduce stabilizing interactions between the TnI N-terminal
domain and TnC, leading to Ca2+ desensitization (Howarth, Meller, Solaro, Trewhella, &
Rosevear, 2007). In the case of TnT, deletion of 14 residues at the C-terminal end
increases ATPase activity and Ca2+ sensitivity of force generation (Franklin et al., 2012;
Gafurov et al., 2004). Likewise, single point mutations in this region increased Ca2+
sensitivity (Brunet, Chase, Mihajlović, & Schoffstall, 2014).

Extrinsic factors like inotropic agents can have dramatic influence on the
activation state of the myofilament (M. X. Li, Robertson, & Sykes, 2008). These
inotropes represent drugs that alter the cardiac muscle force development. One example
is the Ca2+-desensitizing drug (-)-epigallocatechin 3-gallate (EGCG), which causes
desensitization and maximum force development in isometric force measurements of
cardiac muscle fibers and no effects in skeletal muscle fibers (Liou, Kuo, & Hsieh, 2008;
Warren et al., 2015). At the molecular level, EGCG interacts with the C-lobe of TnC and
near the TnI N-terminal region (residues 34-71) (I. M. Robertson, Li, & Sykes, 2009).
Despite this evidence, the mechanism at the molecular level is not clear, which is
necessary to understand the allosteric mechanism of Ca2+ activation (J. M. Robinson et
al., 2004). Of particular interest it is to determine whether there is a common
sensitization/desensitization mechanism to inotropes and TnI Ser23/24 phosphorylation.
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Here, I determined the role of TnI N-terminal region and TnC C-terminal region
by studying the sliding of thin filaments decorated with phosphorylated Ser23/24 TnI and
by truncation of 14 amino acids in TnI C-terminal domain (Δ14TnT). My results
confirmed that TnI serines 23/24 phosphorylation confers Ca2+ desensitization while
Δ14TnT mutant increased the maximum sliding speed with sustained filament sliding
under low Ca2+ concentrations. The effects of TnI serines 23/24 phosphorylation on rAc
sliding demonstrated a common mechanism to EGCG. My results provide a view on the
allosteric role of IDS on Tn regulation and its potential to dramatically affect thin
filaments.
4.3 Materials and Methods
Protein preparation – Actin and tropomyosin, myosin from chicken pectorals,
recombinant wild-type (WT) cardiac troponin C (TnC) from rat (C35S, C84S, S89C),
WT cardiac troponin I (TnI) from mouse, and WT Troponin T (TnT) from rat were
purified and stored as described in Materials and Methods in Chapter 3. Phosphorylation
of Ser23/24 in TnI was performed as described (Finley et al., 1999) using the catalytic
subunit of protein kinase A (PKA) from bovine hearts (Sigma-Aldrich). Briefly, Tn was
phosphorylated by the addition of 125 units of PKA/mg TnI and 5 mM ATP, followed by
incubation at room temperature for 3 hr. Excess ATP was removed by extensive dialysis
against WB. PKA-mediated phosphorylation of Tn complexes exclusively
phosphorylates Ser23/24 in TnI (Ward, Ashton, Trayer, & Trayer, 2001). Human cardiac
Tn and a 14-amino acid deletion on TnT-C terminal domain reconstituted in Tn complex
(TnT-Δ14) were kindly provided by Joseph M. Chalovich from East Carolina University.
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In vitro motility assay – The motility experiments were performed as described in
Chapter 3 with minor changes. For the experiments including PKA phosphorylated Tn
complex, after incubation of phalloidin-AF488-labeled F-actin into the flow chamber a
solution containing 500 µM of PKA phosphorylated Tn and Tm was incubated for 7 min.
After incubation, 5 volumes of MB were incorporated at each specific pCa level
containing 0.1 µM of PKA phosphorylated Tn and 0.1 µM Tm. Measurements at each
pCa level were performed in separate experiments.
Ca2+ titrations of filament sliding – Conditions during the IVMA were performed
as described in Chapter 3. For the phosphorylated Tn and the presence of EGCG were
done as described for the WT. In the phosphorylated Tn, the WT Tn was substituted for
the phosphorylated form. In the case of the EGCG, the optimal concentration of EGCG
found was loaded in the MB using the 1% DMSO added to all the buffers.
Microscopy and imaging – Imaging conditions and video recording wer
performed as described in Chapter 3. Briefly, Wide field epifluorescence images were
acquired on an inverted IX71 Olympus microscope with TE cooled interline CMOS CCD
camera (Zyla, Andor) using a 100x (N.A. 1.4) oil immersion objective (UPlanSApo,
Olympus). Videos were acquired at 10 frames per second (f.p.s) in a 512x512 pixels field
of view. Excitation was from a mercury vapor lamp (X-Cite 120PC, Lumen Dynamics).
Filters (excitation: dichroic: emission) were FF01-475/35: FF495: FF01-550/88
(Semrock) for Alexa Fluor 488. The CCD camera field of view was calibrated by
imaging a dual axis linear scale (Edmund Industrial Optics). The flow chamber
temperature was maintained at 30ºC by using a heating microscope objective jacket
(Bioptechs, Butler, PA).
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Image processing and data analysis – Recorded videos were analyzed using the
FIESTA software to obtain the reconstructed filament tracks (Ruhnow et al., 2011).
Filament tracks were additionally processed using a customized Kalman filter to remove
intrinsic noise generated by the video acquisition process and filament track
reconstruction (See chapter 3). Prior to using the Kalman filter, an optimization process
was executed using video recordings at pCa 3 and pCa 9.
Plots of sliding filament speeds (V) as a function of Ca2+ concentration were fitted
to the Hill equation
!

!"#
!(!"#) = ! + (! − !) !"!!(!"#!"!!"#)

,

(4.1)

where a and b correspond to scaling factors, Vmax is the maximum velocity, nH the
Hill coefficient, pCa50 is the pCa concentration that produces half the value of Vmax, and
pCa is !"#!" = −!"#!" ([!"!! ]).
4.4 Results
To determine the functional role of the intrinsically disordered C-terminal region
of TnT, comprised of 14 amino acids, on rAc activation, we performed pCa titrations
using a reconstituted human cardiac Tn complex containing a 14-amino acid deletion in
the C-terminal domain of TnT (Δ14-TnT). Sliding speed measurements reveal that TnTΔ14 causes a ~98 % percent increase in Vmax compared to WT Tn in rAc (Figure 4.2 A).
This is consistent with TnT-∆14 causing an increase in ATPase activity (Franklin et al.,
2012). TnT-Δ14 causes no significant change in pCa50, and a significant decrease in nH
compared to the control measurements (Figure 4.2 B). In addition, TnT-Δ14 produced
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residual filament sliding under relaxing conditions. The Kalman filter post-processing
approach (see Chapter 3) facilitated unequivocal distinction of these residual velocities.
The parameters derived from the Hill equation curve fit are shown in Table 4.2. These
results reveal that the C-terminal region of TnT is actively involved in regulating Tn
cross-bridge activity, consistent with ATPase activity assays of Δ14-TnT rAc (Franklin et
al., 2012; Gafurov et al., 2004).

Figure 4.2. Deletion of the C-terminus of TnT activates filament sliding. Ca2+dependent sliding of rAc reconstituted with human cardiac Tn containing Δ14-TnT
(filled) and WT TnT (open) were measured. For each Ca2+ concentration, trajectories
from filaments in n = 5 preparations were analyzed using the FIESTA software. The
reconstructed paths were post-processed by using a customized Kalman algorithm (σz
= 0.044 µm , σa = 2.41 µm/s2). Pooled data, mean ± SD (error bars) are shown. Solid
lines represents fits to the Hill equation with parameters in Table 4.2. Filament sliding
speeds (A) and peak-normalized sliding speeds (B) are shown. See appendix 4 for raw
data.
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Table 4.1. Summary of parameters from fits to the Hill equation in Figure 4.2.
WT TnT
Δ14 TnT
Vmax (µm/s)

2.48±0.01

4.61±0.18

Vmin (µm/s)

0.06±0.01

0.39±0.13

pCa50

5.51±0.01

5.53±0.13

nH

4.67±0.65

1.55±0.36

* Trajectories of rAc reconstituted with human cardiac Tn containing WT TnT (n = 69-177 filaments from
5 preparations) or Δ14 TnT (n = 20-127 filaments from 5 preparations) were processed by a Kalman filter.
Ca2+-dependent mean sliding speeds were fit to the Hill equation (Eq. 4.1). Values are maximum likelihood
estimate ± asymptotic SE.

To evaluate the Ca2+-desensitizing properties of EGCG in an IVMA, we
performed a Ca2+-dependent-titration of EGCG on rAc and F-actin (Figure 4.3). We
determined that Ca2+ desensitization occurs in presence of Tn and Tm, suggesting that
EGCG does not interfere with myosin and F-actin cross-bridge formation. From these
results we found the effective concentration (EC50) for EGCG to be 27 ± 8 µM at pCa
4.5. This result is in agreement with ATPase activity studies of rAc with myosin S1 and
EGCG (Fuchs & Grabarek, 2013). When EGCG is not present in the motility buffer, the
maximum sliding velocities correspond to 0.97 ± 0.09 µm/s and 1.19 ± 0.17 µm/s for Factin and rAc respectively. This higher maximum sliding velocity caused by the presence
of Tn and Tm has been previously observed and is a consequence of the alteration of the
myosin cross-bridge kinetics by the regulatory proteins Tn and Tm (Homsher et al.,
2003).
To assess the effect of EGCG and PKA-phosphorylation on the Ca2+-dependent
activation of rAc, we measured the sliding velocities of rAc-WT, PKA-treated rAc-WT,
and rAc-WT supplemented with 20 µM EGCG. Ca2+-dependent titrations reveal a near
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two-fold decrease in Vmax for both rAc with EGCG and PKA-treated rAc when compered
to control measurements (Figure 8 A, left). The respective normalized plot (Figure 4.4 A,
right) emphasizes the change in the sensitivity (pCA50) for rAc with EGCG and PKAtreated rAc, consistent when shown as a percentage of motile filaments (Figure 8 A left).
Desensitization is more evident in the respective normalized plot (Figure 8 B, right), and
is in agreements with previous reports (Gorga, Fishbaugher, & VanBuren, 2003;
Papadaki et al., 2015). Notice the differences in the change in Vmax and percent motile are
100% and 20%, respectively, for EGCG and PKA treatment relative to WT, suggesting
speed measurements are more sensitive to changes in the ordinate axis than the percent
motile. Data derived from the respective Hill equation fits are summarized in Table
4.2.These results suggest both phosphorylation of TnI Ser23/24 and EGCG interact with
Tn to desensitize rAc through a similar mechanism.
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Figure 4.3. Dose-response relation of EGCG concentration and filament sliding speed.
The effect of EGCG on F-actin (solid dots) and rAc (empty dots) sliding speeds was
tested by incorporating EGCG concentrations from 0.1 to 500 µM in MB at pCa 4.5
and 30 ºC. The experimental data for rAc was fitted to a Hill equation (continuous
line, Eq. 4.1): Vmax, 1.2 ± 0.1 µm/s; nH, 1.2 ± 0.1; EC50, 27 ± 8 µM (mean ± SD). Each
data point is composed of 6-28 filaments derived from n = 3 experiments and
represented as mean ± SD.

86

Figure 4.4. PKA-dependent phosphorylation of TnI Ser23/24 and EGCG reduce
filament sliding speed and desensitize rAc to Ca2+. rAc were untreated (red), PKAtreated (blue), or untreated and supplemented with 20 µM EGCG (green). For each
Ca2+ concentration, trajectories from 20-177 filaments in n = 5 preparations were
processed by a Kalman filter (σz = 0.037 µm , σa = 2.74 µm/s2). Solid lines represents
fits to the Hill equation with parameters in Table 4.2. (A, B) Pooled data, mean ± SD
(error bars) of Ca2+-dependent motility. (A) Sliding speed (left) and peak-normalized
sliding speed (right). (B) Fraction of filaments that are motile (left) and peaknormalized fraction of motile filaments (right).
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Table 4.2. Summary of parameters from Hill equation furve fits from Figure 4.4
rAc
rAc + EGCG
PKA-treated rAc

Vmax

Speed

% Motile

Speed

% Motile

Speed

% Motile

1.8±0.1

-

0.76±0.09 -

0.92±0.06 -

(μm/s)
pCa50

5.02±0.07 5.54±0.09

4.6±0.2

4.87±0.04

4.88±0.07 5.11±0.08

nH

1.2±0.2

1.5±0.9

2.3±0.4

1.5±0.3

1.3±0.3

2.7±1.0

* Trajectories of rAc (n = 69-177 filaments from 5 preparations), rAc + 20 µM EGCG (n = 20-127
filaments from 5 preparations), and PKA-treated rAc (n = 18-82 filaments from 5 preparations) were
Kalman filtered. Ca2+-dependent mean sliding speeds and the fraction of motile filaments were fit to the
Hill equation (Ex. 4.1). Values are maximum likelihood estimate ± asymptotic SE.

4.5 Discussion
My observations on increased sliding speeds due to the Δ14-TnT mutant (Figure
4.4, are in agreement with previous reports showing a ∆14-TnT-dependent increase in
ATPase activity (Franklin et al., 2012; Gafurov et al., 2004). Force measurements on
muscle fibers exchanged with Tn (Δ14-TnT) mutant have shown increased Ca2+
sensitivity of skinned skeletal and cardiac muscle fiber, with pCa50 decreases of 0.3 and
0.2, respectively (Gafurov et al., 2004). Our sliding speed measurements show no
significant increases in the Ca2+ sensitivity. However, pCa50 values from speed-pCa
(IVMA) and force-pCa (muscle fiber experiments) may not be interchangeable (Gordon,
LaMadrid, Chen, Luo, & Chase, 1997). My results show a significant two-fold increase
in Vmax, consistent with a 2.4 fold increase in ATPase activity under saturated Ca2+
conditions (Gafurov et al., 2004).
The Δ14-TnT mutant induced residual sliding speeds at sub-saturating Ca2+
concentrations and increased Vmax The residual sliding speeds seen in Δ14-TnT mutant at
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unsaturated Ca2+ conditions suggests the presence of an active Tn population at subsaturating Ca2+ levels. One explanation is that the TnT C-terminal domain stabilizes Tn
inactive state in rAc (Franklin et al., 2012). Second, the reduced cooperativity, compared
to WT, suggests each regulatory unit activates more independently due to the Δ14
deletion. These ideas are supported by the high degree of conservation in cardiac and
skeletal TnT isoforms (Wei & Jin, 2011). Conversely, mutations in this region result in
increased Ca2+sensitivity (Brunet et al., 2014). According to the model proposed by Sich
et al. (2014), Vmax depends on the ATP and ADP concentrations, and the respective actinbound myosin affinities for ATP and ADP (Sich et al., 2010). Since the ATP
concentrations remained unaltered, and no additional ADP was incorporated, it is
possible that the relative decrease of Vmax is due to an alteration in the nucleotide binding
affinities of acto-myosin. This idea is supported by evidence of the role of Tn and Tm in
altering the nucleotide binding kinetics on IVMAs (Homsher et al., 2003).

Our IVMA measurements indicate that both phosphorylated TnI and EGCG have
significant effects on Ca2+ desensitization and a reduction of Vmax. Sich et al. (2014)
suggest that desensitization may arise from (i) a decrease in the number of recruited
cross-bridges, (ii) a decrease in the effective rate of actomyosin attachment, or (iii) a
change in the binding affinity of rAc for Ca2+ (Sich et al., 2010). Based on this model,
case (ii) and (iii) can both produce Ca2+ desensitization in TnI Ser23/24 phosphorylation
and EGCG. However, it is known that TnI Ser23/24 causes desensitization to Ca2+ due to
faster Ca2+ release kinetics (Nixon et al., 2014; R. John Solaro & van der Velden, 2010).
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Therefore, case (iii) is responsible for the decrease in Ca2+ sensitivity; however, case (ii)
can contribute up to some extend to explain the decay in Vmax.
Using pCa titrations, my data suggest that the Ca2+ desensitization of
myofilaments by EGCG is analogous to that of TnI serines 23/24 phosphorylation.
Whereas TnI Ser23/24 phosphorylation causes destabilization of interactions between
TnI and TnC N-terminal domains, EGCG interacts with TnC-C terminal domain. In the
latter, this interaction is believed to be a ternary interaction between TnC C-lobe, the TnI
anchoring region (residues 34-71) and EGCG (I. M. Robertson et al., 2009). Also,
incorporation of EGCG into Ser23/24-phosphorylated TnI shows an additive effect on the
desensitization of thin filaments (Papadaki et al., 2015). From these observations, it is
possible to hypothesize is that ECGC interactions in this region propagate upstream into
the cardiac-specific TnI extension (residues 1-30) causing destabilization of TnI and TnC
N-terminal domain interactions; thereby, phosphorylation of TnI Ser23/24 intensifies this
effect.
Our results provide a glimpse into the potential role of Tn as a target to diverse
cardiopathies. The Ca2+ desensitizing effects of EGCG can be exploited as a therapeutic
strategy to treat hypertrophic cardiomyopathies with phenotypic manifestations of
increased Ca2+ sensitivity to isometric force production or myosin ATPase activity
(Alves et al., 2014; Warren et al., 2015). Second, EGCG may represent a potential
candidate to treat restrictive cardiomyopathies that manifest elevated end diastolic
pressure due to mutations present in the regulatory proteins (J. Davis et al., 2012). As a
corollary, there is a positive correlation between green tea consumption (which is a
natural source of EGCG) and reduced mortality from all causes of cardiovascular disease
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(Kuriyama, Shimazu, Ohmori, & et al., 2006; Suzuki et al., 2009). On the other hand,
EGCG has proven exclusive desensitization to Ca2+ in cardiac muscle fibers (Liou et al.,
2008). Another advantage is the lower pharmacological risks associated to polyphenols
like EGCG (Stangl, Dreger, Stangl, & Lorenz, 2007). The main opportunity here resides
in expanding the current spectrum of treatments for congestive heart failure with reduced
side effects. Thus, further studies are critical to derive solid conclusions on the
cardioprotective properties of polyphenols.

4.6 Conclusions
There is substantial evidence regarding the role of Tn and Tm on the modulation
of cross-bridge activation kinetics (Fraser & Marston, 1995; Gordon et al., 2000;
Homsher et al., 1996; Homsher et al., 2003), and the profound effect of single point
mutations in familial cardiomyopathies (Tardiff, 2011; Thierfelder et al., 1994). Our
results highlight the functional role of the cTnI N-terminal extension (through Ser23/24
phosphorylation) and the TnT C-terminal region on modulating thin filament activity,
with contrasting effects on filament activation. Similarly, EGCG impairs desensitization
in an analogous mechanism to Ser23/24 phosphorylation of TnI. Our results suggest
allosteric mechanisms within Tn IDRs may exert profound changes in the Ca2+ binding
properties. Further studies are required to clarify these observations in light of the
potential benefits of defining Tn as a treatment node of cardiopathies.
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CHAPTER V
STUDY OF CALCIUM AND MYOSIN DEPENDENT
ACTIVATION OF THIN FILAMENTS BY FLIM-FRET
5.1 Abstract
In cardiac muscle, Troponin (Tn) and Tropomyosin (Tm) inhibit actin and myosin
interactions through the steric blocking of cross-bridge formation. This inhibition is
reversed by Ca2+ binding to TnC, which leads to concerted activation of the thin filament.
In the sarcomere, myosin is found in close proximity to thin filaments, and actively
participates in the cooperative Ca2+-dependent force development. Myosin ATP catalytic
cycle presents three degrees of binding affinity to thin filaments designated as relaxed,
weak, and strong binding states. Despite this level of description, cooperative activation
models do not fully define the molecular events that take place in Tn during thin filament
activation. Here, we studied conformational changes within Tn bound to F-actin and Tm
by Fluorescence Lifetime Imaging Microscopy combined with Förster Resonance Energy
Transfer (FLIM-FRET). Fluorescent donor and acceptor dye molecules were attached to
the TnC C-lobe and to the TnI C-terminal domain, respectively, to report Ca2+ and
myosin induced activation of Tn. Reconstituted filaments were deposited on a myosincoated surface, similarly to an in vitro motility assay setup. My results revealed a major
contribution of Ca2+ to Tn activation under all the tested conditions. Conversely, rigor
myosin further activates Tn at sub-saturated and saturated Ca2+ levels, where activation is
more significant in the former case. The addition of ATP-γ-S did not affect Tn activation
significantly; however, blebbistatin induced partial activation at sub-saturating Ca2+
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levels. Finally, I found a positive correlation between transfer efficiency and the donor
lifetime distribution width. To the best of our knowledge this is the first study that
attempts to interrogate intra Tn structural changes in an in vitro motility assay setup. This
data suggests that as Ca2+ and myosin induce Tn activation, an increased degree of
conformational freedom occurs within Tn. I conclude that these results satisfy an
allosteric activation process of the thin filament as a function of Ca2+ and myosin
catalytic cycle state.

5.2 Introduction
Cardiac muscle activation is driven by cyclical interactions between myosin and
actin filaments that result in catalytic conversion of ATP into mechanical force (Gordon
et al., 2000; Kron & Spudich, 1986). Actin and myosin cross-bridges are regulated by
cytosolic Ca2+ concentration transients, which releases inhibitory states promoted by
troponin (Tn) and tropomyosin (Tm) (Ebashi, 1963; Greaser & Gergely, 1971). This
intricate communication network is extended throughout the thin filament assembly by
tight coupling of the regulatory proteins Tn and Tm (Greene & Eisenberg, 1980; T. L.
Hill et al., 1980). Molecular allostery is responsible for remarkable function in the
physiological context (Brandt et al., 1980; Fabiato & Fabiato, 1978).
Tn and Tm concatenate in parallel to each actin filament helix (Haselgrove, 1973;
Huxley, 1973; Parry & Squire, 1973; Spudich et al., 1972). Each Tn-Tm unit spans seven
actin monomers, which interact through tight overlapping with axially presented neighbor
regulatory units (Alan S. Mak & Lawrence B. Smillie, 1981; Weber et al., 1963; White et
al., 1987). Tm is though to occupy three coarse-grained affinity states in F-actin surface
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responsible for differential response to cross-bridge driven ATPase activity in myosin
(McKillop & Geeves, 1993; Vibert et al., 1997). In the blocked state, Tm inhibits weakly
bound myosin (ATP-myosin) cross-bridge formation. The closed state is marked by a 25º
azimuthal rotation in Tm that enables binding of myosin to ionic affinity sites in F-actin
(Behrmann et al., 2012; Gordon et al., 2000; I. Rayment et al., 1993; Xu et al., 1999).
Finally, the open state is promoted by rigor cross-bridges and appears to induce an
additional 10º change in Tm position (Behrmann et al., 2012; Geeves & Conibear, 1995).
Myosin S1 fragments in the presence of ATP, low ionic strengths (16-18 mM), and no
Ca2+, have been shown to actively bind to thin filaments without significant increments
on the ATPase rate, suggesting that Tm inhibits a weak to strong transition in myosin
essential for hydrolysis product release and level arm rotation (J M Chalovich &
Eisenberg, 1982; Tobacman & Adelstein, 1986).
In resting muscle fibers, TnI maintains contact with affinity sites in F-actin trough
multiple peptide regions located in TnI C-terminal domain (Galinska et al., 2010; Tripet
et al., 1997). In combination with the TnI switch peptide responsible binding to TnC Nterminal region, these two sites constitute the mobile domain of TnI (M. X. Li et al.,
1999; Takeda et al., 2003). Increments in the free Ca2+ concentration (~6 µM) promote
switching of TnI mobile domain binding from F-actin-Tm to TnC (J. M. Robinson et al.,
2004). However, this shifting is incomplete and to a large extent, Ca2+-bound to Tn does
not fully switch these regulatory sites (Dong et al., 1999; John M. Robinson, 2008). This
activation deficit is corrected by rigor myosin binding to F-actin which causes shifting of
this equilibrium to enhance proximity between TnC N-terminal and TnI C-terminal
regions (J. P. Davis et al., 2007; J. M. Robinson et al., 2004). Despite of this level of
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detail, a three-state regulatory model of the thin filament is centered on the structural
changes occurring in Tm, leaving a yet to be resolved description of the structural
changes occurring in Tn, particularly in TnI mobile domain. A second question is how
different myosin states affect this equilibrium process.
Here, I report a structural dynamics study of Tn based on an Förster Energy
Transfer (FRET pair) sensitive to changes in TnI mobile domain distance changes
relative its Tn core region (Tn-DA). We deposited Tn-DA reconstituted in thin filaments
into confluent surface-deposited myosin molecules (Figure 5.1) that mimic the fixed state
of myosin heads of thick filaments. I determined changes in FRET from thin filaments as
a function of Ca2+ saturation levels and myosin functional states to better understand the
activation steps of Tn during the cross-bridge cycle. My results support an allosteric
model of activation where Ca2+ and myosin serve as allosteric effectors of Tn activation.
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Figure 5.1. Surface-deposition of regulated actin in decorated flow chambers. rAc
filaments composed of 1 TnDA: 1 Tm : 7 F-actin were deposited on myosin and
blocking buffer decorated surfaces under saturated (pCa 3) or unsaturated (pCa9) Ca2+
concentrations.
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5.3 Materials and Methods
Native protein preparation — Actin and tropomyosin (9:1 of α:β isoforms) were
purified from acetone powder derived from bovine left ventricles as described (J. D.
Pardee & Spudich, 1982; Smillie, 1982). Tm was separated into aliquots, lyophilized and
stored at -80°C. F-actin was stored at 4°C in 50 mM KCl, 2 mM Tris-HCl, 1 mM
Na2ATP, 0.2 mM CaCl2, 2 mM MgCl2, 0.005% NaN3, and pH 8.0. Myosin was purified
from chicken pectoralis muscle as described (Margossian & Lowey, 1982), suspended in
600 mM NaCl, 10 mM Na3PO4, 1 mM EDTA, 1 mM DTT, 50% glycerol, pH 7.0, and
stored at -20ºC for up to one year.
Cloning, mutagenesis, recombinant protein expression, and purification —
Recombinant wild-type (WT) adult rat cardiac troponin C (TnC), WT mouse cardiac
troponin I (TnI), and WT adult rat Troponin T (TnT) were expressed and purified as
described (J. M. Robinson et al., 2004). Briefly, the complementary DNA sequences
(cDNA) of TnI, TnC and TnT were cloned into pET3a (Novagen) plasmids for
expression in E. coli. Cysteines present in TnC (C35/C84) and TnI (C81/C98) were
ablated by QuikChange Lightning Site-Directed Mutagenesis (Agilent) (TnC
modifications, C35S/C84S/T127C; TnI modifications, C81S, C98I, I182C), to produce
non-cysteine TnC (C35S/C84S) and TnI(C81S/C98I) mutants. A single cysteine was
incorporated in non-Cys TnC to produce abbreviated TnC (127C). A single cysteine TnI
was incorporated in non-Cys TnI to produce abbreviated TnI (182C). Single cysteine
mutant TnI and TnC mutants and WT TnT vectors were expressed in E. coli and were
purified as described (J. M. Robinson et al., 2004). Protein purity was analyzed by SDS-
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PAGE, and their molecular weights were determined by MALTI-TOF mass
spectroscopy. Proteins were lyophilized and stored at -80°C.
Fluorescent dye conjugation of troponin — Single cysteine TnC (127C) and TnI
(182C) were labeled with Alexa Fluor 546 and ATTO 655 respectively as described
previously (J. M. Robinson et al., 2004). Briefly, cysteine residues of proteins were
selectively labeled with maleimide moieties conjugated to fluorescent dye molecules.
Cysteine residues were reduced by dialysis against labeling buffer (LB: 50 mM MOPS,
100 mM KCl, 1 mM EDTA, 3M urea, and pH 7.2) in presence of 5 mM DTT. The DTT
was removed by three changes of dialysis against LB. Reduced proteins (~100 µM) were
conjugated to dye molecules in a five-fold excess for 12 hr at 4 °C under nitrogen
bubbling with stirring. Labeling was quenched by the addition of 10 mM DTT. Any
unreacted dye molecules were removed by size exclusion FPLC (Sephacryl S-100 HR,
AKTAprime plus, GE Life Sciences) in LB. The dye-labeling procedure was iterated (up
to 3 times) to achieve labeling efficiencies greater than 90%, the molar ratio of dye to
protein. Protein and dye concentrations were determined by absorption spectroscopy
using the following extinction coefficients (M-1 cm-1): ATTO655 (ATTO-Tec GmbH)
125,000 at 663 nm, Alexa546 (Life Technologies) 104,000 at 555 nm, TnI 11,050 at 280
nm, and TnC 4,080 at 280 nm. Fluorescently labeled protein conjugates were aliquoted
and stored at -80°C for up to 1 year.
Preparation of troponin —Tn was reconstituted from TnC, TnI, and TnT, in a
molar ratio of 1:1.2:1.4, using gradual dialysis into storage buffer (SB: 150mM KCl,
50mM MOPS, 2mM EGTA, 5 mM MgCl2, 5mM BME, and pH 7.2) as described
previously (J. M. Robinson et al., 2004). Uncomplexed TnI and TnT precipitates in SB
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and is removed by centrifugation at 10,000x g (TL-100 Ultracentrifuge, Beckman) for 1
min. Purified Tn complexes were aliquoted and stored at -80 °C.
Preparation of regulated actin filaments — Regulated actin (rAc) filaments were
prepared by incubating F-actin (7 uM) with Tm and Tn at a molar ratio of 7:2:1 in
working buffer (WB: 75 mM KCl, 50 mM MOPS pH 7.0, 5 mM MgCl2, 2 mM EGTA, 5
mM BME) on ice for 1 hr. rAc was stable for up to 6 months when stored at 4 °C.
Reconstitution was confirmed by staining filaments with phalloidin-Alexa Fluor 488
(Alexa488, Life Technologies) at a 20:1 molar ratio of G-actin: phalloidin, dilution to 10
nM in WB, deposition on bare glass coverslips, and imaging on a epifluorescence
microscope (Olympus IX71) with CCD camera (Zyla, Andor).
Preparation of imaging chamber — A customized flow chamber was assembled
(from bottom to the top) from a nitrocellulose-coated coverslip, a 0.5 mm thick silicon
gasket (Electron Microscopy Sciences, Hatfield, PA), and a 25 mm circular microscope
slide with two 0.75 mm internal diameter tubes (IDEX Health & Science, Oak Harbor,
PA) inserted into drilled holes on the slide. Nitrocellulose-coated coverslips were made
by applying a 1% (w/v) nitrocellulose solution in amyl acetate (Ladd Research, Williston,
VT) to the surface of a coverslip. An additional glass coverslip is placed on top to spread
the solution evenly. The coverslip-coverslip sandwich is separated and the solvent is
allowed to evaporate. The flow chamber volume was found to be 20 µL.
On the day of the experiment, catalytically inactive myosin motors (dead heads)
were removed by suspending myosin (200 µg/mL) and F-actin (50 µg/mL) in assay
buffer (AB, 25 mM KCl, 50 mM MOPS pH 7.0, 6 mM MgCl2, 2 mM EGTA, 10 mM
DTT) supplemented with 300 mM KCl, 1 mM ATP, and 10µM dithiothreitol. Dead heads
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co-precipitate with F-actin by centrifugation for 15 min at 180,000x g and 4 ºC (TL-100
Ultracentrifuge, Beckman). Dead heads bind F-actin strongly and co-precipitate with Factin, while myosin Catalytically active myosin remains unbound to actin in the
supernatant. The supernatant was aspirated, and stored on ice for up to 6 hours.
Reserved myosin was injected into the flow chamber and incubated for 2 min (Figure 1).
AB supplemented with 5 mg/mL of milk powder (Carnation, Nestlé) was perfused with 5
volumes of and incubated for 2 min. Remaining dead heads were blocked by incubation
(2 min) with F-actin (5 µM) in AB that has been sheared by aspirating the solution
several times through a 26-gauge syringe. To remove unbound F-actin the chamber was
perfused with 5 volumes of AB. F-actin was released from the catalytically active heads
by incorporating 5 volumes of AB supplemented with 1 mM ATP, then chased with 5
volumes of AB. 3 volumes of rAc-D or rAc-DA (20 nM) were aspirated and incubated
for 2 min. After incubation, 5 volumes of imaging buffer (IB, 25 mM KCl, 50 mM
MOPS pH 7.0, 6 mM MgCl2, 2 mM EGTA, 10 mM DTT, 0.5 % (w/v) methylcellulose in
ddH20, and 1% (v/v) dimethyl sulfoxide) were incorporated under the specified pCa
levels. Measurements at pCa 3 and pCa 9 were performed in separate experiments. ATPϒ-S (A1388-5MG, Sigma) was sorted into several microcentrifuge tubes and frozen to 20ºC. On the day of the assay, ddH2O was poured into a single tube to produce a 500 µM
ATP- ϒ -S solution. Concentration was confirmed by measuring the absorbance at 260
nm (e εATP-γ-S(260 nm) = 15,000 M-1cm-1 (Goody & Eckstein, 1971)). Experiments
including ATP-ϒ-S and blebbistatin, IM was supplemented with 5 mM ATP-ϒ-S on the
former; and 5 mM ADP, 5 mM phosphate, and100 µM blebbistatin on the latter. The (-)blebbistatin (203391-1MG, Milipore) was previously dissolved in dimethyl sulfoxide and
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incorporated into the IB as the 1% (v/v) dimethyl sulfoxide (10 mg/mL blebbistatin) to
facilitate dissolving. The control experiments excluded the incorporation of myosin.
Control experiments started with the addition of AB supplemented with 5 mg/mL of milk
powder, incubation for 2 min, and the flow washing with 5 volumes of AB. Filaments are
incorporated as mentioned previously and the flow chamber is filled with IB. IB was
aspirated into the flow chamber using a syringe pump (Fusion 100, Chemyx) to prevent
filaments drifting out of the surface (speed, 100 µL/min). All measurements were
performed at room temperature (18 ± 2 ºC).
Fast-FLIM measurements — Fluorescence lifetime imaging (FLIM) was
performed on a MicroTime 200 (PicoQuant, GmbH; Berlin, Germany) objective scanning
confocal microscope based on an inverted microscope (IX71, Olympus). Excitation light
from 532 nm or 638 nm pulsed diode lasers (LDH-P-FA-530-B and LDH-D-C-640,
PicoQuant) were passed, respectively, through a quarter wave plate, a single-mode fiber
optic, a triple notch laser clean-up filter (FF01-485/537/627-25, Semrock), a custom
principle dichroic mirror (DC1) (ZT532/638rpc, Chroma), and a 100x (N.A. 1.3) oil
immersion objective (UPlanFLN, Olympus). Emitted light was passed through the
objective and DC1 then through a 550 nm long-pass filter (550lp, Chroma), a 50 µm
pinhole and a secondary dichroic mirror (DC2) (T660LPXR, Chroma). The reflected
light from DC2 was passed through a bandpass filter (HQ580/70, Chroma) and recorded
on an avalanche photodiode (APD2) (MPD PDM series ϕ=100µm, Micro Photon
Devices, Italy). The non-reflected light was passed through a bandpass filter (ET 700/75,
Chroma) and recorded on a second avalanche photodiode (APD2) (MPD PDM series
ϕ=50µm). Timing resolution was set to 16 ps per channel. The laser power from the 532
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and 635 lasers was 50 µW and 20 µW, respectively. FLIM data were collected at 512 x
512 pixel resolution using a scan rate of 0.6 msec/pixel. FLIM images are pseudo-colored
based on the mean photon arrival time per pixel.
Lifetime recovery and transfer efficiency calculation from FLIM images — FastFLIM image reconstruction and pseudo-coloring was performed in MATLAB®
(MathWorks, Natick, MA R2011b) using a customized algorithm. Brefly, Fast-FLIM
data generated by the confocal microscope software (Symphotime, PicoQuant) consist on
ASCII-based character files containing intensity and average arrival time information per
pixel. Average arrival times are transformed into average lifetimes based on the
characteristic instrument response function (IRF) of the confocal microscope (τIRF =
0.120 ps). Only pixels representing the filament regions were used to estimate average
lifetimes and transfer efficiencies (TE). Transfer efficiencies were calculated using
!" = 1 − 〈!!" 〉 〈!! 〉

(5.1),

where 〈!!" 〉 is the average lifetime of the donor (D) in doubly-labeled (donor and
acceptor, DA) sample, 〈!! 〉 is the mean lifetime of the donor in the singly-labeled (donor
only, D) sample. The distance ! between the donor and acceptor dye molecules is given
by
! = !!

!

1 − !" /!"

where !! is the Förster distance of the donor-acceptor dye pair.

(5.2)

102
5.4 Results
The goal of the surface deposition of myosin is to mimic the muscle environment
where myosin heads remain fixed. For this, we surface-deposited rAc-D and rAc-DA
filaments on myosin-coated surfaces (Figure 5.1). Control measurements were made in
the absence of myosin, and only the blocking buffer was applied. We characterized the
energy transfer properties of our donor pair by qualitatively determining the effect to an
attached on the donor lifetime. Incorporation of the acceptor dye (rA-DA) on passivated
coverslips revealed a marked quenching of the donor lifetime as indicated by the pseudocoloring shift to lower lifetime values (Figure 5.2). Incorporation of Ca2+ to rAcDA
deposited on passivated coverslips produced a further decrease of the donor lifetime. This
confirms that the donor-acceptor pair distance is sensitive to Ca2+-induced allosteric
changes in Tn; more precisely between TnI mobile domain and TnC C-terminal domain,
where the later is fully integrated into the Tn core domain (Takeda et al., 2003). When
the passivated surface is supplemented with myosin no qualitative quenching is
appreciated. We confirmed that our flow chamber conditions and our donor-acceptor pair
positions in Tn favor rAc-DA sensitivity to Ca2+-induced quenching compared to
myosin-induced quenching.
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Figure 5.2 Effect of acceptor dye molecule, Ca2+, and rigor myosin on quenching of
donor dye. Fluorescence Lifetime imaging of rAc-labeled with a donor dye molecule
(TnC 127C AF546) (rAc-D) was quenched by incorporating an acceptor dye molecule
(TnI 1862 ATTO 655) at pCa 9 (rAc-DA), pCa 3 (rAc-DA Ca2+), and myosin
deposited on the coverslip surface at pCa 3 (rAc-DA Ca2+, Myo). Fluorescence
lifetime pseudo-coloring represents the product of the fluorescence intensity
(grayscale level) and the lifetime value (color) (See supplemental information section).
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To derive quantitative information from our florescence lifetime images, I
developed an image-processing algorithm to exclude background pixels from the
analysis. Figure 5.3A illustrates the image processing routine used to select pixels
representing the fluorescence lifetime image from bound donor dye molecules. The effect
of this procedure is reflected in Figure 5.3B, where the fluorescence lifetime acquired
from the selected pixels minimizes the inclusion of background fluorescence signal. The
results described validate our fluorescent lifetime image analysis approach to derive
quantitative information.
I proceeded to determine the effects of Ca2+ and myosin catalytic state on rAc
using Tn-DA as a reporter. Figure 5.4A shows the extracted lifetime histograms from Fig
2. Based on the average lifetime of the donor, Ca2+ saturation has a larger effect in the
activation of Tn relative to incorporation of rigor myosin in the flow chamber.
Conversely, rigor myosin appears to activate filaments by a larger margin at pCa 9
compared to pCa 3. Notice that for the depicted conditions the donor lifetime histogram
preserves its quasi-normal distribution (skewness ≈ 0). The TE was estimated from the
lifetime distributions of rAc-D and rAc-DA (equation 5.1) for each myosin state (weak
binding states and rigor) and pCa level. Figure 5.4 B and Table 5.1 summarize the
respective TE values. In general, it is possible to conclude that Ca2+ binding is
responsible for most of the activation seen in Tn. We treated pCa 9 and pCa 3 groups
separately during significance tests.
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Figure 5.3. Filament recognition in fast-FLIM. Fast-FLIM images, composed by a
lifetime and an intensity channel, were analyzed using a customized image-processing
algorithm. (A) A fast-FLIM image of rAc-DA (left) after identification of filaments
(right) as a binary map. The binary map, constructed from the intensity channel, is
used to interrogate the lifetime channel in a fast-FLIM image. (B) The recovered
lifetime histograms from the filament lifetime (red) and the entire image (black) have
lifetime values of 3.23 and 4.97 ns respectively.
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The blocked state of the thin filament, which represents the relaxed state of
muscle fibers and weak binding of myosin (McKillop & Geeves, 1993), was emulated by
incorporation of the non-hydrolysable nucleotide ATP-ϒ-S. TE results indicate that
relative to the control measurements at pCa 9 and pCa 3, no further activation of rAc-DA
in presence of myosin-coated surfaces and ATP-ϒ-S occurs (Figure 5.4 B, Table 5.1).
These results agree with Ca2+ affinities and dissociation rate studies in TnC bound to thin
filaments (J. P. Davis et al., 2007) and ATPase studies employing ATP-ϒ-S (Dantzig,
Walker, Trentham, & Goldman, 1988; Kraft, Yu, Kuhn, & Brenner, 1992) or ATP (J M
Chalovich & Eisenberg, 1982; Tobacman & Adelstein, 1986). These observations,
however, do not exclude the possibility of myosin binding to Tn without activation of
thin filaments (J M Chalovich & Eisenberg, 1982; Tobacman & Adelstein, 1986).
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Figure 5.4. Effect of Ca2+ and myosin state on Tn activation within regulated actin.
(A) Lifetime histograms of rAc-DA at pCa 9 (red) and pCa 3 (green) on a passivated
surface, and at pCa 9 (orange) and pCa 3 (blue) or a myosin-decorated surface.
Lifetime histograms were fitted to Gaussian distributions. Arrows denote average
values from each distribution. (B) Transfer efficiencies derived from rAc-D and rAcDAs donor fast-FLIM histograms at pCa9 (white) and pCa 3(gray). (B) FWHM
distances from rAc-DA donor fast-FLIM histograms at pCa 9 (white) and pCa 3
(gray). Lifetime measurements were preformed in presence of a passivated surface
and imaging buffer (control) in presence of imaging buffer or a myosin-decorated
surface in presence of imaging buffer supplemented with 5 mM ATP-γ-S (ATP-γ-S);
100 µM blebbistatin, 5 mM ADP, and 5 mM potassium phosphate (Bleb); and the
imaging buffer alone (Rigor).

108
In the case of ADP.Pi.blebbistatin, which resembles the weak-bound state of
myosin, a significant increase in Tn activation is seen at pCa 9 relative to the control
measurements (p<0.01) (Figure 5.4B, Table 5.1). Conversely, no additional activation is
seen at pCa 3. Previous reports on the incorporation of blebbistatin into permeabilized
muscle fibers revealed no significant change in TnC N-lobe orientations as a function of
pCa except for the C-lobe (Sun et al., 2009). Myosin weak bound state analogs, such as
N,N'-p-phenylenedinaleimide (pPDM)-S1, do not show significant ATPase activation of
thin filaments. However, these conjugates are able to bind to thin filaments (J. M.
Chalovich, Greene, & Eisenberg, 1983; Greene, Chalovich, & Eisenberg, 1986). In vitro
motility assay experiments have suggested a non-null drag force caused by blebbistatin
bound to myosin (Sakamoto et al., 2004). Our results suggest that a blebbistatin-induced
weakly bound state in myosin can induce a small activation of Tn at pCa 9 levels but no
further activation at pCa 3.
Finally, the strong bound state of myosin is represented by rigor myosin and
clearly denotes significant activation at pCa9 (p<0.001) and pCa 3 (p<0.001) relative to
control measurements, myosin-ATP-ϒ-S, and myosin-ADP.Pi.blebbistatin (Fig 5.4 B,
Table 1). Our results in rigor conditions are in agreement with previous physiological and
biochemical reports (R. D. Bremel & Weber, 1972; Fitzsimons et al., 2001; Kad, Kim,
Warshaw, VanBuren, & Baker, 2005; K. L. Li, Rieck, Solaro, & Dong, 2014). This result
constitutes a positive control to myosin-induced activation of rAc-DA. Moreover, rigor
myosin and pCa 3 conditions reflect an additive effect in the TEs in agreement with
previous reports (J. M. Robinson et al., 2004).
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An additional parameter derived from the donor fluorescence lifetime
distributions (Figure 5.4 A) is the fill-width at half maximum (FWHM). In the presence
of a proximal acceptor dye molecule, the most significant effect in FWHM arises from
the donor-acceptor interprobe distance distribution (Equation 5.2) and the relative
interprobe orientation distribution (Lakowicz, 2006). Figure 5.4 C shows the FWHM
recovered from the donor lifetime distributions in rAc-DA. Based on the treatment of pCa
9 and pCa 3 results as different groups, it is found that only the rigor state is significantly
different (p<0.01) from the respective control measurements. We compared these results
with the respective TEs in Figure 5.4 B. This relation produced a positive correlation
between TE and FWHM as denoted by the fitted line in Figure 5.5. This relation clearly
shows a direct increase in Tn conformational freedom as a function of increasing Tn
activation.
Table 5.1. FLIM-FRET results
Conditio
n

pCa 9
τD (ns)

τDA
FWHM DA
(ns)
(ns)
Control
3.09 ±
2.97 ±
0.47 ± 0.04
0.01
0.01
ATP-γ-S
3.09 ±
2.97 ±
0.53 ± 0.05
0.02
0.02
Bleb
2.95 ±
2.78 ±
0.55 ± 0.07
0.03
0.01
Rigor
3.12 ±
2.89 ±
0.63±0.08
0.01
0.02
* Values are represented as mean ± s.d (n = 5).

pCa 3
TE pCa9
(%)
3.8 ±
0.4
3.8 ±
1.0
5.6 ±
0.8
7.4 ±
0.8

τD (ns)
3.09 ±
0.01
3.10 ±
0.01
2.98 ±
0.01
3.11 ±
0.01

τDA
(ns)
2.76 ±
0.01
2.76 ±
0.01
2.64 ±
0.01
2.73 ±
0.01

FWHM DA
(ns)
0.58 ± 0.05
0.65 ± 0.05
0.64 ± 0.08
0.78 ± 0.10

ΔEpCa3-pCa 9
(%)
TE pCa3
(%)
10.7 ±
0.4
10.8 ±
0.4
11.2 ±
0.3
12.1 ±
0.4

7.0 ± 0.5
7.1 ± 1.1
5.6 ± 0.8
4.7 ± 0.8
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Figure 5.5. Correlation between transfer efficiencies and lifetime distribution widths.
The pooled transfer efficiencies and donor lifetime distribution FWHM were
represented in a correlation plot. Line represents linear curve fit model. Data points
represent mean ± SD (n = 5).
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5.5 Discussion
To the best of our knowledge this is the first study that attempts to interrogate intra Tn
structural changes in an in vitro motility assay setup. This approach is unique because it
provides a structural support to myosin. Therefore, my results offer a more accurate
representation of thin filament dynamics within the sarcomere. I will proceed to discuss
the technical implications of my analysis followed by the implications of my results to
the field of study of muscle activation.
One of the main concerns employing dye conjugates in FRET analysis is the
appropriate location of the fluorescent dye molecule without interfering with the native
protein structure and function. The selection of the labeling positions in TnI and TnC
obeyed to locate the fluorescent probes at a distance proximal to the Förster radius (R0 =
59 Å). In addition the selected fluorescent probes demonstrate better photostability than
previously used fluorophores (John M. Robinson, 2008). Although one of our florescent
probes is located in the TnI mobile domain (186C ATTO655), a number of reasons
suggest that this probe location does not interfere on the thin filament activation process.
First, the known critical TnI mobile domain residues responsible for actin-Tm binding
(inhibitory peptides I/II/III) and TnC binding (switch peptide) regions correspond to the
cardiac TnI residues 128-148/172-180/193-210 and 148-163 respectively (Galinska et al.,
2010; Gordon et al., 2000; Tripet et al., 1997). Second, our wide spectrum of Ca2+induced ΔTE suggests that in the absence of Ca2+ and myosin, the average state of Tn is
occupying the blocked conformation with TnI inhibitory peptides bound to F-actin and
Tm. Third, at low TE levels (i.e. no Ca2+ nor myosin is present), the FWHM corresponds
to the minimal value found (Figure 5.5); this correlates with a restricted conformational

112
freedom at long interprobe distances between TnI mobile domain and TnC core domain
since TnI motile domain is bound to the Tm-F-actin surface. In the case of TnC, the
probe (127C AF546) corresponds to the donor molecule, which is clearly visible in all the
tested conditions. The C-lobe is particularly critical for providing anchoring of TnC to the
Tn core region and any deleterious modification will compromise this interaction
(Takeda et al., 2003). Therefore, we consider that our selected probe locations in TnI and
TnC do not interfere with the essential allosteric nodes present in Tn.
The most notable feature of this in vitro motility assay is that myosin remains
bound to the surface. One recent report raises the question on whether solution studies
bias myosin binding to neighbor myosin regulatory units (Walcott & Kad, 2015). From a
structural perspective, myosin heads are bound to discrete positions within the
myofilament (Squire, Al-Khayat, Knupp, & Luther, 2005). A free solution study does not
entirely reflect the activation properties of muscle due to the fixed structural arrangement
of proteins in the sarcomere. Therefore, my results may represent a midway step on the
activation properties of myosin within the sarcomere ultrastructure architecture. On the
other hand, surface deposition of myosin binding is non-specific ad it is expected to be
randomly oriented. A second feature of in vitro motility assay setups is that myosin
contacts a single face throughout the filament axis. This may explain the reduced myosin
activation at pCa 3, which does not correspond to a further 50% increase (J. M. Robinson
et al., 2004). Myosin was deposited at 0.2 mg/mL; this is equivalent to a myosin
density of 2000> myosins/μm2 or a myosin-myosin interspace distance of > 37nm
(Harris & Warshaw, 1993). This inter-monomer distance is sufficient to regulate
proximal regulatory units located at approximately at 40 nm intervals (Squire et al.,
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2005). Therefore we consider that interactions between contiguous Tm units are
minimal due to saturated myosin densities.
It is remarkable that myosin in the putative weakly bound state can induce
moderate Tn activation. Myosin in presence of blebbistatin (100 µM blebbistatin, 5 mM
ADP, and 5 mM phosphate) produced moderate activation of Tn at pCa9 but no
additional activation at pCa 3 (Figure 5.4 B, Table 5.1). Blebbistatin inhibits the cleft
closure of the myosin-ADP-phosphate state in a pre-force generation state (Allingham,
Smith, & Rayment, 2005; Kovacs, Toth, Hetenyi, Malnasi-Csizmadia, & Sellers, 2004).
One potential source of error is due to the cross-excitation of blebbistatin [λmax = 430 nm
(Kolega, 2004)]. However, the influence of blebbistatin fluorescence is unlikely to affect
our results for a number of reasons: (i) the background caused by blebbistatin is discarded
in the selection of our regions of interest (Figure 5.3); (ii) the lifetime of blebbistatin is
long (Muretta et al., 2015) and it is not detected in the florescence lifetime histograms;
(iii) the transfer efficiency calculation is based solely on the donor lifetime fluorescence
and the quotient will minimize any change in the lifetime distribution of the donor only
and the donor in presence of the acceptor. Therefore, I suggest that my methodology is
reflecting the true dynamics of the system. One explanation for the activation effect of
blebbistatin on Tn is that the equilibrium between myosin.ADP.Pi.bleb and
myosin.ADP.bleb + free Pi is more reversible in presence of the regulatory proteins.
Previous studies suggest that the myosin.ADP.bleb complex presents an increased
binding affinity for F-actin without rotation of the myosin lever arm (Takacs et al., 2010).
This condition could explain the increment in Tn activation due to increased myosin
affinity without transitioning of myosin level arm due to blebbistatin inhibition. This
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hypothesis would satisfy the well-known effect of the regulatory proteins on the ATPase
activity of myosin (S S Lehrer & Morris, 1982). These results imply that thin filament
access of Tn active states is an ergodic process and rather favors an allosteric
interpretation of Tn activation by myosin ((S. S. Lehrer & Geeves, 1998)). It is of interest
to test this hypothesis by correlating myosin allosteric transitions and phosphate release
to Tn activation.
The correlation seen in Figure 5.5 reveals an intrinsic property of Tn mobile
domain, which indicates different dynamics during activation. Ca2+ binding by TnC, TnI
switch region is capable of binding to the TnC N-lobe, leading to an average interprobe
distance shortening. Conversely, TnI is no longer bound to F-actin, but it rather freely
diffuses causing a broadening in the lifetime distributions. Our results conduct to two
alternative hypotheses: (i) Ca2+ and myosin dependent activation of thin filament reduces
TnI mobile domain affinity for F-actin-Tm binding sites leading to rapid binding-release
kinetics from F-actin-Tm sites and TnC N-lobe hydrophobic pocket; and (ii) Ca2+ and
myosin activation of Tn is incomplete and the apparent conformational freedom increase
is caused by partial redistribution of actin-bound Tn mobile domains to TnC-bound and
unbound states. We consider that these hypotheses will be able to be tested in the near
future by developing increased spatiotemporal resolution studies. In terms of structural
biology studies, the high conformational freedom present in higher activation states of the
thin filament (+Ca2+ and rigor myosin) suggests that resolution of experimental atomic
models will be particularly more difficult than in non-active states due to high
conformational freedom in TnI mobile domain.
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FRET measurements in myofibrils based exchanged fluorescently labeled Tn
draws many parallels to our current results: additive activation of Ca2+ and rigor myosin,
incomplete Tn activation by weakly bound cross-bridges, and existence of multiple Tn
conformations in specific states (K. L. Li et al., 2014). It is possible to use these results to
complete a structural description of Tn dynamics. First, in the mentioned work, the FRET
pair is located within TnC and it is responsive to Ca2+ binding and TnI switch peptide
binding to the TnC N-terminal hydrophobic pocket (Rieck, Li, Ouyang, Solaro, & Dong,
2013). Ca2+ and strongly bound cross-bridges appear to increase the interprobe distance
and reduce the conformational freedom. These changes reflect an increasing occupation
of the open conformation due to Ca2+ binding and TnI switch region interactions upon
strong cross-bridge formation. Increased conformational freedom in TnC N-terminal
domain is restricted to the closed position in absence of both, Ca2+ and strong crossbridges (K. L. Li et al., 2014; Rieck et al., 2013). When combining these observations
into our results a complementary description can be described. This is, in absence of
strongly bound cross-bridges and Ca2+, TnI C-terminal region is mostly bound to F-actinTm. Ca2+ saturation increases the fraction of TnC open state, leading to increases
conformational freedom; TnI mobile domain release from F-actin gives more
conformational freedom, presumably due to interchanging interactions between TnC Nlobe and F-actin. Strong cross-bridge formation leads to further displacement of TnI
mobile domain, which partially binds to TnC. Conversely, TnC conformational freedom
is reduced by saturation of the open conformation due to increments in the effective
concentration of TnI switch peptide regions in the local environment. This interpretation
is consistent with several studies (Galinska et al., 2010; K. L. Li et al., 2014; John M.
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Robinson, 2008; J. M. Robinson et al., 2004; Spyracopoulos et al., 1997). However, it is
not possible to extend our results to interpretations of other aspects like length –
dependent activation since it is out of the scope of this work. Finally, the ADP.vanadate
(Vi) complex used in previous reports (K. L. Li et al., 2014), analogous to
ADP.Pi.blebbistatin, appears insensitive to activation of TnC relative to ATP at pCa 9. At
pCa 9, Myosin.ADP. Vi reduces TnC active state shifting relative to Myosin.ATP. One
interpretation would be that ADP.Vi experiments promote TnC dissociation from thin
filaments (Strauss et al., 1992). Due to the high cooperativity present in relaxed muscle
fibers (Sun et al., 2009), a partial extraction of Tn or TnC would interrupt allosteric
communication throughout the thin filament (Moss et al., 1986; Moss, Giulian, &
Greaser, 1985). However this hypothesis remains to be tested.
In vitro motility assays do not show steep activation curves in pCa-speed
curves. This can be due to low effective concentrations of myosin accessible to the
thin filament surface. Tn already shows to be almost fully activated. The presence of
rigor myosin and Ca2+ (ΔTE+Ca2+, +rigor = 8.1%) does not contribute to Tn activation
relative to Ca2+ (ΔTE+Ca2+ = 6.6%). It is possible that myosin activation in Ca2+-bound
filaments is larger than it is seen in our results due to reduced number of myosins
presented on the actin-myosin interface. In our experiments, actin and myosin
interactions only occur in the surface-filament interface.
Based on our results, I propose an allosteric model that complies with
experimental data (Figure 5.6). In this model, I represented Ca2+ incorporation as the
vertical transition and thin filament state as horizontal. Each vertex is consider reversible
to explain the additive properties seen in our results, particularly in the myosin + Ca2+
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conditions. Thin model is distinct from previous thin filament activation models in the
sense that Tn dynamics are integrated (McKillop & Geeves, 1993). Here, myosin and
Ca2+ are considered allosteric effectors responsible for population shifting relative to the
selected interprobe distances. A distinction is made form a previous four-state model to
account for the effects of the pre-power stroke weakly bound state (S. S. Lehrer, 2011;
Mello & Thomas, 2012). Finally, our model presents a high resemblance with recent
models which allow for Ca2+ independent activation of thin filaments in agreement with
our observations in rigor, weakly bound cross bridges and conformational freedom in Tn
mobile domain (Aboelkassem et al., 2015). Our results imply that regardless of the
distribution of thin filament populations on each activation state, Ca2+ and myosin are
capable of triggering Tn activation.
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Figure 5.6. Allosteric model of thin filament activation. Filaments under relaxing
conditions (neither Ca2+ nor myosin is present) are in the blocked state. When myosin
is present, ATP-γ-S (and hence ATP) retains rAc in the blocked state. Ca2+ binding is
responsible for major structural changes in Tn activation. Myosin is retained in the
weak-bound state by blebbistatin, which confers moderate activation of the filament
by interacting with affinity regions in F-actin (light gray ellipses). The strong myosin
binding state is facilitated by the presence of strongly-bound myosin heads and to a
greater extent by Ca2+ binding to Tn. Myosin binds to additional affinity regions in F-
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5.6 Conclusions
My measurements represent an attempt to conciliate biochemical and muscle
studies in a platform that mimics the muscle scarcomeric environment. My results
clearly demonstrated a major contribution of Ca2+ on activation of Tn units in
consistency with a blocked to close transition of regulatory units. Weakly bound
states of myosin do not play a major role in this transition process although
activation cannot be discarded. Rigor myosins are able to further activate thin
filaments, suggesting that Ca2+ activation is incomplete. Finally, I demonstrate that
Tn activation the thin filament microenvironment leads to increased partitioning of
conformational states.
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CHAPTER VI
DISCUSION
The overall goal of my dissertation is to provide evidence of the mechanism of
activation of the thin filament through single particle measurements using regulated actin
as a model system of thin filaments found within native cardiac sarcomeres. This goal
was divided into four specific objectives corresponding to (i) study of T-Tm assembly on
F-actin, (ii) development of a noise-suppression algorithm to obtain accurate speed
estimates of regulated actin sliding on in vitro motility assays, (iii) study of the effect of
TnI and TnT intrinsically disordered regions on activation of thin filaments on in vitro
motility assays, and (iv) structural dynamics of TnI mobile domain as a function of Ca2+
and myosin activation state; these objectives correspond to results reported in Chapters II,
II, IV, and V respectively. These individual projects revealed complementary aspects of
the activation mechanism of thin filaments, which provide new evidence of the structural
and functional roles of the regulatory proteins bound to F-actin and their allosteric role in
cardiac muscle regulation.
This project takes advantage the meso-scale properties of thin filaments, visible
trough conventional fluorescence light microscopy. Unlike nano-scale techniques, like
electron microscopy, the high-resolution emphasis of EM diminishes sampling of large
fields of view. Moreover, this technique currently presents difficulties in localizing
regulatory proteins bound to actin filaments and sample-staining step does not rule out
any perturbation of the sample from its native-state properties {{Poole, 2006 #466}}.
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In specific objective (i), we determined the molecular assembly aspects of Tn-Tm on Factin, which together constitute the three principal components of striated muscle thin
filaments. The hypothesis the motivated the work presented in this section is that binding
properties of Tn-Tm are strongly correlated to Tn-Tm activation. More specifically,
through high cooperativity present in isothermal binding experiments. Our results
indicate that Tn-Tm bind to regulated actin non-cooperatively, which stands in contrast
with physiological results on isometric force development as a function of free Ca2+
concentrations in cardiac muscle fibers{{Fabiato, 1978 #77}}{{Brandt, 1980 #83}}.
However from a functional perspective a non-cooperative assembly suggests that one
single type of interaction between contiguous Tn-Tm units exists throughout the thin
filament. A single interaction may provide concerted response to stimulus (i.e. Ca2+
binding by Tn) because the energy of activation of each regulatory unit (RU) is the same
and is define by the binding interactions within Tn-Tm bound to F-actin. On the other
hand, multiple levels of interaction may lead to a gradual change to fully activated
filaments. The notion of a predominant type of interaction was reinforced trough our
simulation of Tn-Tm binding to F-actin. Here, each RU unit was more likely to interact
with two RUs in a side-to-side basis when filaments are fully saturated as it is found in
native thin filaments. This implies that activation of thin filament rather occurs by a more
simple mechanism.
The motivation of the project described in chapter III was to improve data
collection from in vitro motility assays (IVMA). In vitro motility assays are capable of
mimicking thin and thick filament sliding dynamics. However, data collection is

122
susceptible to noise. We introduced the Kalman filter to explicitly solve the Kalman
sensitivity parameters Q and R using experimental data. Conventionally, Q and R are
solved through combination of experimental data and modeling. Here, we implemented a
method that solely uses experimental data to solve optimal parameters for Q and R.
Previous work optimized experimental Q and R parameters by modeling. Moreover, the
objects of interests were quantum dots and the computer vision statistics are simple to
define due to symmetry found in diffraction-limited objects {{Wu, 2010 #616}}. On the
other hand, actin filaments present complex shapes and the statistical parameterization
results trivial. To the best of our knowledge, our work is the first dedicated to implement
Kalman filtering on in vitro motility assay with filter optimization from experimental
data. We consider that our results increase the automation of video analysis and reduce
the potential bias due to human intervention on threshold value assignments to estimated
filament sliding speeds. I consider that Kalman filters may be extended to other
microscopy applications like tracking of single particles diffusing inside cellular
environments and as a feedback control tool of the microscope focusing system to adapt
the field to view to a particle instantaneous motion.
In Chapter IV, we applied our filament sliding speed analysis method developed
in Chapter II to study the effects to alterations in TnI and TnT intrinsically disordered
regions (IDR). Our specific objective was to determine the contribution of IDRs in Tn on
the inhibitory properties of regulated actin on in vitro motility assays. My results showed
that modification of TnI N-terminal region by phosphorylation of serines 23 and 24
(Ser23/24) produce an overall enhance inhibitory effect, represented by a reduced
sensitivity to Ca2+ (pCa50) and reduce maximum sliding speeds (Vmax). Surprisingly,
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epigallocatechin-3-gallate (EGCG) mimicked Ser23/24 effects on pCa50 and Vmax. This
suggests that a common structural mechanism should exist in common. Interestingly,
EGCG is believed to interact with TnC C-Terminal domain and the bound TnI binding
interphase in this region {{Robertson, 2009 #551}}. This TnI region is found
downstream from Ser23/24 phosphorylation sites. Thus, it is plausible for these two
desensitizing mechanisms to be interrelated. As discussed in Chapter I, Ser23/24 occurs
trough sympathetic release of catecholamines, specifically epinephrine. Under Bactivator influence, the heart experiments increasing relaxation kinetics. Thus, EGCG
may offer therapeutic effects on restrictive cardiomyopathies characterized by impaired
relaxation of the cardiac muscle {{Metzger, 1995 #227}}. Conversely, truncation of 14
amino acids in TnT C-terminal region (Δ14TnT) doubled Vmax without significant change
in pCa50. This activator affect reflects the marked effects of Tn on the kinetics of
actomyosin and it fits the assignation of Tn as an allosteric regulator.
Finally In chapter V we developed structural studies on Tn activation to provide
further evidence of Tn role as an allosteric switch. We studied Tn activation bound to Tm
and F-actin using Ca2+ and myosin trapped in various states. An in vitro motility assay
setup as used to mimic the muscle microenvironment where myosin is located in fixed
positions on the thick filament. Our results revealed that Ca2+ and myosin states have an
additive effect on Tn activation, where maximum activation occurs in present of
saturating Ca2+ concentrations and rigor myosin states. This evidence reinforces the role
of Tn as an allosteric regulator of the thin filament.
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APPENDIX
A.1 Section 1

A.1.1 General properties of selected myofilament proteins
Table A1.1. Biochemical properties of selected proteins*.
Name
Rat Cardiac Troponin T (cTnC) isoform 2
(PMCID NP_036808.1)
Mouse Cardiac troponin I (cTnC) (PMCID
NP_033432.1)
Rat Cardiac troponin C (cTnC) (PMCID
NP_001029277.1)
Mice cardiac troponin complex (Tn)

Residues
299

Molar mass (kDa)
35.729

ε280 (M-1cm-1)
20910

211

24.258

11050

161

18.42

4080

---

78.41

36040

Bovine cardiac tropomyosin β-chain (c-β-Tm)
(PMCID XP_005210126.1)

284

33.010

7800

Bovine cardiac tropomyosin α-chain (c-α-Tm)
(PMCID NP_001013608.1)

284

32.693

7800

Bovine Cardiac Tropomyosin dimmer (c-dTm)
566-568
65.703
(17% β-form; Lu et al. J.Muscle Res Cell Motil.
(2010) 31:93-109)
377
42.017
Bovine actin α cardiac muscle 1
Chicken Myosin
--~540
Heavy meromyosin (HMM)
~3180
~350
* Source: National library of Medicine. National Institutes of Health
(http://www.ncbi.nlm.nih.gov/pubmed).

23230
43960
286200
210000

A.1.2 Fundamental properties of regulated acin
Regulated actin (rAc) is composed of Troponin, Tropomyosin, and F-actin. The
molecular weight of rAc can be estimated based on the principles found in Chapter 2. rAc
shows an exponential distribution of filament lengths presenting an average length of 1.6
µm. To calculate the average molecular weigh of rAc it is necessary to take into
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consideration the double-helical symmetry. Thus, a regulatory unit (RU) equals 2 Tn: 2
Tm: 14 F-actin.
!"!! = 2 ∗ 78 !"# + 2 ∗ 68 !"# + 14 ∗ 42 !"# = 376 !"#

(A1.1)

Considering a helical pitch in rAc to be 77 nm, where each helical pitch consists of 1 RU
(Poole et al., 2006), the average molecular weigh of rAc is defined as
!"!"# = 1600 !" ∗

!"# !"#

= 7813 !"# = 7.813 !"#

!! !"

(A1.2)

To determine diffusion of rAc in working buffer, it is possible to use a derivation of the
Einstein–Smoluchowski relation for a long rod (Ortega & Garcı́a de la Torre, 2003). The
translational diffusion coefficient for a log rod is defined by
!! =

!! !(!" !!!! )
!!!! !

,

(A1.3)

where !! is the Boltzmann constant (1.38×10-23 m2 kg s-2 K-1), ! is the temperature taken
as 303 K (30ºC), ! = !/! where L is the rod length and d the rod diameter, !! is the
dynamic viscosity of the solution. We considered L = 1.6 µm and d = 10 nm (Fujii,
Iwane, Yanagida, & Namba, 2010).
!! is the rod end-effect term defined by
!! = 0.312 +

!.!"!
!

+

!.!""
!!

.

(A1.4)

The viscosity !! of the media can be derived from the estimated ionic strength !!/! of
working buffer (!!/! ≅ 125 !") and considering the viscosity of a KCl solution of
equivalent ionic strength at 303 K. Thus an approximate value for !! is considered to be
0.08902 mPa s-1 (Zhang & Han, 1996). Applying Eq. A.3 gives !! = 0.3155 and
!! = 1.70 !!! ! !! . The mean-square displacement of a particle freely diffusing can
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determine distance r a filament crosses in a given amount of time. For a two-dimensional
case
!!! = 2!" ,
! ! = !!! + !!! ,
! ! = !!! + !!! = 4!" ,
!=

!

4!" .

(A1.5)
(A1.6)
(A1.7)
(A1.8)

For ! = 0.1 ! (equivalent to the exposure time of a CMOS camera used in Chapter 3)
equation. A1.8 results in ! = 0.82 !" or 12 pixels in a CMOS camera (see Materials and
Methods in Chapter 3).
In the case of a fluorescence correlation spectroscopy (FCS) experiment, it is possible to
use the diffusion coefficient and the optical properties of the confocal microscope to find
the dwell time (τ) of rAc in the confocal volume. Using a Micro Time 200 (PicoQuant
GmbH, Berlin, Germany) confocal microscope (100x N.A. 1.4, pinhole aperture, 50 µm),
the approximate effective confocal volume is defined as
!!"" = ! !/! !!!! .

(A1.9)

For a Veff = 1.0 fL (or 1.0 µm3), the lateral radius (ω0) and the eccentricity of the confocal
volume (k) equal to 0.36 µm and 4.6 respectively (Lakowicz, 2006). The relation between
τ and the diffusion coefficient Dt is
!!! = 4!! ! .

(A1.10)

For a rAc filament, with average length of 1.6 um, the dwell time across the confocal
volume is 0.02 s.
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A.1.3 Selected images

Figure A1.1. Flow chamber for in vitro motility assays. The internal
volume is 20µL, the height inside the chamber is 0.5 mm, and the inner
diameter of the tubing is 0.75 mm.
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A.2 Section 2
This section corresponds to supporting information from Chapter II: ANALYSIS OF
CARDIAC TRPONIN-TROPOMYOSIN BINDING TO F-ACTIN BY
FLUORESCENCE COLOCALIZATION
A.2.1 Filament analysis

Figure A2.1 Image processing and analysis workflow. Data sets consist of three
16-bit images corresponding to fluorescent emission signal from Tm (ATTO
655), Tn (AF 546), and F-actin (phalloidin AF488). After edge-based
thresholding, the conjunction of Tn and Tm binary images (an AND Boolean
operation) gives the regulated actin regions. Skeletonization produces filament
layouts with one-pixel thickness. These pixels were assigned to be the F-actin and
regulated actin region’s coordinates. The filament analysis algorithm can be
found in the online repository GitHub
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A.2.2 Stochastic simulation
Tn-Tpm binding of F-actin (Ac) was modeled by a stochastic simulation reaction
(Gillespie, 1977). Tn-Tpm was considered to be the ligand and F-actin as onedimensional lattice (McGhee & von Hippel, 1974). Each lattice space corresponds to a
single regulatory unit (1 RU equals 1 Tn: 1Tpm: 7 Ac). The reaction follows the scheme
!!
TnTpm + Ac! ⇌ TnTpmAc!
!!!

(A2.1),

where !! and !!! define the forward and backward stochastic reaction constants
respectively (Gillespie, 1977). Since our goal is to adopt a simple model, we considered
two assumptions: (i) !! constitutes the diffusion controlled and activation controlled rate
constants; (ii) this assumption is equivalent for a ligand binding to an empty site adjacent
to one or two ligand occupied spaces. Positive cooperativity is considered in this model
by introducing a coefficient that depends on the number of nearest neighbor ligands
bound to the lattice. This coefficient affects the backward reaction constant !!! . For a
given time interval dt, the deterministic solution to the rate of saturation of a linear lattice
is given by

!"
!"

= !! !" − !"

!

!! − 1

!" !
!

− !!!

!
!

!!

!!

!" !
!

(A2.2),

where !" − !" ! is the free Tn-Tpm concentration found at time t, !! is the fractional
saturation density, !"

!

is the total Ac concentration, ! is a cooperativity parameter,

and ! is the average number of nearest-neighbor interactions in a bound Tn-Tm unit at
the previous iteration step k-1 (! = {0,1,2}). The numerical form of (A2.2) considers the

144
rate of formation of regulatory units (RU) in linear matrix of size 1 by m. For a given
iteration step k in a time interval of !", the deterministic solution to the rate of formation
of RUs in a single lattice unit ! is given by

!"!,! = !! !" − !"

where !" − !"
!"

!

!!!

!
!!! !"

!
!!!

!

!"!!!,! − !!! !"

!
!!!

!"!!!,!

! !!!!,!

(A2.3),

!

is the free Tn-Tpm concentration found in the previous iteration k-1,

is the total Ac concentration, ! is a cooperativity parameter, and !!!!,! is the

average number of nearest-neighbor interactions in a bound ligand i at the previous
iteration step k-1 (n={0,1,2}).
The respective fractional density !! and the free ligand concentration !" − !"

!

are

given by
!

!
!!! !"!,!

!! = !

!" − !"

where !" − !"

!

!

= !" − !"

(A2.4),

!

− !! !

(A2.5),

is the total Tn-Tpm concentration. Each simulation is repeated over a

population of filaments (N = 100) with variable lattice lengths. The population of selected
filament lattices is modeled by

!(!) = exp (−!/ ! )

(A2.6),
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where the probability P of a filament presenting the number of lattice space m is a
function of the average filament length ! . From our experimental results (Figure 2.2
D), the average F-actin length is 1.6 µm, equivalent to ! ≅ 40 RU. This simulation
algorithm can be found in the online repository GitHub
(https://github.com/chsolis/Stoch_binding_sim) and in the Appendix 6 section.
McGhee and von Hippel (1974) were the first to propose an analytical solution to
models describing a ligand binding to a linear lattice (McGhee & von Hippel, 1974). In
this model, the cooperativity parameter ! describes the relation

! = !!!

(A2.7),

where ! and ! ! correspond to the binding constants of ligands bound next to other
ligands or to an isolated site in the linear lattice. In this model, cooperativity is implicitly
defined in Eqn. A.2.3. Therefore, the relation to Eqn. A.2.3 is given by

! = !!

(A2.8)

where ! corresponds to the average number of interactions experiend by a bound RU.
The abundance of each type of interaction is derived from the area under each curve in
Fig. 5 E. The relative abundances for isolated RUs, one-sided, and two-sided interactions
correspond to 2.7%, 1.5%, and 95.8% respectively. From these results, the average
number of interactions corresponds to 1.93 interactions per bound RU. Application of
Eqn. A.2.6 (using ! = 3.7) results in ! = 12.
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A.3 Section 3
This section corresponds to supporting information from Chapter III: APPLICATION OF
A KALMAN FILTER TO in vitro MOTILITY ASSAYS TO ASSES MYOFILAMENT
FUNCTION.
A.3.1 Equations
A general bivariate function is defined as
! !, ! =

!

!!! !

!

!!!! !! !!!

!"# − ! !!!!
!

!!

− 2!

!!!

!!!

!!

!!

+

!!!

!

!!

,

(A3.1)

where the intensity I at any point in the x-y coordinate system is specified by the
respective center location of the distribution (!, !), the standard deviation on the x and y
axis (!! , !! ), and the x-y correlation (!). ! is known as the Pearson correlation
coefficient and is defined as
!=

! (!!!)(!!!)
!! !!

.

(A3.2)

The isotropic or spherical bivariate distribution is defined as
! !, ! =

!

!

!!!! !! !!!

!"# − ! !!!!
!

!!! !
!

+

!!! !
!

,

(A3.3)

where a unique standard deviation (!) defines the distribution width and the x-y
correlation is null, i.e. the distribution becomes isotropic. The skewness of x is defined as
!! =
where ! ! − !!

!

! !!!! !
! !!!! !

!

,

corresponds to the third central moment about the mean !! .

The root-mean-squared difference between a vector x and a verctor y is defined by

(A.3.4)
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!"#$ ! =

! ! + ! − !(!)

!

+ ! ! + ! − !(!)

!

(A3.4)

where ! represents the time interval in a particular displacement.

A.3.2 Extended experimental results
Table A3.1. Sliding speed data
Unfiltered data
Speed (µm/s) SD
SEM
(n=5)
4.0
1.57
0.17
0.07
4.5
1.45
0.13
0.06
5.0
0.95
0.11
0.05
5.5
0.55
0.05
0.02
6.0
0.46
0.11
0.05
6.5
0.33
0.15
0.07
7.0
0.28
0.05
0.02
* n = 5 separate experiments for each data point.

Kalman-filtered data
Speed (µm/s) SD
SEM
(n=5)
1.62
0.15
0.07
1.75
0.13
0.06
1.45
0.23
0.10
1.01
0.25
0.11
0.49
0.10
0.05
0.16
0.06
0.03
0.13
0.07
0.03

pCa

A.3.3 Preparation of calibrated pCa buffer solutions
The calibration of the pCa buffers was performed by the ratiometic method as
described by McGuigan et al. (McGuian, Luchi & Buri, 1991). We employed a Ca2+EGTA solution containing 1 mM excess of Ca2+ (i.e. 2 mM EGTA and 3 mM Ca2+) to
cover a broader range of pCa values and a EGTA solution containing 2 mM EGTA). We
prepared a 4x working buffer solution by mixing the components described in Table
A3.2. After dilution of the component, the pH was set to 7.0 (using 1 M HCl) and to a
final volume of 1.0 L.
Table A3.2. Composition of 4x working buffer
Compound
KCl
KOH
MgCl2
MOPS
EGTA

Concentration (mM)
10
35
20
200
8

M.M.
74.55
56.11
203.3
209.206
380.35

Amount (g) for 1 L
7.4550
1.9600
4.0660
41.8412
3.0428
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The buffer was split into two 500 mL solutions and labeled as CaEGTA and
EGTA buffers. CaCl2 was incorporated to one of the solutions using the components
described in Table A3.3. Finally, the volumes were brought to 1.0 L with ddH2O. When
the CaEGTA buffer is diluted to 1x it yields a ~1 mM free Ca2+ solution (~pCa 3).

Table A3.3. Additional compounds for CaEGTA and EGTA buffers
Buffer

Compound

Concentration (mM)

Amount (g) for 1 L

CaEGTA

KOH

10

0.6000

CaCl2

6

0.88206

KCl

10

0.7455

EGTA

Table A3.4 shows the recovered CaEGTA/EGTA ratios necessary to produce the
pCa values obtained through the pCa calculator (Patton, C., S. Thompson, and D. Epel.,
2004).
Table A3.4. Preparation of pCa buffers by mixture of CaEGTA and EGTA buffers
Soln.

2x buffer ratios
2x buffer vol. (mL)
On 1x buffer
EGTA
CaEGTA
EGTA
CaEGTA
Tot.
[Ca2+]tot.
[Ca2+]*
pCa
1
0
10
0.0
30.0
30
3.0E-03
9.1E-04
3.0
2
1
3
10.0
30.0
40
2.3E-03
2.3E-04
3.6
3
1
2.4
11.8
28.2
40
2.1E-03
1.1E-04
4.0
4
1
2.05
13.1
26.9
40
2.0E-03
3.5E-05
4.5
5
1
1.8
14.3
25.7
40
1.9E-03
9.3E-06
5.0
6
1
1.5
16.0
24.0
40
1.8E-03
3.4E-06
5.5
7
1
1.25
17.8
22.2
40
1.7E-03
1.9E-06
5.7
8
1
1
20.0
20.0
40
1.5E-03
1.1E-06
6.0
9
1
0.6
18.8
11.3
30
1.1E-03
5.1E-07
6.3
10
1
0.4
21.4
8.6
30
8.6E-04
3.0E-07
6.5
11
2
0.3
26.1
3.9
30
3.9E-04
9.6E-08
7.0
12
1
0
30.0
0.0
30
0.0E+00
1.0E-09
9.0
* Free Ca2+ concentrations were determined by using the Max-Chelator program (Patton, Thompson, &
Epel, 2004). To recover the free calcium concentration for each total calcium concentration, the following
parameters were used: the ionic force is 0.071 M, the EGTA concentration is 0.002 M, the ATP
concentration is 0.001 M, and the pH is 7.0.

To calibrate the pCa buffer solutions, we employed a fluorescent assay using the
Ca2+-sensitive fluorescent indicator Fluo-4ff. 1 mM ATP, 1 mM DTT, and 0.5 uM Fluo-
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4ff, and 0.7% methyl cellulose (from a 1.4 % (w/v) solution were diluted on each of the
pCa buffers to produce a 1x solution. A pCa 2 solution was prepared by adding 9 mM of
CaCl2 (from a 500 mM CaCl2 solution) to a pCa buffer solution. After gentle mixing,
samples were measured in a fluorimeter (Horiba Fluorolog 3) with excitation wavelength
of 490 nm, emission wavelength of 520 nm, and 0.5 s integration time. The free Ca2+
concentrations were determined on each solution using equation 1.
[!!!!"# ]

[!"!! ]!"## = !! [!

!"# !!]

,

(A.3.5)

where Kd equals 9.7 uM (Molecular Probes, 2011) , F equals the fluorescence for each
pCa solution, Fmin equals the fluorescence in absence of Ca2+ (i.e. pCa 9 solution), and
Fmax is the fluorescence at saturating Ca2+ conditions for Fluo 4FF dye (this is reached at
concentrations of Ca2+ ≥ 1 uM; thus, the pCa 2 solution will be used for measuring Fmax).
the resulting pCa concentrations are shown in Table 3.S.5 and the experimental and
theoretical pCa values are represented in Figure 3.S.1.
Table A3.5. Calculation of experimental pCa levels in pCa MB buffers
Theo.
pCa
9.0
7.0
6.5
6.0
5.8
5.5
5.3
5.0
4.5
4.0
3.0
2.0

Theo.
[Ca2+]
1.00E-09
1.00E-07
3.16E-07
1.00E-06
1.78E-06
3.16E-06
5.62E-06
1.00E-05
3.16E-05
1.00E-04
1.00E-03
1.00E-02

Average Singal
(AU)
1.53E+04
3.65E+04
9.13E+04
2.02E+05
6.11E+05
6.29E+05
8.66E+05
1.04E+06
1.08E+06
1.10E+06
1.11E+06
1.15E+06

* n = 3 independent repetitions.

Exp.
[Ca2+]
NA
9.12E+03
2.28E+04
5.06E+04
1.53E+05
1.57E+05
2.17E+05
2.59E+05
2.69E+05
2.74E+05
2.77E+05
NA

Average Exp.
pCa
NA
7.24
6.67
6.23
5.48
5.45
5.04
4.55
4.30
3.87
3.79
NA

SD Exp.
pCa
NA
0.01
0.02
0.01
0.02
0.03
0.00
0.09
0.07
0.35
0.32
NA
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Figure A3.1. Estimation of the free Ca2+ present in a motility buffer
solution. The fluorescence intensity corresponds to the experimental
fluorescence of each pCa solution. The theoretical (Theo, red squres) is
compared to the experimental (Exp., blue circles) pCa values.

A.3.4 References
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A.4 Section 4
This section corresponds to supporting information from Chapter IV: EFFECT OF
INTRINSICALLY DISORDERED REGIONS OF TROPONIN ON THE SLIDING
DYNAMICS OF THE CARDIAC THIN FILAMENT

Table A4.1. WT TnT and Δ 14 TnT sliding speed data under varying pCa levels
pCa
4.0
4.5
5.0
5.5
6.0
6.5
7.0

Speed (µm/s)
2.47
2.47
2.47
1.35
0.08
0.06
0.06

WT TnT
SD
0.06
0.07
0.07
0.47
0.01
0.01
0.01

SEM (n=5)
0.027
0.03
0.03
0.21
0.003
0.003
0.004

Speed (µm/s)
4.46
4.57
3.98
2.71
0.10
0.52
0.44

Δ 14 TnT
SD
0.67
0.32
0.17
0.31
0.22
0.17
0.34

SEM (n=5)
0.30
0.14
0.08
0.14
0.10
0.07
0.15

* n = 5 separate experiments for each data points.

Table A4.2. F-actin and regulated actin sliding speed data under varying [EGCG]
EGCG
conc.
(µM)
0
1
10
20
50
100
500

F-actin
Speed (µm/s)

SD

rAc
Speed (µm/s)

SD

0.97
1.12
1.00
1.11
1.05
1.03
0.97

0.09
0.02
0.05
0.12
0.16
0.18
0.12

1.19
1.24
0.94
0.67
0.30
0.12
0.14

0.17
0.19
0.13
0.06
0.18
0.02
0.10

* n = 3 separate experiments for each data points.

Table A4.3. Sliding speed data of Tn complex, native, PKA-, and EGCG treatments
under varying pCa levels
pCa
4.0
4.5
5.0
5.5
6.0
6.5
7.0

Speed
(µm/s)
1.62
1.7502
1.45
1.016
0.491
0.161
0.13

Native
SD
0.15
0.13
0.23
0.25
0.10
0.06
0.07

SEM
(n=5)
0.07
0.06
0.10
0.11
0.05
0.03
0.03

Speed
(µm/s)
0.9474
0.8954
0.7466
0.4468
0.1608
0.1568
0.1112

* n = 5 separate experiments for each data point.

PKA-treated
SD
SEM
(n=5)
0.21
0.09
0.16
0.07
0.22
0.10
0.06
0.03
0.09
0.04
0.06
0.03
0.06
0.03

Speed
(µm/s)
0.69
0.78
0.46
0.32
0.20
0.12
0.23

EGCG-treated
SD
SEM (n=5)
0.10
0.14
0.17
0.07
0.11
0.10
0.15

0.04
0.06
0.08
0.03
0.05
0.04
0.07
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A.5 Section 5
This section corresponds to supporting information from Chapter V: STUDY OF
CALCIUM AND MYOSIN DEPENDENT ACTIVATION OF THIN FILAMENTS BY
FLIM-FRET

Table 5.S1. Post-hoc analysis on the transfer efficiencies at pCa 9 and pCa 3 conditions
from figure 5.4.
Condition
1. Control

pCa 9
2. ATPγS
3.
ADP.Pi.bleb

4.
Rigor

1. Control

pCa 3
2. ATPγS
3.
ADP.Pi.bleb

4.
Rigor

1. Control
2. ATPγS
0.9999
0.9649
3. Bleb
0.0087**
0.0084**
0.2878
0.5285
4. Rigor
<0.0001***
<0.0001***
0.0064**
0.0001***
0.0003***
0.0046**
‡ Significances are derived from Tukey’s honestly significance tests applied to one-way ANOVA outputs. Values are represented as
mean ± s.d (n = 5). Asterisks denote significant differences at α = { <0.05 (*), <0.01 (**), and <0.001 (***)} respectively.
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A.5 Section 5
A.5.1 Filament length analysis scripts
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
%
%%%FILAMENT LENGTH ANALYSIS% %
%
%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

FILENAME: FilamentAnalysis_v1_9.m, First Created on July 02, 2012
DESCRIPTION: This script allows to determine filament leght distributions
of regulated actins (Actin + Tn + Tm) and non-regulated actins.
CHANGES TO VERSION: INcluding curvefitting of binding data base on
intensity trajectories
INPUT FILES: .tif images. It is necessary to have images for red,
green, and blue channels.3
OUTPUT FILES
INSTRUCTIONS:
Set USER VARIABLES (filename, pathname) using the GUI.
Upload red, green, and blue channel images in .tif format.
Its necesasary to have the same number of images for each color.
Tested with Matlab R2011b
Christopher Solis, South Dakota State University, updated January 2012
BEFORE WE BEGIN

% Set constants
clear all;
close all;
clc;
CURR_DIRECT = pwd; %Scripts directory
% BEGIN
prompt = {'Enter pixels per microns:'};
dlg_title = 'Constants';
num_lines = 1;
def = {'15'};
answer = inputdlg(prompt,dlg_title,num_lines,def);
ppum = str2double(answer);
if isequal(ppum,0)
errordlg({'Input must an interger'},'modal');
end
ImageDataCell =
{'N','rAcLength','nrAcLength','AcLength','Y1_TnTm','Y2_TnTm','Y3_TnTm','CorrTnTm','CorrTn
Ac','CorrTmAc','Y_IntRed','Y_IntGreen','rAc_CurvIdx','nrAc_CurvIdx','AcT_CurvIdx','X_Leng
th','Ac_Length','rAc_Length','nrAc_Length','rAcLength','nrAcLength','AcLength'};
%% 1. Upload images (R G B)
%
% Get names of image files to be imported
% Select Red images
DiagR = helpdlg('Load Red (Tm) channel images');
uiwait(DiagR);
[FileNameR,PathNameR] = uigetfile({'*.tif;*.tiff','TIFF(*.tif,*.tiff)'},...
'SELECT RED CHANNEL IMAGES','MultiSelect','on');
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cd(PathNameR); PathNameR
% Select Green images
DiagG = helpdlg('Load Green (Tn) channel images');
uiwait(DiagG);
[FileNameG,PathNameG] = uigetfile({'*.tif;*.tiff','TIFF(*.tif,*.tiff)'},...
'SELECT GREEN CHANNEL IMAGES','MultiSelect','on');
%
% Select Blue images
DiagB = helpdlg('Load Blue (Actin) channel images');
uiwait(DiagB);
[FileNameB,PathNameB] = uigetfile({'*.tif;*.tiff','TIFF(*.tif,*.tiff)'},...
'SELECT BLUE CHANNEL IMAGES','MultiSelect','on');
%
if isequal(FileNameB,0)
errordlg({'Cannot continue without specifiying files',...
'Files must be in TIFFF format'},'Software Error','modal');
end
if not(length(FileNameG) == length(FileNameR))
errordlg({'Image color series must have same length'},'modal');
end
%% 2. Catalog all the Images
% Import images into data structure:
cd(PathNameR)
for k = 1:length(FileNameR);
Red(:,:,k) = imread(char(FileNameR(k)));
end
%figure, imshow(Red(:,:,2));
cd(PathNameR)
for k = 1:length(FileNameG);
Green(:,:,k) = imread(char(FileNameG(k)));
end
%figure, imshow(Green(:,:,2));
cd(PathNameR)
for k = 1:length(FileNameB);
Blue(:,:,k) = imread(char(FileNameB(k)));
end
%figure, imshow(Blue(:,:,2));
%% 3. Median filter
% (change to Redu8, Greenu8 or Redu8 to use uint8 images)
MeaFilt = fspecial('average', [3 3]);
for k = 1:length(FileNameR);
Red(:,:,k) = medfilt2(Red(:,:,k),[3 3]);
Red(:,:,k) = imfilter(Red(:,:,k),MeaFilt);
end
%figure, imshow(Redb(:,:,6));
for k = 1:length(FileNameG);
Green(:,:,k) = medfilt2(Green(:,:,k),[3 3]);
Green(:,:,k) = imfilter(Green(:,:,k),MeaFilt);
end
%figure, imshow(Greenb(:,:,6));
for k = 1:length(FileNameB);
Blue(:,:,k) = medfilt2(Blue(:,:,k),[3 3]);
Blue(:,:,k) = imfilter(Blue(:,:,k),MeaFilt);
end
%figure, imshow(Blueb(:,:,6));
%% 4. Pixel Index
cd(CURR_DIRECT)
SLOPE = 0.2;
for k = 1:length(FileNameR); % TmA equals regulated actins
rAcMask(:,:,k) = mask1plusmask2_2(Red(:,:,k),Green(:,:,k),SLOPE,SLOPE);
end
for k = 1:length(FileNameB); % TmA equals regulated actins
AcTMask(:,:,k) = getMask2(Blue(:,:,k),SLOPE);
end
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for k = 1:length(FileNameB) % this is to find the non regualted actins
nrAcMask(:,:,k) =
mask1minusmask2and3(Blue(:,:,k),Red(:,:,k),Green(:,:,k),SLOPE,SLOPE,SLOPE);
end
%% 5. Pixel Listing
for k = 1:length(FileNameR) % for regulated actins
rAcMask_k = rAcMask(:,:,k);
for p=1:rAcMask_k.NumObjects
PixListrAc{p,k} = rAcMask_k.PixelIdxList{p};
end
end
for k = 1:length(FileNameB) % for total actins
AcTMask_k = AcTMask(:,:,k);
for p=1:AcTMask_k.NumObjects
PixListAcTMask{p,k} = AcTMask_k.PixelIdxList{p};
end
end
for k = 1:length(FileNameB)% for non-regulated actins
nrAcMask_k = nrAcMask(:,:,k);
for p=1:nrAcMask_k.NumObjects
PixListnrAc{p,k} = nrAcMask_k.PixelIdxList{p};
end
end
%% 6. Reduced Masks
MIN_VAL = 2; % filaments less or equal are not considered
ReducedListAcT = PixListAcTMask;
for q = 1:length(ReducedListAcT(:,1))
for w = 1:length(ReducedListAcT(1,:))
if length(ReducedListAcT{q,w}) <= MIN_VAL
ReducedListAcT{q,w} = [];
else
end
end
end
ReducedListrAc = PixListrAc;
for q = 1:length(ReducedListrAc(:,1))
for w = 1:length(ReducedListrAc(1,:))
if length(ReducedListrAc{q,w}) <= MIN_VAL
ReducedListrAc{q,w} = [];
else
end
end
end
ReducedListnrAc = PixListnrAc;
for q = 1:length(ReducedListnrAc(:,1))
for w = 1:length(ReducedListnrAc(1,:))
if length(ReducedListnrAc{q,w}) <= MIN_VAL
ReducedListnrAc{q,w} = [];
else
end
end
end
%% 7. Check Images
IMAGE = 1; % select image to display
MAX_NUM = uint16(2^16-1);
color = logical([1 0 0]); % red!
%
R
G
B

Adjust image
= Red(:,:,IMAGE);
= Green(:,:,IMAGE);
= Blue(:,:,IMAGE);

LIM_R = stretchlim(R);
LIM_G = stretchlim(G);
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LIM_B = stretchlim(B);
GammaR = 8;
GammaG = 6;
GammaB = 2;
R = round(imadjust(R,LIM_R,[],GammaR));
G = round(imadjust(G,LIM_G,[],GammaG));
B = round(imadjust(B,LIM_B,[],GammaB));
myRGB = cat(3,R,G,B);
%TotalFilPix = cat(1,ReducedListAcT{:,IMAGE});
RegulatedPix = cat(1,ReducedListrAc{:,IMAGE});
nonRegulatedPix = cat(1,ReducedListnrAc{:,IMAGE});
pr = imposeMask2(myRGB,RegulatedPix,MAX_NUM,color); % regulated filaments
nrpr = imposeMask2(myRGB,nonRegulatedPix,MAX_NUM,color); %non-regulated filaments
%Acpr = imposeMask2(myRGB,TotalFilPix,MAX_NUM,color); %non-regulated filaments
%figure, imshow(myRGB); % shows image without mask!
figure, imshow(pr);
figure, imshow(nrpr);
%figure, imshow(Acpr);
%% 8. Check Image Approach No3
YES = 0;
IMAGE = 1;
if YES
MAX_NUM2 = uint8(255/1);
color2 = logical([1 0 0]);
mask1 = edge(Blue(:,:,IMAGE),'canny',0.15,2);
TotalPix = cat(1,ReducedListrAc{:,IMAGE});
myRGB3 = double(cat(3,mask1,mask1,mask1));
haha = imposeMask2(myRGB3,TotalPix,MAX_NUM2,color2);
figure, imshow(haha);
end
%% 9. Curvefitting Length and area
BINSIZE = 0.2;
NoBINS = BINSIZE:BINSIZE:10;
HrAcy_tot = [];
HAcTy_tot = [];
HnrAcy_tot = [];
LrAc_um3_tot = [];
LAcT_um3_tot = [];
LnrAc_um3_tot = [];
startingVals = [1,100];
for u = 1:length(FileNameR)
ImrAc = ReducedListrAc(:,u); % obtain number of pixels
for n = 1:length(ImrAc);
LrAc(:,n) =length(ImrAc{n});
end
LrAc_um = (LrAc./ppum)';
LrAc_um2 = LrAc_um > 0;% remove fillaments with zero value length
LrAc_um3 = LrAc_um(LrAc_um2);
ImAcT = ReducedListAcT(:,u);
for n = 1:length(ImAcT);
LAcT(:,n) =length(ImAcT{n});
end
LAcT_um = (LAcT./ppum)';
LAcT_um2 = LAcT_um > 0; % remove fillaments with zero value length
LAcT_um3 = LAcT_um(LAcT_um2);
ImnrAc = ReducedListnrAc(:,u);
for n = 1:length(ImnrAc);
LnrAc(:,n) =length(ImnrAc{n});
end
LnrAc_um = (LnrAc./ppum)';
LnrAc_um2 = LnrAc_um > 0; % remove fillaments with zero value length
LnrAc_um3 = LnrAc_um(LnrAc_um2);
% accumulation of filament's length
LrAc_um3_tot(u) = sum(LrAc_um3);
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LAcT_um3_tot(u) = sum(LAcT_um3);
LnrAc_um3_tot(u) = sum(LnrAc_um3);
% histograms
[HrAcy,HrAcx]=hist(LrAc_um3,NoBINS); %figure, hist(LrAc_um3,NoBINS);
[HAcTy,HAcTx]=hist(LAcT_um3,NoBINS); %figure, hist(LAcT_um3,NoBINS);
[HnrAcy,HnrAcx]=hist(LnrAc_um3,NoBINS); %figure, hist(LnrAc_um3,NoBINS);
HrAcy_tot(u,:) = HrAcy;
HAcTy_tot(u,:) = HAcTy;
HnrAcy_tot(u,:) = HnrAcy;
ImageDataCell{u+1,1} = u; % Image Number
end
%% Combiend histograms
HrAcy_sum = sum(HrAcy_tot);
HAcTy_sum = sum(HAcTy_tot);
HnrAcy_sum = sum(HnrAcy_tot);
% Combined lengths
LrAc_um3_sum = sum(LrAc_um3_tot);
LAcT_um3_sum = sum(LAcT_um3_tot);
LnrAc_um3_sum =sum(LnrAc_um3_tot);
% plotting distributions
[FR_rAc,GOF_rAc,OUT_rAc] = fit(HrAcx',HrAcy_sum',fittype( 'exp1' ));
[FR_AcT,GOF_AcT,OUT_AcT] = fit(HAcTx',HAcTy_sum',fittype( 'exp1' ));
[FR_nrAc,GOF_nrAc,OUT_nrAc] = fit(HnrAcx',HnrAcy_sum',fittype( 'exp1' ));
% getting the fit datapoints
coefrAc_vals = FR_rAc(HrAcx);
coefrAcT_vals = FR_AcT(HAcTx);
coefnrAc_vals = FR_nrAc(HnrAcx);
coefrAc_resid = OUT_rAc.residuals;
coefAcT_resid = OUT_AcT.residuals;
coefnrAc_resid = OUT_nrAc.residuals;
% Coefficients
rAc_Ca = FR_rAc.a;
rAc_Cb = FR_rAc.b;
AcT_Ca = FR_AcT.a;
AcT_Cb = FR_AcT.b;
nrAc_Ca = FR_nrAc.a;
nrAc_Cb = FR_nrAc.b;
% Error of the coefficients
FErr_rAc = confint(FR_rAc,0.95);
FErr_AcT = confint(FR_AcT,0.95);
FErr_nrAc = confint(FR_nrAc,0.95);
% Area calculations
FunrAc = @(x) rAc_Ca.*exp(rAc_Cb.*x);%+ rAc_Cc.*exp(rAc_Cd.*x);
FunAcT = @(x) AcT_Ca.*exp(AcT_Cb.*x);% + AcT_Cc.*exp(AcT_Cd.*x);
FunnrAc = @(x) nrAc_Ca.*exp(nrAc_Cb.*x);% + nrAc_Cc.*exp(nrAc_Cd.*x);
ArAc = quad(FunrAc,BINSIZE,max(HrAcx));
AAcT = quad(FunAcT,BINSIZE,max(HAcTx));
AnrAc = quad(FunnrAc,BINSIZE,max(HnrAcx));
% Calculation of TnTm saturation or rAc ratio
% Approach 1: Using the sum of the filament lengths
YrAc_L = LrAc_um3_tot./LAcT_um3_tot;
YnrAc_L = LnrAc_um3_tot./LAcT_um3_tot;
% Approach 2: The areas of rAc relative to the total filaments
YrAc_A1 = ArAc/(AAcT);
YnrAc_A1 = AnrAc/(AAcT);
% Approach 3: The areas of rAc relative to the sume of rAc and nrAc
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YrAc_A2 = ArAc/(ArAc+AnrAc);
YnrAc_A2 = AnrAc/(ArAc+AnrAc);
% Combination of 3 approachces
YrAc = geomean([YrAc_L,YrAc_A1,YrAc_A2]); % geometric mean
YnrAc = geomean([YnrAc_L,YnrAc_A1,YnrAc_A2]); % geometric mean
% Length calculations
Lfit_rAc = abs(1/rAc_Cb);
Lfit_AcT = abs(1/AcT_Cb);
Lfit_nrAc = abs(1/nrAc_Cb);
% Error Length Calculations
LErrfit_rAc = abs(1/(rAc_Cb-abs(FErr_rAc(1,2))));
LErrfit_AcT = abs(1/(AcT_Cb-abs(FErr_AcT(1,2))));
LErrfit_nrAc = abs(1/(nrAc_Cb-abs(FErr_nrAc(1,2))));
for u = 1:length(FileNameR)
ImageDataCell{u+1,2} = Lfit_rAc;
ImageDataCell{u+1,3} = Lfit_nrAc;
ImageDataCell{u+1,4} = Lfit_AcT;
ImageDataCell{u+1,5} = YrAc_L;
ImageDataCell{u+1,6} = YrAc_A1;
ImageDataCell{u+1,7} = YrAc_A2;
end
% 10. Plot curves
X_MAXLIM = 5;
%Y_MAXLIM = 70;
Y_MAXLIM = max([0 max([HrAcy_sum HnrAcy_sum HAcTy_sum])]);
RES_Y_LIM = 28;
figure,
subplot(3,2,1:4);
stairs(HrAcx,HrAcy_sum,'r');
hold on
stairs(HnrAcx,HnrAcy_sum,'b');
stairs(HAcTx,HAcTy_sum,'m');
plot(HrAcx,coefrAc_vals, '--r','Linewidth',2);
plot(HnrAcx,coefnrAc_vals, '--b','Linewidth',2);
plot(HAcTx,coefrAcT_vals, '--m','Linewidth',2);
set(gca,'XTick',[]);
hold off
% set(gca, 'FontName', 'Helvetica');
% set(gca, 'FontSize', 18);
ylabel('Counts')
axis([0 X_MAXLIM 0 Y_MAXLIM])
subplot(3,2, 5:6)
plot(HrAcx,coefrAc_resid,'-r');
hold on
plot(HAcTx,coefAcT_resid,'-m');
plot(HnrAcx,coefnrAc_resid,'-b');
plot([0 X_MAXLIM],[0 0],'-k');
hold off
axis([0 X_MAXLIM -RES_Y_LIM RES_Y_LIM])
ylabel('Residuals');
xlabel('Filament length (\mum)');
daspect([0.023 1 1]) % Adjust the first value to fit both graphs: this is critical
text(2.5,155,[sprintf('<L>_A_c= %0.01f',Lfit_AcT),'\pm',num2str(LErrfit_AcT,'%0.01f'),'
\muM'], 'FontName', 'Helvetica','FontSize',14,'BackgroundColor',[1 0.6 1]);
text(2.5,135,[sprintf('<L>_r_A_c= %0.01f',Lfit_rAc),'\pm',num2str(LErrfit_rAc,'%0.01f'),'
\muM'], 'FontName', 'Helvetica','FontSize',14,'BackgroundColor',[1 0.6 0.6]);
text(2.5,115,[sprintf('<L>_n_r_A_c=
%0.01f',Lfit_nrAc),'\pm',num2str(LErrfit_nrAc,'%0.01f'),' \muM'], 'FontName',
'Helvetica','FontSize',14,'BackgroundColor',[0.6 0.6 1]);
text(2.5,95,sprintf('Y_T_n_T_m= %0.2f',YrAc), 'FontName',
'Helvetica','FontSize',14,'BackgroundColor',[0.5 0.5 0.6]);
ImageDataCell{2,16}
ImageDataCell{2,17}
ImageDataCell{2,18}
ImageDataCell{2,19}

=
=
=
=

HAcTx;
HAcTy_sum;
HrAcy_sum;
HnrAcy_sum;

%% 11. Correlation data
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for u = 1:length(FileNameR);
OrderedPix = cat(1,ReducedListAcT{:,u});
RedI = spreadpointint(Red(:,:,u),OrderedPix);
GreenI = spreadpointint(Green(:,:,u),OrderedPix);
BlueI = spreadpointint(Blue(:,:,u),OrderedPix);
GreenI = GreenI - min(GreenI);
RedI = RedI - min(RedI);
BlueI = BlueI - min(BlueI);

% yeah weird if I don't divide by the min
%there in not much relative change of one
% intensity to the other an the correlation
%is higher.

GreenI_T{u} = GreenI'; % Collection of all green intensities
RedI_T{u} = RedI';
% Collection of all red intensities
BlueI_T{u} = BlueI';
% Collection of all red intensities
GreenxRed = max(abs(xcorr(GreenI,RedI)))/(norm(GreenI,2)*norm(RedI,2));
GreenxBlue = max(abs(xcorr(GreenI,BlueI)))/(norm(GreenI,2)*norm(BlueI,2));
RedxBlue = max(abs(xcorr(RedI,BlueI)))/(norm(RedI,2)*norm(BlueI,2));
ImageDataCell{u+1,8} = GreenxRed;
ImageDataCell{u+1,9} = GreenxBlue;
ImageDataCell{u+1,10} = RedxBlue;
end
%% 12. Binding amount from intensity trajectories
No_BINS = 50;
%IMAGE = 3;
GAUSS = 1; %choose 1 for 2-gaussian curvefit or 0 for 3 gaussian
HisTot_RedCounts = [];
HisTot_GreenCounts = [];
HisTot_BlueCounts = [];
Red_bin_N = [];
Green_bin_N = [];
Blue_bin_N = [];
for IMAGE = 1:length(FileNameR);
Red_Ii = RedI_T{IMAGE};
Green_Ii = GreenI_T{IMAGE};
Blue_Ii = BlueI_T{IMAGE};
Red_Iinorm = Red_Ii/max(Red_Ii);
Green_Iinorm = Green_Ii/max(Green_Ii);
Blue_Iinorm = Blue_Ii/max(Blue_Ii);
[Red_counts,Red_bin] = hist(Red_Iinorm,No_BINS);
[Green_counts,Green_bin] = hist(Green_Iinorm,No_BINS);
[Blue_counts,Blue_bin] = hist(Blue_Iinorm,No_BINS);
Iinorm_List{IMAGE,1} = Red_Iinorm;
Iinorm_List{IMAGE,2} = Green_Iinorm;
Iinorm_List{IMAGE,3} = Blue_Iinorm;
HisTot_RedCounts(:,IMAGE) = Red_counts';
HisTot_GreenCounts(:,IMAGE) = Green_counts';
HisTot_BlueCounts(:,IMAGE) = Blue_counts';
%end
OptionsG1 = fitoptions('gauss1');
OptionsG1.Lower = [0 0 0];
OptionsG1.Upper = [10e5 1 1];
OptionsG1.Robust = 'off';
OptionsG2 = fitoptions('gauss2');
OptionsG2.Lower = [0 0 0 0 0.15 0];
OptionsG2.Upper = [10e5 0.3 0.15 10e5 1 1];
OptionsG2.Robust = 'off';
OptionsG3 = fitoptions('gauss3');
OptionsG3.Lower = [0 0 0 0 0.15 0 0 0 0 ];
OptionsG3.Upper = [10e5 0.5 1 10e5 0.15 1 10e5 1 1 ];
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OptionsG3.Robust = 'off';
if GAUSS
FIT_RED = fit(Red_bin',HisTot_RedCounts(:,IMAGE),'gauss2',OptionsG2);
FIT_GREEN = fit(Green_bin',HisTot_GreenCounts(:,IMAGE),'gauss2',OptionsG2);
FIT_BLUE = fit(Blue_bin',HisTot_BlueCounts(:,IMAGE),'gauss1',OptionsG1);
else
FIT_RED = fit(Red_bin',HisTot_RedCounts(:,IMAGE),'gauss3',OptionsG3);
FIT_GREEN = fit(Green_bin',HisTot_GreenCounts(:,IMAGE),'gauss3',OptionsG3);
FIT_BLUE = fit(Blue_bin',HisTot_BlueCounts(:,IMAGE),'gauss1',OptionsG1);
end
Coef_RED = coeffvalues(FIT_RED);
Coef_GREEN = coeffvalues(FIT_GREEN);
Coef_BLUE = coeffvalues(FIT_BLUE);
if GAUSS
% separate the 2 gussian equations
EQN1_RED = @(x) Coef_RED(1)*exp(-((x-Coef_RED(2))/Coef_RED(3)).^2);
EQN2_RED = @(x) Coef_RED(4)*exp(-((x-Coef_RED(5))/Coef_RED(6)).^2);
% get the area ratios of the 2nd gaussian divided by the 2-gaussian area
A_EQN1_RED = quad(EQN1_RED,0,max(Red_bin));
A_EQN2_RED = quad(EQN2_RED,0,max(Red_bin));
% Condition to divide the area of bigger mean relative to the total
if Coef_RED(6) > Coef_RED(3)
A_ratio_RED = A_EQN2_RED./(A_EQN1_RED+A_EQN2_RED);
else
A_ratio_RED = A_EQN1_RED./(A_EQN1_RED+A_EQN2_RED);
end
% separate the 2 gussian equations
EQN1_GREEN = @(x) Coef_GREEN(1)*exp(-((x-Coef_GREEN(2))/Coef_GREEN(3)).^2);
EQN2_GREEN = @(x) Coef_GREEN(4)*exp(-((x-Coef_GREEN(5))/Coef_GREEN(6)).^2);
% get the area ratios of the 2nd gaussian divided by the 2-gaussian area
A_EQN1_GREEN = quad(EQN1_GREEN,0,max(Red_bin));
A_EQN2_GREEN = quad(EQN2_GREEN,0,max(Red_bin));
% Condition to divide the area of bigger mean relative to the total
% use the std(sigma) since one peak is wider
if Coef_GREEN(6) > Coef_GREEN(3)
A_ratio_GREEN = A_EQN2_GREEN./(A_EQN1_GREEN+A_EQN2_GREEN);
else
A_ratio_GREEN = A_EQN1_GREEN./(A_EQN1_GREEN+A_EQN2_GREEN);
end
else
% separate
EQN1_RED =
EQN2_RED =
EQN3_RED =

the 3 gussian equations
@(x) Coef_RED(1)*exp(-0.5*((x-Coef_RED(2))/Coef_RED(3)).^2);
@(x) Coef_RED(4)*exp(-0.5*((x-Coef_RED(5))/Coef_RED(6)).^2);
@(x) Coef_RED(7)*exp(-0.5*((x-Coef_RED(8))/Coef_RED(9)).^2);

% separate
EQN1_GREEN
EQN2_GREEN
EQN3_GREEN

the 3 gussian equations
= @(x) Coef_GREEN(1)*exp(-0.5*((x-Coef_GREEN(2))/Coef_GREEN(3)).^2);
= @(x) Coef_GREEN(4)*exp(-0.5*((x-Coef_GREEN(5))/Coef_GREEN(6)).^2);
= @(x) Coef_GREEN(7)*exp(-0.5*((x-Coef_GREEN(8))/Coef_GREEN(9)).^2);

% get the area ratios of the 3rd gaussian divided by the 3-gaussian area
A_EQN1_RED = quad(EQN1_RED,0,max(Red_bin));
A_EQN2_RED = quad(EQN2_RED,0,max(Red_bin));
A_EQN3_RED = quad(EQN3_RED,0,max(Red_bin));
% Condition to divide the area of bigger mean relative to the total
if Coef_RED(2) > ( Coef_RED(5) & Coef_RED(8) )
A_ratio_RED = A_EQN1_RED./(A_EQN1_RED+A_EQN2_RED+A_EQN3_RED);
elseif Coef_RED(5) > ( Coef_RED(8) & Coef_RED(2) )
A_ratio_RED = A_EQN2_RED./(A_EQN1_RED+A_EQN2_RED+A_EQN3_RED);
else
A_ratio_RED = A_EQN3_RED./(A_EQN1_RED+A_EQN2_RED+A_EQN3_RED);
end
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% get the area
A_EQN1_GREEN =
A_EQN2_GREEN =
A_EQN3_GREEN =

ratios of the 3rd gaussian divided by the 3-gaussian area
quad(EQN1_GREEN,0,max(Red_bin));
quad(EQN2_GREEN,0,max(Red_bin));
quad(EQN3_GREEN,0,max(Red_bin));

% Condition to divide the area of bigger mean relative to the total
if Coef_GREEN(2) > ( Coef_GREEN(5) & Coef_GREEN(8) )
A_ratio_GREEN = A_EQN1_GREEN./(A_EQN1_GREEN+A_EQN2_GREEN+A_EQN3_GREEN);
elseif Coef_GREEN(5) > ( Coef_GREEN(8) & Coef_GREEN(2) )
A_ratio_GREEN = A_EQN2_GREEN./(A_EQN1_GREEN+A_EQN2_GREEN+A_EQN3_GREEN);
else
A_ratio_GREEN = A_EQN3_GREEN./(A_EQN1_GREEN+A_EQN2_GREEN+A_EQN3_GREEN);
end
end % from the gauss...
% get the datapoints of the curvefitting
DatapointsFIT_Red(:,IMAGE) = feval(FIT_RED,Red_bin'); % Red is 1
DatapointsFIT_Green(:,IMAGE) = feval(FIT_GREEN,Green_bin'); % Green is 2
DatapointsFIT_Blue(:,IMAGE) = feval(FIT_BLUE,Blue_bin'); % Blue is 3
% Normalized histograms
DatapointsFIT_Red_N(:,IMAGE) =
DatapointsFIT_Red(:,IMAGE)/max(DatapointsFIT_Red(:,IMAGE));
DatapointsFIT_Green_N(:,IMAGE) =
DatapointsFIT_Green(:,IMAGE)/max(DatapointsFIT_Green(:,IMAGE));
DatapointsFIT_Blue_N(:,IMAGE) =
DatapointsFIT_Blue(:,IMAGE)/max(DatapointsFIT_Blue(:,IMAGE));
Hist_Counts_Red_N(:,IMAGE) = HisTot_RedCounts(:,IMAGE)./max(DatapointsFIT_Red(:,IMAGE));
Hist_Counts_Green_N(:,IMAGE) =
HisTot_GreenCounts(:,IMAGE)./max(DatapointsFIT_Green(:,IMAGE));
Hist_Counts_Blue_N(:,IMAGE) =
HisTot_BlueCounts(:,IMAGE)./max(DatapointsFIT_Blue(:,IMAGE));
Red_bin_N(:,IMAGE) = Red_bin/max(Red_bin);
Green_bin_N(:,IMAGE) = Green_bin/max(Green_bin);
Blue_bin_N(:,IMAGE) = Blue_bin/max(Blue_bin);
end
% Save in matrix
%ImageDataCell{1+1,11} = A_ratio_RED; % RED
%mageDataCell{1+1,12} = A_ratio_GREEN; % GREEN
%end
IMAGE = 2;
%
%% to check each gaussian curve %
%plot(Red_bin,EQN1_GREEN(Red_bin),'r');
%hold on
%plot(Red_bin,EQN2_GREEN(Red_bin),'g');
%plot(EQN3_GREEN(Red_bin),'b');
%
%% to check curvefitting %
figure,stairs(Red_bin_N(:,IMAGE),Hist_Counts_Red_N(:,IMAGE),'r');
hold on
plot(Red_bin_N(:,IMAGE),DatapointsFIT_Red_N(:,IMAGE),'k'); %ylim([0 100])
legend off
figure,stairs(Green_bin_N(:,IMAGE),Hist_Counts_Green_N(:,IMAGE),'g');
hold on
plot(Green_bin_N(:,IMAGE),DatapointsFIT_Green_N(:,IMAGE),'k'); %ylim([0 100]);
legend off
%figure,stairs(Blue_bin,Hist_Counts_Blue,'b');
%hold on
%plot(FIT_BLUE,'k'); %ylim([0 100])
%legend off
%%
%Gridss = ReducedListAcT(:,3);
%%
%for i = iFIL:fFIL
%

step = length(Gridss{3,:})
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%
Lines = [i,1:0.1:10];
%end
%% 13. Intensity plots
YES = 1;
if YES
IMAGE = 1;
iFIL = 1; % initial filament
fFIL = 600; % final filament
x_axis = (1:length(Iinorm_List{IMAGE,1}))/ppum; % all colors measure =
RedIN = Iinorm_List{IMAGE,1};
GreenIN = Iinorm_List{IMAGE,2};
BlueIN = Iinorm_List{IMAGE,3};
Hmax_plot =
max([HisTot_RedCounts(:,IMAGE);HisTot_GreenCounts(:,IMAGE);HisTot_BlueCounts(:,IMAGE)]);
figure,
% Intensity trarjectories
subplot(3,4,[1,2,3]);
plot(x_axis(iFIL:fFIL),RedIN(iFIL:fFIL),'r');
set(gca,'XTickLabel',{''}); ylim([0 1]); ylabel({'Tm norm.';'intensity'});
axis fill;
subplot(3,4,[5,6,7]);
plot(x_axis(iFIL:fFIL),GreenIN(iFIL:fFIL),'g');
set(gca,'XTickLabel',{''}); ylim([0 1]); ylabel({'Tn norm.';'intensity'});
axis fill;
subplot(3,4,[9,10,11]);
plot(x_axis(iFIL:fFIL),BlueIN(iFIL:fFIL),'b');
xlabel('Filament coordinate (\mum)'); ylabel({'Ac norm.';'intensity'});
ylim([0 1]); axis fill;
% histograms
subplot(3,4,[4]);
barh(Red_bin,Hist_Counts_Red_N(:,IMAGE),'r','EdgeColor','r');
hold on
plot(DatapointsFIT_Red_N(:,IMAGE),Red_bin_N,'-k'); %xlim([0 Hmax_plot]);
set(gca,'XTickLabel',{''}); set(gca,'YTickLabel',{''}); axis fill;
xlim([0 1]);
text(0.1*Hmax_plot,0.85,['Y=',num2str(ImageDataCell{1+1,11},'%1.2f')],'FontSize',18);
hold off
subplot(3,4,[8]);
barh(Green_bin,Hist_Counts_Green_N(:,IMAGE),'g','EdgeColor','g');
hold on
plot(DatapointsFIT_Green_N(:,IMAGE),Green_bin_N,'-k'); %xlim([0 Hmax_plot]);
set(gca,'XTickLabel',{''}); set(gca,'YTickLabel',{''}); axis fill;
xlim([0 1]);
text(0.1*Hmax_plot,0.85,['Y=',num2str(ImageDataCell{1+1,12},'%1.2f')],'FontSize',18);
hold off
subplot(3,4,[12]);
barh(Blue_bin,Hist_Counts_Blue_N(:,IMAGE),'b','EdgeColor','b');
hold on
plot(DatapointsFIT_Blue_N(:,IMAGE),Blue_bin,'-k'); %xlim([0 Hmax_plot]);
xlim([0 1]);
xlabel('Norm. counts'); set(gca,'YTickLabel',{''}); axis fill;
hold off
end
%% 14. Curvature
rAc_curvature = [];
mean_rAc_curvature = [];
for u = 1:length(FileNameR)
for f = 1:length(ReducedListrAc(:,u));
FILrAc = [];
rAc_curvature_u = [];
rAc_curvature_u2 = [];
FILrAc = ReducedListrAc{f,u};

164
if numel(FILrAc) > 0;% removes small filaments
IND = [FILrAc(1);FILrAc(end)];
[I,J] = ind2sub(size(Red(:,:,1)),IND);
Distance = (((I(2)-I(1)))^2 + ((J(2)-J(1)))^2)^0.5;
Length = length(FILrAc);
rAc_curvature(f,u) = Length./Distance;
else
end
end
rAc_curvature_u = rAc_curvature(:,u) >0;
rAc_curvature_u2 = rAc_curvature(rAc_curvature_u,u);
mean_rAc_curvature = mean(rAc_curvature_u2);
ImageDataCell{u+1,13} = mean_rAc_curvature';
end
nrAc_curvature = [];
mean_nrAc_curvature = [];
for u = 1:length(FileNameR)
for f = 1:length(ReducedListnrAc(:,u));
FILnrAc = [];
nrAc_curvature_u = [];
nrAc_curvature_u2 = [];
FILnrAc = ReducedListnrAc{f,u};
if numel(FILnrAc) > 0;% removes small filaments
IND = [FILnrAc(1);FILnrAc(end)];
[I,J] = ind2sub(size(Red(:,:,1)),IND);
Distance = (((I(2)-I(1)))^2 + ((J(2)-J(1)))^2)^0.5;
Length = length(FILnrAc);
nrAc_curvature(f,u) = Length./Distance;
else
end
end
nrAc_curvature_u = nrAc_curvature(:,u) >0;
nrAc_curvature_u2 = nrAc_curvature(nrAc_curvature_u,u);
mean_nrAc_curvature = mean(nrAc_curvature_u2);
ImageDataCell{u+1,14} = mean_nrAc_curvature';
end
AcT_curvature = [];
mean_AcT_curvature = [];
for u = 1:length(FileNameR)
for f = 1:length(ReducedListAcT(:,u));
FILAcT = [];
AcT_curvature_u = [];
AcT_curvature_u2 = [];
FILAcT = ReducedListAcT{f,u};
if numel(FILAcT) > 0;% removes small filaments
IND = [FILAcT(1);FILAcT(end)];
[I,J] = ind2sub(size(Red(:,:,1)),IND);
Distance = (((I(2)-I(1)))^2 + ((J(2)-J(1)))^2)^0.5;
Length = length(FILAcT);
AcT_curvature(f,u) = Length./Distance;
else
end
end
AcT_curvature_u = AcT_curvature(:,u) >0;
AcT_curvature_u2 = AcT_curvature(AcT_curvature_u,u);
mean_AcT_curvature = mean(AcT_curvature_u2);
ImageDataCell{u+1,15} = mean_AcT_curvature';
end
CURV_rAC = ImageDataCell(:,13);
CURV_nrAC = ImageDataCell(:,14);
CURV_AcT = ImageDataCell(:,15);
figure,
boxplot([cell2mat(CURV_rAC(2:length(FileNameR)+1)),cell2mat(CURV_nrAC(2:length(FileNameR)
+1)),cell2mat(CURV_AcT(2:length(FileNameR)+1))],'labels',{'rAc','nrAc','AcT'});
ylabel('Curvature Index');
%ylim([1 1.6]);
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A.5.2 Stochastic simulation of Tn-Tm binding to F-actin
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
%
% Stochastic Tn-TM bindign simulation %
%
%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
%
%
%
%
%
%
%
%

FILENAME: simulation_stoch_2.m, First Created on October 2013
DESCRIPTION: Simulation of a two-compoent reaction with a compoent being
a lattice
Tested with Matlab R2011b
Christopher Solis, South Dakota State University, updated July 2016
BEFORE WE BEGIN

% BEGIN
clear all;
clc;
PathName = pwd;
%Constants
TIME = 40;
NN = 100;
k_on = 120000;
k_off = 1;
sigma = 1; % when there is cooperativity sigma>1;
Totbins = round(logspace(1,3,NN));
ReservoirN = round(logspace(0,3,NN));
%
% Generate random filament lengths following an exponential distribution
Pn = rand(Totbins(end),1);
n_mu = 40;
ni = round(-n_mu.*log(Pn));
%% Matrix
Ym = [];
Free_Bm = [];
InteractConts = [];
for N = 1:NN
AB_save = [];
Free_B = [];
NUMBINS = Totbins(N);
ReservoirB = ReservoirN(N); % number of free particles of A.
ReservoirB_t = ReservoirB;
A = zeros(1,NUMBINS); % filament length
AB_save(1,:) = A;
% Select the location of the divisions in the filament template NUMBINS
DIVS1 = 1;
DIVS2 = 1;
Count = 1;
if ni(1) >NUMBINS
DIVS1 = 1;
else
while DIVS2(end)<NUMBINS
DIVS1 = DIVS2;
DIVS2 = [DIVS2;sum(ni(1:Count))];
Count = Count+1;
end
end
for i=1:TIME;
r=rand(1,NUMBINS);
for j=1:NUMBINS
if A(1,j) == 0 % JUMP ON
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if r(1,j)<k_on*(ReservoirB_t)*((NUMBINS-sum(A)));
A(1,j) = 1;
end
else % % JUMP OFF
num_contacts = 0;
if j > 1% not left edge
if ismember(j,DIVS1)
else
num_contacts = num_contacts + A(j-1);
end
end
if j< NUMBINS % not right edge
if ismember(j,DIVS1-1)
else
num_contacts = num_contacts + A(j+1);
end
end
k_off_eff = k_off*((1/sigma)^num_contacts);
if r(1,j)<k_off_eff
A(1,j) = 0;
end
end
end
% recycled variables
ReservoirB_t = ReservoirB - sum(A); % Current cocnetration of A
AB_save(i,:) = A;
Free_B(i) = ReservoirB_t;
end
%saved variables
VALUES = round(0.05*TIME);
Ym(N) = mean(sum(AB_save(TIME-VALUES:TIME,:),2))/NUMBINS;
Free_Bm(N) = mean(Free_B(TIME-VALUES:TIME));
CC = [];
CC = bwconncomp(AB_save(TIME,:));
LL = []; % Length determination!
for k = 1:length(CC.PixelIdxList);
LL(k) = length(CC.PixelIdxList{k});
end
Length(N) = mean(LL(LL>1));
InteractConts(N,:) = [sum(LL(LL==1))./NUMBINS sum(LL(LL==2))./NUMBINS
sum(LL(LL>2))./NUMBINS];
Percent = N*100/NN
end
%%
UNIT = 10000;
X_DAT = Free_Bm/UNIT;
Y_DAT = Ym;
%plot(Free_Bm,Ym,'.k')
%semilogx(X_DAT,Y_DAT,'.k');
HILL = 1;
if HILL
X_DAT2 = logspace(log10(min(X_DAT)),log10(max(X_DAT)),100);
Options = statset('Robust','on','MaxIter',100);
HillModel = @(p,x) p(1) + p(2).*((x.^p(3))./(p(4)+(x.^p(3))));
startingVals = [0.2, 1.9, 1,1E-5];
[coefEsts,Resid,Jacobian] = nlinfit(X_DAT(5:end),Y_DAT(5:end), HillModel,
startingVals,Options);
CurvData = HillModel(coefEsts,X_DAT2);
CoeffErr = nlparci(coefEsts,Resid,'jacobian',Jacobian,'alpha',0.32);
Kd = coefEsts(4); % as M
Kd2 = Kd*1E6; % as uM
Kd_Err = CoeffErr(4,2)-Kd;
Kd_Err2 = Kd_Err*1E6;
n = coefEsts(3);
nErr = CoeffErr(3,2)-n;
%s = fitoptions('Method','NonlinearLeastSquares',...
%
'Lower',[0,0,0,1E-8],...
%
'Upper',[10,10,4,1E-2],...
%
'Startpoint',[0, 1, 1,1E-3]);
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%f = fittype('a + b*((x^c)/(d+x^c))','options',s);
%[c2,gof2] = fit(X_DAT',Y_DAT',f);
fig1 = figure(1);
semilogx(X_DAT,Y_DAT,'.k','Linewidth',2,'MarkerSize',20);% DATA
hold on
semilogx(X_DAT2,CurvData,'-k','Linewidth',4);% CURVEFIT
%plot(((0.5*coefEsts(2)*coefEsts(4)1.5*coefEsts(1)*coefEsts(4))/(0.5*coefEsts(2)+1.5*coefEsts(1)))^(1/coefEsts(3)),coefEsts(
2)/2,'*g')
%legend('location', 'NorthWest');
%ylim([0 1]);
%plot(X_DAT,c2(X_DAT))
axis([1E-8 1E-5 -0.01 1]);
hold off
xlabel('Free Tn concetration (M)');
ylabel('\theta_{Tn-Tpm}');
text(1.5*min(X_DAT(1)),0.95*max(CurvData),[sprintf('Kd =
%0.3f',Kd2),'\pm',num2str(Kd_Err2,'%0.3f'),' \muM'], 'FontName',
'Helvetica','FontSize',18,'BackgroundColor',[1 1 1]);
text(1.5*min(X_DAT(1)),0.75*max(CurvData),[sprintf('n =
%0.1f',n),'\pm',num2str(nErr,'%0.1f')], 'FontName',
'Helvetica','FontSize',18,'BackgroundColor',[1 1 1]);
end
axis square
%% Plot length
fig2 = figure(2);
DO = 1;
if DO
plot(X_DAT,Length./max(Length),'.k','MarkerSize',20);
set(gca,'Xscale','log');
xlabel('Free Tn-Tm concetration (M)');
ylabel('Normalized lenght'); % normalized length of continour ligand-bound regions
xlim([1E-8,1E-5]);
%ylim([0 1])
%ylim([-0.01 1]);
axis square
end
%% Types of bindign interactions
% Isolated Tn-Tpm bindign events versus contigous Tn-Tpm binding events
fig3 =figure(3);
plot(X_DAT,InteractConts(:,3),'.','Color',[0 0 0],'MarkerSize',20)% loooks better as blue
though
hold on
plot(X_DAT,InteractConts(:,1),'o','Color',[0.5 0.5
0.5],'LineWidth',1.5,'MarkerSize',7,'MarkerEdgeColor','k','MarkerFaceColor',[1 1 1])%
loooks better as blue though
plot(X_DAT,InteractConts(:,2),'.','Color',[0.5 0.5 0.5],'MarkerSize',20);% loooks better
as continous red though

set(gca,'XScale','log');
axis([1E-8 1E-5 0 1]);
hold off
xlabel('Free Tn concetration (M)');
ylabel('Probability of interactions'); % normalized length of continour ligand-bound
regions
LEG = legend('Contigous, two sides','Contigous, one side','Isolated');
set(LEG,'Box','off','Location','NorthWest');
set(LEG,'Location','NorthWest');
set(LEG,'FontSize',20);
axis square
% Areas under the curve
A1 = trapz(X_DAT,InteractConts(:,1));
A2 = trapz(X_DAT,InteractConts(:,2));
A3 = trapz(X_DAT,InteractConts(:,3));
A1p = 100*A1./sum([A1 A2 A3]); % Percent of 1-side interactions
A2p = 100*A2./sum([A1 A2 A3]); % Percent of 0-side interactions
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A3p = 100*A3./sum([A1 A2 A3]); % Percent of 2-side interactions
A_weight = 1*A1p/100 + 0*A2p/100 + 2*A3p/100; % Average number of interactions
%% Binding Constnat
%Teoretical
%Kb_0 = k_on./k_off
%Esperimental
%A_eq = (NUMBINS - sum(mean(A_save(TIME-VALUES:TIME,:))))/VOLUME;
%B_eq = (mean(Free_B(TIME-VALUES:TIME)))/VOLUME;
%AB_eq = (sum(mean(A_save(TIME-VALUES:TIME,:))))/VOLUME
%Kb = AB_eq/(A_eq*B_eq)
%Kd = 1/Kb
%% Save data into data file
%
Choice = questdlg('Save data?', 'Save3','Yes','No','No');
switch Choice
%
case 'Yes'
Msg = msgbox('Select destination','Destination Folder','help');
uiwait(Msg);
folder_name = uigetdir(PathName,'Select Folder'); % select folder
print(fig1,'-depsc2', '-painters', [folder_name,'/','_BindCurv','.eps']);
print(fig2,'-depsc2', '-painters', [folder_name,'/','_Length','.eps']);
print(fig3,'-depsc2', '-painters', [folder_name,'/','_Ratios','.eps']);
disp('Data saved');
case 'No'
disp('Data was not saved');
end
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A.5.3 Kalman filter algorithm

%
% ===============================================
% KALMAN FILTERING ALGORITHM 2D MOVING PARTICLES
% ===============================================
%
% Version 1.3
%
%Edited by Christpher Solis-Ocampo
% South Dakota State University
% Oct 26 2015
%
clear all;
close all;
clc;
%
% BEGIN
%% 1. Default Font Parameters
GraphDef.FontSize = 24;
GraphDef.FontName = 'Helvetica';
GraphDef.MarkerSize = 10;
GraphDef.LineWidth = 2;
%% 2. Load files
% Select filament coordinate files
[FileName,PathName] = uigetfile({'*.txt','Text(*.txt)'},...
'Select Filament Coordinates file','MultiSelect','on');
% becuase the number of headerlines in a 'Molecule' is 2, 'Filament' is 3
if isequal('Filament',FileName{1}(1:8));
HLines = 3;
else
HLines = 2;
end
% Load data
for k = 1:length(FileName);
data_i = importdata([PathName,FileName{k}], '\t',HLines);
BigData(k) = data_i;
end
time = cell(length(FileName),1);
x_position = cell(length(FileName),1);
y_position = cell(length(FileName),1);
for k = 1:length(FileName);
% load time
time_i = [];
time_i = BigData(k).data(:,2);
time{k} = time_i;
% load x
x_pos_i = [];
x_pos_i = BigData(k).data(:,3);
x_position{k} = x_pos_i;
% load y
y_pos_i = [];
y_pos_i = BigData(k).data(:,4);
y_position{k} = y_pos_i;
end
%% 3. Define Constnats and vector parameters
% Input constants
Prompt = {'Filament No:','Initial speed (nm/s):'...
,'Proc noise mag(\sigma_{Q}):',...
'Measurement noise mag (\sigma_{R})'};
dlg_title = 'Define filter parameters';
num_lines = [1, length(dlg_title)+70]; % makes box width larger
DefAns = {'1','0.1','1.0','0.08'};
Options.Resize='on';
Options.WindowStyle='modal';
Options.Interpreter='tex';

170
Answer = inputdlg(Prompt,dlg_title,num_lines,DefAns,Options);
%
filament = str2num(Answer{1}); % filament/track to analyze
v_0 = str2num(Answer{2});
% initial velocity (um/sec)
Q_mag = str2num(Answer{3});
% Measuremtn noise magnitude
R_mag = str2num(Answer{4});
% Process noise magnitude
CM_idxnm = [x_position{filament} y_position{filament}];
CM_idx = CM_idxnm./1000; % convert to microns/sec
timeF = time{filament};
dt = diff(timeF); % creating time intervals
dt = [min(dt);dt]; %hist(dt);% ideally dt is one single value but not so
LFile = length(CM_idx(:,1));
x_k0 = [CM_idx(1,1); CM_idx(1,2); v_0; v_0]; %initized state--it has four components:
[positionX; positionY; velocityX; velocityY]
x_k = x_k0; %estimate of initial location estimation of where the hexbug is (what we are
updating)
A = [];
C = [ 1 0 0 0; ...
0 1 0 0];
Ex = [];
Ez = [ 1 0 ; ...
0 1 ].*R_mag^2;
%
for t = 1:LFile
dti = dt(t);
A(:,:,t) = [ 1
0
0
1
0
0
0
0
Ex(:,:,t) = [ dti^4/4
0
0
0

dti
0
1
0

0
dti
0
1

0
dti^4/4
0
0

;
;
;
];

...
...
...
...

0
0
dti^2
0

0
0
0
dti^2

; ...
; ...
; ...
].*Q_mag^2;

end
% initize estimation variables
z_k = []; % Theestimated state
x_k_xest = []; % X-position estimate
x_k_yest = []; % Y-position estimate
x_k_Vxest = []; % X-velocity estimate
x_k_Vyest = []; % Y-velocity estimate
Vx_obs = [];
% X-velocity observed
Vy_obs = [];
% Y-velocity observed
Vxy_obs = [];
P = Ex(:,:,1);
Inres = [];
% Run Kalman filter
% to save the animation as a .avi file
%aviobj = avifile([PathName,FileName{filament}(1:end4),'_original.avi'],'compression','None');
aviobj = avifile([PathName,FileName{filament}(1:end4),'Q',num2str(Q_mag,'%0.2f'),'_original.avi'],'compression','None');
fig = figure;
%t = 1;
for t = 1:LFile
dti = dt(t);
% load the given tracking
z_k(:,t) = [ CM_idx(t,1); CM_idx(t,2)];
% Predict next state of the particle with the last state and predicted motion.
x_k = A(:,:,t) * x_k ;
%predict next covariance
P = A(:,:,t) * P * A(:,:,t)' + Ex(:,:,t);
% Inovation residuals
Inresi = z_k(:,t) - C*x_k;
Inres = [Inres;Inresi];
% predicted measurement covariance

171
% Kalman Gain
K = P*C'*inv(C*P*C'); % Riccati equation
% Update the state estimate.
if ~isnan(z_k(:,t))
x_k = x_k + K * (z_k(:,t) - C);
end
% update covariance estimation.
P = (eye(4)-K*C)*P;
% Measured
if t == 1;
Vx_obs(t)
Vy_obs(t)
else
Vx_obs(t)
Vy_obs(t)
end

velocity
= v_0;
= v_0;
= diff(CM_idx(t-1:t,1))./dti;
= diff(CM_idx(t-1:t,2))./dti;

Vxy_obs(t) = (Vx_obs(t).^2 + Vy_obs(t).^2).^0.5;
%velx_measureddat =
[velx_measureddat; Vx_obs];
%vely_measureddat =
[vely_measureddat; Vy_obs];
% Store data
x_k_xest = [x_k_xest; x_k(2)];
x_k_yest = [x_k_yest; x_k(1)];
x_k_Vxest = [x_k_Vxest; x_k(4)];
x_k_Vyest = [x_k_Vyest; x_k(3)];
Velxy_estimate = (x_k_Vxest.^2+x_k_Vyest.^2).^0.5;
% plot the images with the tracking
subplot(211),
plot(CM_idx(:,2),CM_idx(:,1),'.k','MarkerSize',GraphDef.MarkerSize)
set(fig,'Color',[1 1 1]);
hold on;
plot(x_k_xest(1:t),x_k_yest(1:t),'r','LineWidth',GraphDef.LineWidth);
plot(z_k(2,t),z_k(1,t),'*k','MarkerSize',GraphDef.MarkerSize); % the actual tracking
plot(x_k(2),x_k(1),'or','MarkerSize',GraphDef.MarkerSize); % the kalman filtered
tracking
axis fill
axis([0.95*min(CM_idx(:,2)) 1.05*max(CM_idx(:,2)) 0.95*min(CM_idx(:,1))
1.05*max(CM_idx(:,1))]);
%axis([19 21 22 24]);
%axis([min(CM_idx(:,2)) max(CM_idx(:,2)) min(CM_idx(:,1)) max(CM_idx(:,1))]);
xlabel('x-position
(\mum)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
ylabel('y-position
(\mum)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
%L1 = legend('track','measured position','estimated
position','Location','NorthWest');
%set(L1,'PlotBoxAspectRatio',[7 2.5 1])
set(gca,'PlotBoxAspectRatio',[16 9 1])
hold off
subplot(212),
plot(timeF(1:t)-timeF(1),Vxy_obs(1:t),'k'); % t0 is shifted to t0 = 0;
hold on
plot(timeF(1:t)-timeF(1),Velxy_estimate(1:t),'r'); %t0 is shifted to t0 = 0;
axis fill
axis([timeF(1)-timeF(1) timeF(end)-timeF(1) 0 5]);
%axis([timeF(1)-timeF(1) timeF(end)-timeF(1) 0 5]); % t0 is shifted to t0 = 0;
%axis([timeF(1)-timeF(1) timeF(end)-timeF(1) 0 max(Vxy_obs)]); % t0 is shifted to t0
= 0;
xlabel('Time (s)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
ylabel('Speed (\mum/s)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
%L2 = legend('measured velocity','estimated velocity','Location','NorthWest');
%set(L2,'PlotBoxAspectRatio',[9 2.5 1])
set(gca,'PlotBoxAspectRatio',[16 9 1])
hold off
%pause(0.00001)
F = getframe(fig);
aviobj = addframe(aviobj,F);
PP(t) = P(1,1);
end
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%close(fig);
aviobj = close(aviobj);
%Velxy_estimate = ((velx_estimate).^2+(vely_estimate).^2).^0.5;
%% Fourier transform on the velocities
FFT_Vobs = abs(fft(Vxy_obs));
FFT_Vest = abs(fft(Velxy_estimate));
Limit = round(0.5*length(Vxy_obs));
plot(FFT_Vobs(1:Limit),'r');
hold on
plot(FFT_Vest(1:Limit),'b');
hold off
xlabel('Frecuency (AU)');
ylabel('Amplituce (AU)');
legend('Observed speed','Estiamted speed')
%% 5. Mean Squared Displacement (MSD)
YES = 1;
if YES
MyColormap = jet(length(FileName));
figure,
%MSD = msd(x_position{k},y_position{k},time{k});
RMSD1 = rmsd(CM_idx(:,1),CM_idx(:,2),time{filament});
RMSD2 = rmsd(x_k_xest,x_k_yest,time{filament});
%
%AA =fit(RMSD1(:,1),RMSD1(:,2),'poly1');
%BB =fit(RMSD2(1:Lim,1),RMSD2(1:Lim,2),'poly1');
%CC =fit(RMSD2(Lim+1:end,1),RMSD2(Lim+1:end,2),'poly1');
plot(RMSD1(:,1),RMSD1(:,2),'r');
hold on
plot(RMSD2(:,1),RMSD2(:,2),'b');
%plot(RMSD1(:,1),AA(RMSD1(:,1)),'--k')
%plot(RMSD2(1:Lim+1,1),BB(RMSD2(1:Lim+1,1)),'--k')
%plot(RMSD2(Lim-1:end,1),CC(RMSD2(Lim-1:end,1)),'--k')
ylabel('MSD (\mum^2)');
%ylabel('RMSD (\mum)');
xlabel('Lag time (s)');
%set(gca,'XScale','log','YScale','log');
%ylim([0 3]);
end
%% 6. Plot Covariance
figure,
plot(PP); PP(end)
xlabel('Time (s)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
ylabel('Covariance (AU)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
%
%% 7. Autocorrelation of innovation residuals
% This is the autocorrelation of measured and predicted residuals (
Inresx = Inres(1:2:end);
InvRes = [];
InvRes = x_k_xest - z_k(2,:)';
[AA,Lags] = xcorr(InvRes,'coeff');
BB = fftshift(AA);
CC = flipud(BB);
LagLimit = 0.5*(length(AA)-1);
stem(timeF(1:5:LagLimit),CC(1:5:LagLimit),'LineWidth',GraphDef.LineWidth,'MarkerSize',Gra
phDef.MarkerSize);
xlabel('Lag time (s)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
ylabel({'Autocorrelation of','innovation
residuals'},'FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
%axis([0 timeF3(LagLimit) 1.3*min(CC) 1.1*max(CC)]);
% Histogram of autocorrelation
%sigma_AA = std(AA);
%[DD,EE] = hist(AA,30);
%stairs(EE,DD);
%xlabel({'Autocorrelation of','innovation
residuals'},'FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
%ylabel('Counts','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
%axis([-4*sigma_AA 4*sigma_AA 0 1.1*max(DD)]);
%
%% Histogram innovation residuals
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[CC BB] = hist(InvRes);
MeanInres = mean(InvRes)
Skewness = skewness(InvRes)
subplot(1,3,1:2)
plot(timeF,InvRes);
xlim([timeF(1) timeF(end)]);
xlabel('Time step (s)');
ylabel('Residual (\mum)');
subplot(1,3,3)
H = barh(BB,CC,'hist');
set(H,'EdgeColor','none');
set(gca,'YTickLabel','');
xlabel('Counts')
pbaspect([1 1.4 1 ])
%
%% 8. Plot Histogram and Curvefit
[Counts,Bins] = hist(Velxy_estimate,30);
X_Data = Bins';
Y_Data = Counts';
X_Data2 = 0:0.1*dti:max(X_Data);
fig2 = figure;
stairs(X_Data,Y_Data);
hold on
% Y/N question, Select curvefitting type
%Choice = questdlg('Select curve fitting model', ...
% 'Speed Distribution Curve Fitting', ...
% 'Gaussian','2-Gaussian','3-Gaussian','Gamma','default');
NameFit = {'Gaussian','2-Gaussian','3-Gaussian','Gamma'};
[Choice,OK] = listdlg('PromptString','Select a file:',...
'SelectionMode','single',...
'ListString',NameFit);
% Handle response/Begin Curve fitting
CurvFit = [];
Y_DataFit = [];
switch NameFit{Choice}
case 'Gaussian'
disp('Gaussian Distribution');
% Gaussian Curve fitting
Options = fitoptions('gauss1');
Options.Lower = [0 0 0];
CurvFit = fit(X_Data,Y_Data,'gauss1',Options);
MeanVal = CurvFit.b1;
Y_DataFit = CurvFit(X_Data2);
case '2-Gaussian'
disp('Gaussian Distribution');
% 2-Gaussian Curve fitting
Options = fitoptions('gauss2');
Options.Lower = [0 0 0 0 0 0];
CurvFit = fit(X_Data,Y_Data,'gauss2',Options);
F1 = @(x) CurvFit.a1.*exp(-((x-CurvFit.b1)./CurvFit.c1).^2);
F2 = @(x) CurvFit.a2.*exp(-((x-CurvFit.b2)./CurvFit.c2).^2);
A1 = quad(F1,X_Data2(1),X_Data2(end));
A2 = quad(F2,X_Data2(1),X_Data2(end));
%MeanVal = (CurvFit.b1*A1+CurvFit.b2*A2)/(A1+A2);
MeanVal = (CurvFit.b1.^2*A1+CurvFit.b2.^2*A2)/(CurvFit.b1*A1+CurvFit.b2*A2);
Y_DataFit = CurvFit(X_Data2);
case '3-Gaussian'
disp('Gaussian Distribution');
% 3-Gaussian Curve fitting
Options = fitoptions('gauss3');
Options.Lower = [0 0 0 0 0 0 0 0 0];
CurvFit = fit(X_Data,Y_Data,'gauss3',Options);
MeanVal = CurvFit.b1;
F1 = @(x) CurvFit.a1.*exp(-((x-CurvFit.b1)./CurvFit.c1).^2);
F2 = @(x) CurvFit.a2.*exp(-((x-CurvFit.b2)./CurvFit.c2).^2);
F3 = @(x) CurvFit.a3.*exp(-((x-CurvFit.b3)./CurvFit.c3).^2);
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A1 = quad(F1,X_Data2(1),X_Data2(end));
A2 = quad(F2,X_Data2(1),X_Data2(end));
A3 = quad(F3,X_Data2(1),X_Data2(end));
%MeanVal = (CurvFit.b1*A1+CurvFit.b2*A2+CurvFit.b3*A3)/(A1+A2+A3);
MeanVal =
(CurvFit.b1.^2*A1+CurvFit.b2.^2*A2+CurvFit.b3.^2*A3)/(CurvFit.b1*A1+CurvFit.b2*A2+CurvFit
.b3*A3);
%INTERESTING....!
Y_DataFit = CurvFit(X_Data2);
case 'Gamma'
disp('Gamma Distribution');
% Gamma PDF Curve fitting
Func = @(a,x) (x.^(a(1)-1).*exp(-x./a(2)))./(gamma(a(1)).*a(2).^a(1));
%beta0 = [1 1];
beta0 = gamfit(Y_Data);
CurvFit = nlinfit(X_Data,Y_Data,Func,beta0);
Y_DataFit = gampdf(X_Data2,CurvFit(1),CurvFit(2));
MeanVal = CurvFit(1)*CurvFit(2);
end
plot(X_Data2,Y_DataFit,'-','Color',[1,0,0]);
xlabel('Speed (\mum/s)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
ylabel('Counts','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
text(0.96*min(X_Data),1.1*max(Y_Data),['\mu_v = ',num2str(MeanVal,'%0.3f'),'
\mum/s'],'FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
xlim([0 1.1*max(X_Data)]);
ylim([0 1.2*max(Y_Data)]);
hold off
folder_name = uigetdir(PathName,'Select Destination Folder');
saveas(fig2,[PathName,FileName{filament}(1:end-4),'.eps'])
close(fig2)
%% 6. 2D velocity Histogram
%%plot(velx_real,vely_real,'.k')
%[NN,CC] = hist3([Vx_obs' Vy_obs'],[20 20]);
%figure,
%surf(CC{2},CC{1},NN)
%axis([min(CC{2}) max(CC{2}) min(CC{1}) max(CC{1})])
%xlabel('x-velocity (\mum)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
%ylabel('y-velocity (\mum)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
%zlabel('Counts (AU)','FontSize',GraphDef.FontSize,'FontName',GraphDef.FontName);
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A.5.4 FLIM data analysis

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
%
%
FLIM CURVE FITTING
%
%
%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
% FILENAME: FLIM_curve_fit_v1.m, First created on January 31, 2015
%
% DESCRIPTION: This script allows to obtain FLIM images and curve fitting
%
of fluorescence decay curves
%
%
% INPUT FILES: .dat files (PicoHarp, PicaoQuant)
%
% OUTPUT FILES
%
% INSTRUCTIONS: Load fLuorescence data and IRF
%
% Tested with Matlab R2011b
% Christopher Solis-Ocampo
%South Dakota State University
%
%
%UPDATES
% BarLocations was added to resize locations of ticks on FLIM colorbar
%
%
clear all;
close all;
clc;
%BEGIN
%% 1. Default Font Parameters
GraphDef.FontSize = 30;
GraphDef.FontSize2 = 24;
GraphDef.FontName = 'Helvetica';
GraphDef.MarkerSize = 10;
GraphDef.LineWidth = 2;
%
%% 2. Load files
% Select filament coordinate files
[FileName,PathName] = uigetfile({'*.dat','Data(*.dat)'},...
'Select FLIM file','MultiSelect','off');
DELIMITER = ' ';% delimiter is a space in this case
HEADERLINES = 8;
HEADERLINES2 = 209;
% Import the file
newData1 = importdata([PathName,FileName], DELIMITER, HEADERLINES);
newData2 = importdata([PathName,FileName], DELIMITER, HEADERLINES2);
%
FileInt = newData1.data;
Filelifet = newData2.data;
%
%%
% Choose IRF file
Choice = questdlg('Load IRF?', 'IRF','Yes','No','No');
switch Choice
case 'Yes'
DELIMITER2 = '\t';
HEADERLINES2 = 0;
disp(['IRF loaded']);
[FileName2,PathName2] = uigetfile({'*.dat;*txt','Data(*.dat)';
'*.txt','Text(*.txt)'},'FLIM data file');
IRF = importdata([PathName2,FileName2], DELIMITER2, HEADERLINES2);
meanIRF = sum(IRF(1:300,1).*IRF(1:300,2))/sum(IRF(1:300,2));
[Dy Dx] = max(diff(IRF(:,2)));
IRF_tau = meanIRF - IRF(Dx,1);
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%semilogy(IRF(:,1),IRF(:,2));
case 'No'
IRF = 0;
disp(['IRF not loaded']);
IRF_tau = 0;
end
%
%%
%FLT_T = [];
%IntTot = reshape(FileInt,1,[]);
%FltTot = reshape(Filelifet,1,[]);
%Bins = 500;
%[AA,BB] = hist(IntTot,Bins);
%figure,semilogy(BB,AA); xlabel('Intensity');ylabel('Number of pixels');
%[CC,DD] = hist(FltTot,Bins);
%figure,semilogy(DD,CC); xlabel('Lifetime');ylabel('Number of pixels');
%xlim([-2 8]);
%%
%for k = 1:length(IntTot);
%
FLT_i = FltTot(k)*ones(IntTot(k),1);
%
FLT_T = [FLT_T;FLT_i];
%end
%% 3. Intensity image
%
INT_min = min(min(FileInt));
INT_max = max(max(FileInt));
INT_range = INT_max - INT_min;
FileInt_norm = round(FileInt*255/INT_range - INT_min);
FileImg = cat(3,FileInt_norm,FileInt_norm,FileInt_norm);
GammaAdj = 1.1;
FileImg_adjust = imadjust(uint8(FileImg),[0 0.4],[],GammaAdj);
%
%figure, image(uint8(FileImg_adjust));
%daspect([1 1 1]);
%colormap(gray(256));
%title('Intensity map');
%
%% 4. Lifetime image
%
LT_colorrange = [2.5 3.5];
ColRange = LT_colorrange(1):1:LT_colorrange(2);
%LT_colorrange = [0 6];
qlvl = 32; % color levels
Colormap_LT = jet(qlvl);
Filelifet_ed = Filelifet;
Filelifet_min = Filelifet_ed < LT_colorrange(1);
Filelifet_ed(Filelifet_min) = LT_colorrange(1);
Filelifet_max = Filelifet_ed > LT_colorrange(2);
Filelifet_ed(Filelifet_max) = LT_colorrange(2);
Filelifet_ed = uint8((Filelifet_ed - LT_colorrange(1))*(qlvl-1)/range(LT_colorrange));
%
Filelifet_3 = zeros([size(Filelifet),3]);
%
for I = 1:size(Filelifet,1);
for J = 1:size(Filelifet,2);
IDX = Filelifet_ed(I,J)+1;
RGB = cat(3,Colormap_LT(IDX,1),Colormap_LT(IDX,2),Colormap_LT(IDX,3));
Filelifet_3(I,J,:) = RGB;
end
end
%
%interval = ceil(max(LT_colorrange)/qlvl);
%ColorLabels = min(LT_colorrange):interval:max(LT_colorrange);
%
%interval = ceil(max(LT_colorrange)/4);
interval = (max(LT_colorrange) - min(LT_colorrange))/4;
ColorLabels = min(LT_colorrange):interval:max(LT_colorrange);
FileImgLT = uint8(double(FileImg_adjust).*Filelifet_3);
BarLocations = round((ColorLabels-min(ColorLabels))*(qlvl-1)/(max(ColorLabels)min(ColorLabels)));
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fig1 = figure(1);
image(FileImgLT);
daspect([1 1 1]);
colormap(jet(numel(ColorLabels)));
caxis([1 9])
Colbar =
colorbar('YTickLabel',ColorLabels,'location','EastOutside','PlotBoxAspectRatio',[1 17
1]);
colormap(jet(qlvl));
set(Colbar,'YTickMode','manual');
set(Colbar,'YTick',BarLocations);
%set(Colbar,'YTickMode','manual');
%axis off
title('Lifetime (ns)','Rotation',90,'Position',[size(Filelifet,1)+40,0.5*size(Filelifet,1)]);
axis off
%
%% 5. Binarization
FileImS = medfilt2(FileInt, [3 3]);
FileIm_BWlow = FileImS > 1;
%FileIm_BWhigh = FileImS < 0.99*max(max(FileImS));
FileIm_BWhigh = FileImS < 1.1*max(max(FileImS));
FileIm_BW = logical(FileIm_BWlow.*FileIm_BWhigh);
FileIm_BW = FileImS > 40;
SizeThresh = 50;
CC = bwconncomp(FileIm_BW);
numPixels = cellfun(@numel,CC.PixelIdxList);
[~,Col] = find(numPixels < SizeThresh);
for c = 1:numel(Col)
Idx = Col(c);
FileIm_BW(CC.PixelIdxList{Idx}) = 0;
end
%imshow(FileIm_BW)
%daspect([2 1 1]);
figure(2), image(FileIm_BW); colormap(gray(2));
title('Binary map');
daspect([1 1 1]);
axis off;
%
% 6. Expand data points
%
FLT = Filelifet(FileIm_BW);
INT = FileInt(FileIm_BW);
%
CountsINT = round(reshape(INT,1,[]));
FLT_T = [];
%
for k = 1:length(INT);
FLT_i = [];
FLT_i = FLT(k)*ones(INT(k),1);
FLT_T = [FLT_T;FLT_i];
end
%
% % lifetime hist for those outside the filaments
%
%FLT2 = Filelifet(combo_XOR);
%INT2 = FileInt(combo_XOR);
%FLT_T2 = [];
%for k = 1:length(INT2);
%
FLT_i = [];
%
FLT_i = FLT2(k)*ones(INT2(k),1);
%
FLT_T2 = [FLT_T2;FLT_i];
%end
%
% 7. PLot Lifetime histogram within filaments
Bins =100;
[CC,BB] = hist(reshape(FLT_T,1,[]),Bins);
%bb = 0:0.2:10;
%cc = spline(BB,CC,bb);
ff = fit(BB',CC','gauss1');
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fig3 = figure(3),
FWHM = fwhm(BB',CC');
%[EE,DD] = hist(reshape(FLT_T2,1,[]),Bins);
%plot(DD,EE,'-k');
%hold on
plot(BB,CC,'-k');
hold on
plot(ff,'r');
legend off
hold off
xlabel('Lifetime (ns)');
ylabel('Counts (AU)');
%axis([min(BB) max(BB) min(CC) 5*max(CC)]);
axis fill
xlim([0 10]);
ylim([0 1.3*max(CC)]);
text(2.0*abs(min(BB)),1.2*max(CC),['Arrival time =',num2str(ff.b1,'%0.2f'),'
ns'],'FontSize',GraphDef.FontSize2,'FontName',GraphDef.FontName);
text(2.0*abs(min(BB)),1.0*max(CC),['Counts per pix
=',num2str(mean(INT),'%0.0f')],'FontSize',GraphDef.FontSize2,'FontName',GraphDef.FontName
);
if IRF_tau>0
text(2.0*abs(min(BB)),1.1*max(CC),['<\tau >=',num2str(ff.b1-IRF_tau,'%0.2f'),'
ns'],'FontSize',GraphDef.FontSize2,'FontName',GraphDef.FontName);
end
text(2.0*abs(min(BB)),0.9*max(CC),['FWHM =',num2str(FWHM,'%0.2f'),'
ns'],'FontSize',GraphDef.FontSize2,'FontName',GraphDef.FontName);
%text(20.5*abs(min(BB)),0.95*max(CC),['< \tau >=',num2str(mean(FLT_T2),'%0.2f'),'
ns'],'FontSize',30);
%
%% 8 .Lifetime In and Out
FileIm_BWN = logical(ones(size(FileIm_BW))-FileIm_BW);
FLT_BKD = Filelifet(FileIm_BWN);
Bins =100;
[EE,DD] = hist(reshape(FLT_BKD(FLT_BKD>0),1,[]),Bins);
[GG,FF] = hist(reshape(FLT,1,[]),Bins);
%bb = 0:0.2:10;
%cc = spline(BB,CC,bb);
fig3 = figure(4);
%[EE,DD] = hist(reshape(FLT_T2,1,[]),Bins);
%plot(DD,EE,'-k');
%hold on
plot(DD,EE/max(EE),'-k');
hold on
plot(FF,GG/max(GG),'-r');
%plot(IRF(1:300,1),IRF(1:300,2)/max(IRF(1:300,2)),'-b')
legend off
hold off
text(4.5,0.95,['Arrival time In =',num2str(mean(FLT),'%0.2f'),'
ns'],'FontSize',GraphDef.FontSize2,'FontName',GraphDef.FontName);
text(4.5,0.85,['Arrival time Out =',num2str(mean(FLT_BKD(FLT_BKD>0)),'%0.2f'),'
ns'],'FontSize',GraphDef.FontSize2,'FontName',GraphDef.FontName);
%set(gca,'YScale','log');
xlabel('Lifetime (ns)');
ylabel('Normalized counts (AU)');
%axis([min(BB) max(BB) min(CC) 5*max(CC)]);
axis fill

